List of life saving transplantations

We securely store stem cells for each individual family. These always remain the property of the family and are released exclusively for their own medical treatments.

In addition, the FamiCord Group is also active in the field of donations: through our international network of transplant centers, more than 7’000 patients have already been successfully treated with stem cells from the group’s laboratories – using both family-owned stem cells (“related”) and voluntarily donated stem cells (“unrelated”).

The list shows the source of the stem cells, the diagnoses they were used for, and much more.

 

List of treatments with stem cell samples released by the FamiCord Group laboratories:

Lp.SourceSource typeDiagnosisMedicine AreaApplication yearTherapyCountryRecipient age
1Cord TissueAllogeneic - Related Chronic renal disease Endocrinology2025Experimental TherapyRomania50
2Cord TissueAllogeneic - RelatedAutismNeurology2025Experimental TherapyRomania6
3Cord TissueAutologousAutismNeurology2025Experimental TherapyRomania6
4Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2025Experimental TherapyPoland57,2
5Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland3,1
6Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland3,4
7Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland2,8
8Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland5,9
9Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland11,9
10Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedics2025Experimental TherapyPoland54,2
11Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedics2025Experimental TherapyPoland78,4
12Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland6,8
13Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedics2025Experimental TherapyPoland58,2
14Cord TissueAutologousAutismNeurology2025Experimental TherapyRomania5
15Cord TissueAllogeneic - RelatedAutismNeurology2025Experimental TherapyRomania5
16Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland4,1
17Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland7,9
18Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland7,8
19Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2025Experimental TherapyPoland25,8
20Cord BloodAllogeneic - RelatedThalassemia MajorHematology2025Standard TherapyTurkey5,9
21Cord BloodAutologousAplastic AnemiaHematology2025Standard TherapyPoland2
22Cord BloodAllogeneic - RelatedThalassemia MajorHematology2025Standard TherapyTurkey6,8
23Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2025Experimental TherapyPortugal1 year and 8 months
24Cord BloodAutologousAutismNeurology2025Experimental TherapyRomania5
25Cord BloodAllogeneicAcute lymphoblastic leukemiaHematology2025Standard TherapyPoland13
26Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland5 ,5
27Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland7,2
28Cord BloodAllogeneicThalassemia MajorHematology2025Standard TherapyTurkey10,9
29Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland4,1
30Bone Marrow FamilyAllogeneicMyelofibrosisHematology2025Standard TherapyPoland71
31Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUnited Kingdom72
32Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance47
33Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUkraine43
34Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly49
35Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance51
36Bone Marrow FamilyAllogeneicPhiladelphia - positive Acute Lymphoblastic LeukemiaHematology2025Standard TherapyGermany61
37Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance58
38Bone Marrow FamilyAllogeneicMyelofibrosisHematology2025Standard TherapyNETHERLANDS63
39Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland65
40Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyFrance63
41Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland68
42Bone Marrow FamilyAllogeneicMyelofibrosisHematology2025Standard TherapyFrance71
43Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyRussia51
44Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany62
45Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCzechia54
46Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUnited Kingdom16
47Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA61
48Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyPoland61
49Bone MarrowAllogeneicAplastic AnemiaHematology2025Standard TherapySpain15
50Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyNorway55
51Bone MarrowAllogeneicInherited Immune System DisorderHematology2025Standard TherapyFrance3
52Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA7
53Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyUkraine36
54Bone MarrowAllogeneicInherited Immune System DisorderHematology2025Standard TherapyFrance10
55Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA76
56Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland39
57Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySouth Africa6
58Bone MarrowAllogeneicWiskott-Aldrich syndromeHematology2025Standard TherapyTurkey6
59Bone MarrowAllogeneicCombined immnunodeficiencyHematology2025Standard TherapyUkraine3 months
60Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2025Standard TherapyPoland3
61Bone MarrowAllogeneicMixed Phenotype Acute LeukemiaHematology2025Standard TherapyPoland13
62Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland7
63Bone MarrowAllogeneicB-cell precursor Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland56
64Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland43
65Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland19
66Bone MarrowAllogeneicVery Severe Aplastic AnemiaHematology2025Standard TherapyPoland12
67Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland5
68Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland10 months
69Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland6
70Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland44
71Bone MarrowAllogeneicParoxysmal Nocturnal HemoglobinuriaHematology2025Standard TherapyPoland25
72Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2025Standard TherapyPoland4
73Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyUSA21
74Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly12
75Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyHungary10
76Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCzechia68
77Bone MarrowAllogeneicAdrenoleukodystrophyHematology2025Standard TherapyPoland53
78Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyGermany4
79Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyFrance4
80Bone MarrowAllogeneicParoxysmal Nocturnal HemoglobinuriaHematology2025Standard TherapyNorway18
81Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapySpain24
82Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyBelarus5
83Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyGermany53
84Bone MarrowAllogeneicdiamond-Balckfan anemiaHematology2025Standard TherapyGermany11
85Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland57
86Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland61
87ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany58
88ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA34
89ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly61
90ApheresisAllogeneicMyelodysplastic Syndrome/Myeloproliferative neoplasmHematology2025Standard TherapyNETHERLANDS62
91ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyAustria68
92ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany70
93ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany66
94ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA77
95ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUkraine12
96ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany58
97ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA67
98ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland4
99ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyUSA73
100ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany56
101ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly50
102ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland39
103ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyLithuania43
104ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyPoland66
105ApheresisAllogeneicMultiple MyelomaHematology2025Standard TherapyUSA61
106ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyAustria55
107ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly69
108ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyDenmark 67
109ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUnited Kingdom75
110ApheresisAllogeneicT - cell Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland24
111ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyBelgium68
112ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUkraine42
113ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA50
114ApheresisAllogeneicProlymphocytic LeukemiaHematology2025Standard TherapyUSA62
115ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUnited Kingdom62
116ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyUSA69
117ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany85
118ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA54
119ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyUSA39
120ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany45
121ApheresisAutologousAcute myeloid leukemiaHematology2025Standard TherapyGermany59
122ApheresisAllogeneicMultiple myelomaHematology2025Standard TherapyGermany68
123ApheresisAllogeneicMultiple myelomaHematology2025Standard TherapyGermany68
124ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany73
125ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany66
126ApheresisAutologousAcute myeloid leukemiaHematology2025Standard TherapyGermany69
127ApheresisAutologousHodgkin lymphomaHematology2025Standard TherapyGermany38
128ApheresisAllogeneicTcell acute leukemiaHematology2025Standard TherapyRomania31
129ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly37
130ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySweden69
131ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA55
132ApheresisAllogeneicFanconi's AnemiaHematology2025Standard TherapyRussia14
133ApheresisAllogeneicPeripheral T-cell Lymphoma not otherwise specifiedHematology2025Standard TherapyGermany54
134ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance63
135ApheresisAllogeneicMyeloid SarcomaHematology2025Standard TherapyPoland48
136ApheresisAllogeneicOther Myelofibrosis/MyelosclerosisHematology2025Standard TherapyUSA72
137ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyGermany11
138ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA37
139ApheresisAllogeneicMyelofibrosisHematology2025Standard TherapyAustralia59
140ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA35
141ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland51
142ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany59
143ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland70
144ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA70
145ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA66
146ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany63
147ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany66
148ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyItaly61
149ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA71
150ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2025Standard TherapyCzechia45
151ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyBrazil61
152ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyHungary35
153ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyNETHERLANDS48
154ApheresisAllogeneicMantle Cell LymphomaHematology2025Standard TherapyIreland62
155ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland62
156ApheresisAllogeneicAcute Myeloid Leukemia, Myelodysplasia-RelatedHematology2025Standard TherapyRussia53
157ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany56
158ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyUSA68
159ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany70
160ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany62
161ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany53
162ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany52
163ApheresisAutologousDiffuse large B-cell lymphomaHematology2025Standard TherapyGermany63
164ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany72
165ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany64
166ApheresisAllogeneicAcute myeloid leukemiaHematology2025Standard TherapyGermany74
167ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyGermany65
168ApheresisAllogeneicT-cell prolymphocytic leukemiaHematology2025Standard TherapyGermany53
169ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany70
170ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany61
171ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland54
172ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland41
173ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland32
174ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland72
175ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyPoland52
176ApheresisAllogeneicChronic Myeloid LeukemiaHematology2025Standard TherapyPoland50
177ApheresisAllogeneicT-cell Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland17
178ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland66
179ApheresisAllogeneicMultiple Myeloma Hematology2025Standard TherapyPoland49
180ApheresisAllogeneicChronic Granulomatous DiseaseHematology2025Standard TherapyPoland5
181ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland55
182ApheresisAllogeneicDiffuse Large B-cell LymphomaHematology2025Standard TherapyPoland68
183ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland64
184ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland51
185ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland58
186ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland65
187ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland61
188ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland65
189ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland19
190ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland65
191ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2025Standard TherapyPoland47
192ApheresisAllogeneicPolycythemia VeraHematology2025Standard TherapyPoland61
193ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland56
194ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland53
195ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland55
196ApheresisAllogeneicMyelodysplastic Syndrome, Myeloproliferative NeoplasmsHematology2025Standard TherapyPoland34
197ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland50
198ApheresisAllogeneicMyelodysplastic DisordersHematology2025Standard TherapyPoland71
199ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyPoland64
200ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland54
201ApheresisAutologousNon-Hodgkin lymphomaHematology2025Standard TherapyGermany50
202ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany50
203ApheresisAllogeneicAcute myeloid leukemiaHematology2025Standard TherapyGermany35
204ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany54
205ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany52
206ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany61
207ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany55
208ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany64
209ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany68
210ApheresisAllogeneicPrimary myelofibrosisHematology2025Standard TherapyGermany71
211ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany47
212ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany58
213ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany68
214ApheresisAutologousNo dataHematology2025Standard TherapyPortugal44
215ApheresisAutologousNo dataHematology2025Standard TherapyPortugal59
216ApheresisAutologousLymphomaHematology2025Standard TherapyPortugal58
217ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySweden59
218ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland2
219ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA41
220ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyFrance48
221ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySweden64
222ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUnited Kingdom63
223ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance64
224ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA58
225ApheresisAllogeneicMyelodysplastic Syndrome, Myeloproliferative NeoplasmsHematology2025Standard TherapyPoland68
226ApheresisAllogeneicMyelodysplastic Syndrome, Myeloproliferative NeoplasmsHematology2025Standard TherapyGermany59
227ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland56
228ApheresisAllogeneicDiffuse Large B-cell LymphomaHematology2025Standard TherapyBelarus53
229ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA60
230ApheresisAllogeneicImmunodeficiency – LRBAHematology2025Standard TherapyTurkey14
231ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyPoland20
232ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA65
233ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUkraine54
234ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA75
235ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA58
236ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland48
237ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland37
238ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyChile40
239ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany72
240ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySwitzerland65
241ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyPortugal68
242ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyEstonia9
243ApheresisAllogeneicHodgkin LymphomaHematology2025Standard TherapyUSA63
244ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySweden67
245ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyLithuania45
246ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland59
247ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland69
248ApheresisAutologousT-cell lymphomaHematology2025Standard TherapyGermany64
249ApheresisAllogeneicAcute lymphoblastic leukemiaHematology2025Standard TherapyGermany42
250ApheresisAutologousPrimary central nervous system lymphomaHematology2025Standard TherapyGermany64
251ApheresisAllogeneicmyelodysplastic syndrome/ Acute myeloid leukemiaHematology2025Standard TherapyGermany62
252ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany42
253ApheresisAutologousT-cell lymphomaHematology2025Standard TherapyGermany55
254ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany72
255ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany58
256ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany65
257ApheresisAutologousFollicular lymphomaHematology2025Standard TherapyGermany67
258ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany70
259ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany60
260ApheresisAutologousNo DataHematology2025Standard TherapyPortugal64
261ApheresisAutologousNo DataHematology2025Standard TherapyPortugal63
262ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany67
263ApheresisAutologousAcute myeloid leukemiaHematology2025Standard TherapyGermany60
264ApheresisAutologousHodgkin lymphoma rezidivHematology2025Standard TherapyGermany65
265ApheresisAutologousNon-Hodgkin lymphomaHematology2025Standard TherapyGermany64
266ApheresisAutologousT-cell lymphomaHematology2025Standard TherapyGermany67
267ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany70
268ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany62
269ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany62
270ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany66
271ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA55
272ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland60
273ApheresisAllogeneicFanconi's AnemiaHematology2025Standard TherapyUkraine6
274ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA69
275ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyLithuania54
276ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyMacedonia56
277ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyCROATIA64
278ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA75
279ApheresisAllogeneicT-cell LymphomaHematology2025Standard TherapyNETHERLANDS65
280ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland65
281ApheresisAllogeneicMyeloid SarcomaHematology2025Standard TherapyBrazil48
282ApheresisAllogeneicT-cell Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland17
283ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyUnited Kingdom13
284ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyUSA69
285ApheresisAllogeneicT-cell Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland13
286ApheresisAllogeneicB-cell precursor Acute Lymphoblastic LeukemiaHematology2025Standard TherapySlovakia67
287ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA72
288ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly52
289ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyBelgium64
290ApheresisAllogeneicMyelofibrosisHematology2025Standard TherapyItaly68
291ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyCanada56
292ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA64
293ApheresisAllogeneicOther Myelofibrosis/MyelosclerosisHematology2025Standard TherapyUSA55
294ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA64
295ApheresisAllogeneicMyelodysplastic disorderHematology2025Standard TherapyFrance63
296ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany63
297ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA20
298ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance23
299ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA73
300ApheresisAllogeneicInherited Immune System DisorderHematology2025Standard TherapyFrance9
301ApheresisAllogeneicLymphoma - DLBCLHematology2025Standard TherapyUnited Kingdom55
302ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany61
303ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyLithuania58
304ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyGermany73
305ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland35
306Cord TissueAutologousAutismNeurology2024Experimental TherapyRomania6
307Cord TissueAllogeneic - RelatedAutismNeurology2024Experimental TherapyRomania6
308Cord TissueAutologousAutismNeurology2024Experimental TherapyRomania4
309Cord TissueAllogeneic - RelatedAutismNeurology2024Experimental TherapyRomania6
310Cord TissueAllogeneic - UnrelatedDegenerative and Traumatic CartilageOrthopedy2024Experimental TherapyPoland50,3
311Cord TissueAllogeneic - UnrelatedDegenerative and Traumatic CartilageOrthopedy2024Experimental TherapyPoland49,5
312Cord TissueAllogeneic - UnrelatedDegenerative and Traumatic CartilageOrthopedy2024Experimental TherapyPoland58,11
313Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2024Experimental TherapyPoland7,7
314Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2024Experimental TherapyPoland15,7
315Cord TissueAllogeneic - UnrelatedOvarian DysfunctionGynecology2024Experimental TherapyPoland48,1
316Cord TissueAllogeneic - RelatedSevere Pulmonary Hypertension +Mitral RegurgitationCardiovascular/Pulmonary2024Experimental TherapyRomania2,6
317Cord TissueAllogeneic - UnrelatedAmyotrophic lateral sclerosisNeurology2024Experimental TherapyPoland57,6
318Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2024Experimental TherapyPoland68,2
319Cord TissueAllogeneic - RelatedAutismNeurology2024Experimental TherapyRomania17
320Cord TissueAutologousAutismNeurology2024Experimental TherapyRomania7
321Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2024Experimental TherapyPoland61,9
322Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2024Experimental TherapyPoland45,4
323Cord TissueAllogeneic - UnrelatedAmyotrophic lateral sclerosisNeurology2024Experimental TherapyPoland56,9
324Cord TissueAllogeneic - UnrelatedGraft-versus-host diseaseHematology2024Experimental TherapyPoland0,10
325Cord TissueAllogeneic - UnrelatedAmyotrophic lateral sclerosisNeurology2024Experimental TherapyPoland39,0
326Cord TissueAllogeneic - UnrelatedGvHDNeurology2024Experimental TherapyPoland9,2
327Cord TissueAllogeneic - UnrelatedCerebral palsyNeurology2024Experimental TherapyPoland5,11
328Cord TissueAllogeneic - UnrelatedCerebral palsyNeurology2024Experimental TherapyPoland13,10
329Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2024Experimental TherapyPoland1,9
330Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2024Experimental TherapyPoland7,11
331Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2024Experimental TherapyPoland1
332Cord TissueAllogeneic - UnrelatedCerebellar-spinal ataxiaNeurology2024Experimental TherapyPoland35,5
333Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2024Experimental TherapyPoland1,9
334Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2024Experimental TherapyPoland4,5
335Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania11
336Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania10
337Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania6
338Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania4
339Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania5
340Cord BloodAllogeneicCerebral PalsyNeurology2024Experimental TherapyPoland3,5
341Cord BloodAllogeneicCerebral PalsyNeurology2024Experimental TherapyPoland7,7
342Cord BloodAutologousCPNeurology2024Experimental TherapyHungary4
343Cord BloodAutologousPervasive Developmental DisorderNeurology2024Experimental TherapyPoland3,7
344Cord BloodAutologousPervasive Developmental DisorderNeurology2024Experimental TherapyPoland5,9
345Cord BloodAutologousPervasive developmental disorderNeurology2024Experimental TherapyPoland4,8
346Cord BloodAllogeneic - Relatedfanconi aplastic anemiaHematology2024Standard TherapyTurkey12
347Cord BloodAutologousNeuroblastomaNeurology2024Standard TherapyPoland4
348Cord BloodAutologousPervasive developmental disorderNeurology2024Experimental TherapyPoland9,9
349Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
350Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland70
351Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland75
352Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland56
353Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland23
354Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland54
355Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
356Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland70
357Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland65
358Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland48
359Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany72
360Bone Marrow FamilyAllogeneicChronic Lymphocytic Leukemia Richter TransformationHematology2024Standard TherapyPoland55
361Bone Marrow FamilyAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland63
362Bone Marrow FamilyAllogeneicFollicular LymphomaHematology2024Standard TherapyPoland48
363Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland65
364Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany58
365Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland70
366Bone Marrow FamilyAllogeneicMyelodysplastic Syndrome - Refractory Cytopenia Of ChildhoodHematology2024Standard TherapyPoland14
367Bone Marrow FamilyAllogeneicMyelodysplastic Syndrome/ Myeloproliferative NeoplasmsHematology2024Standard TherapyGermany61
368Bone Marrow FamilyAllogeneicMyelodysplastic Syndrome-MPNHematology2024Standard TherapyPoland71
369Bone Marrow FamilyAllogeneicMyelofibrosisHematology2024Standard TherapyPoland68
370Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyPoland64
371Bone Marrow FamilyAllogeneicPolycythemia Vera/MyelofibrosisHematology2024Standard TherapyPoland74
372Bone Marrow FamilyAllogeneicPrimary MyelofibrosisHematology2024Standard TherapyGermany62
373Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland68
374Bone Marrow FamilyAllogeneicmyelodysplasiaHematology2024Standard TherapyUnited Kingdom57
375Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany69
376Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA58
377Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA60
378Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland71
379Bone Marrow FamilyAllogeneicHigh risk Myelodysplastic SyndromeHematology2024Standard TherapyGermany69
380Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA74
381Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland15
382Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland8
383Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland12
384Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland8
385Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland52
386Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland57
387Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland66
388Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland5
389Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland54
390Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland56
391Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland3
392Bone MarrowAllogeneicAdrenoleukodystrophyHematology2024Standard TherapyPoland7
393Bone MarrowAllogeneicAdrenoleukodystrophyHematology2024Standard TherapyPoland7
394Bone MarrowAllogeneicAdrenoleukodystrophyHematology2024Standard TherapyPoland9
395Bone MarrowAllogeneicB-Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland7
396Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2024Standard TherapyPoland4
397Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2024Standard TherapyPoland41
398Bone MarrowAllogeneicChronic Lymphocytic Leukemia Richter TransformationHematology2024Standard TherapyPoland55
399Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland67
400Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland12
401Bone MarrowAllogeneicDiffuse Large B-Cell LymphomaHematology2024Standard TherapyPoland61
402Bone MarrowAllogeneicGenetically Determined ThrombocytopeniaHematology2024Standard TherapyPoland4
403Bone MarrowAllogeneicHigh Risk Acute Myeloid LeukaemiaHematology2024Standard TherapyPoland13
404Bone MarrowAllogeneicHodgkin LymphomaHematology2024Standard TherapyPoland32
405Bone MarrowAllogeneicInherited Metabolic DiseaseHematology2024Standard TherapyPoland11
406Bone MarrowAllogeneicMds-Rcc RelapseHematology2024Standard TherapyPoland14
407Bone MarrowAllogeneicMixed Cellularity Hodgkin LymphomaHematology2024Standard TherapyPoland43
408Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland14
409Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland8
410Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland14
411Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
412Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland9
413Bone MarrowAllogeneicOsteopetrosis type BHematology2024Standard TherapyPoland13
414Bone MarrowAllogeneicOther LeukemiaHematology2024Standard TherapyPoland9
415Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2024Standard TherapyPoland7
416Bone MarrowAllogeneicPrimary Immunodeficiency Xlp-1Hematology2024Standard TherapyPoland18
417Bone MarrowAllogeneicRelapse T-Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland12
418Bone MarrowAllogeneicSecondary Acute Myelogenous LeukemiaHematology2024Standard TherapyPoland4
419Bone MarrowAllogeneicSecondary Acute Myelogenous LeukemiaHematology2024Standard TherapyPoland15
420Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland7
421Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland3
422Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland10
423Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland21
424Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland18
425Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland49
426Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland16
427Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland24
428Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland13
429Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland14
430Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland21
431Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland7
432Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2024Standard TherapyPoland2
433Bone MarrowAllogeneicSevere Congenital NeutropeniaHematology2024Standard TherapyPoland1
434Bone MarrowAllogeneicShwachman-Diamond SyndromeHematology2024Standard TherapyPoland10
435Bone MarrowAllogeneicSickle Cell Disease Hematology2024Standard TherapyPoland9
436Bone MarrowAllogeneicBiphenotypic Acute Leukemia Hematology2024Standard TherapyUkraine10
437Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland58
438Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyUnited Kingdom12
439Bone MarrowAllogeneichemophagocytic lymphohistiocytosisHematology2024Standard TherapySweden4 months
440Bone MarrowAllogeneicSevere combined immunodeficiencyHematology2024Standard TherapyGermany1
441Bone MarrowAllogeneicBeta-Thalassemia MajorHematology2024Standard TherapyIndia11
442Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyAustria4
443Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyNorway33
444Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapySpain 16
445Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapySwitzerland5
446Bone MarrowAllogeneicT- Acute Lymphoblastic LeukemiaHematology2024Standard TherapyIreland6
447Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland12
448Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2024Standard TherapyUSA4 months
449Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyBelgium50
450Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyFrance31
451Bone MarrowAllogeneicChronic myelomonocytic leukemiaHematology2024Standard TherapyItaly64
452Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyFrance10
453Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland12
454Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyUSA4
455Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyCanada8
456Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland17
457Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyUSA8
458Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyUSA67
459Bone MarrowAllogeneicHodgkins LymphomaHematology2024Standard TherapyUnited Kingdom36
460Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA72
461Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA9
462Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2024Standard TherapyUSA3
463ApheresisAllogeneicA- ThalassemiaHematology2024Standard TherapyPoland11
464ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland13
465ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland21
466ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland22
467ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland38
468ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany41
469ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland44
470ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland44
471ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland48
472ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland50
473ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany50
474ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland55
475ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland59
476ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany60
477ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland63
478ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland44
479ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland59
480ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland51
481ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland34
482ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland1
483ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland10
484ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland20
485ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland25
486ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland26
487ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland28
488ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland34
489ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland35
490ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland37
491ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland38
492ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland38
493ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland40
494ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland41
495ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland43
496ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland51
497ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland51
498ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland51
499ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland59
500ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland59
501ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
502ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
503ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
504ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland61
505ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland61
506ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
507ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
508ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland64
509ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland65
510ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland66
511ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland67
512ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland67
513ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland68
514ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
515ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
516ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
517ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
518ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
519ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland70
520ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland70
521ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland72
522ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland73
523ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland77
524ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland59
525ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland66
526ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland58
527ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland54
528ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland29
529ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland64
530ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland27
531ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
532ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland63
533ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland50
534ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
535ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland30
536ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland68
537ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland77
538ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
539ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland47
540ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
541ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland65
542ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland64
543ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland61
544ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland64
545ApheresisAllogeneicAcute Myelogenous Leukemia- Core-Binding FactorHematology2024Standard TherapyPoland68
546ApheresisAllogeneicAcute Myelogenous Leukemia, Post MyelofibrosisHematology2024Standard TherapyPoland63
547ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany36
548ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany46
549ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany48
550ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany52
551ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany58
552ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany61
553ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyPoland67
554ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany71
555ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany72
556ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany63
557ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany32
558ApheresisAutologousAcute Myeloid Leukemia - RelapseHematology2024Standard TherapyGermany68
559ApheresisAllogeneicAcute Myeloid Leukemia RelapseHematology2024Standard TherapyGermany33
560ApheresisAllogeneicAmegakaryocytic/Congenital ThrombocytopeniaHematology2024Standard TherapyPoland63
561ApheresisAllogeneicAnaplastic Large Cell LymphomaHematology2024Standard TherapyPoland52
562ApheresisAllogeneicAngioimmunoblastic T-Cell LymphomaHematology2024Standard TherapyPoland47
563ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland19
564ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2024Standard TherapyPoland62
565ApheresisAllogeneicB-Cell Progenitor Acute Lymphoblastic Leukemia High RiskHematology2024Standard TherapyPoland4
566ApheresisAllogeneicCalr Positive MyelofibrosisHematology2024Standard TherapyPoland61
567ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2024Standard TherapyPoland60
568ApheresisAllogeneicChronic Myelogenous LeukaemiaHematology2024Standard TherapyPoland62
569ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland10
570ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland35
571ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyGermany42
572ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland49
573ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland72
574ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2024Standard TherapyPoland71
575ApheresisAllogeneicFanconi Aplastic AnemiaHematology2024Standard TherapyPoland20
576ApheresisAllogeneicFollicular LymphomaHematology2024Standard TherapyPoland48
577ApheresisAllogeneicHigh Risk Acute Myeloid LeukaemiaHematology2024Standard TherapyPoland15
578ApheresisAllogeneicHigh Risk Myelodysplastic SyndromeHematology2024Standard TherapyPoland69
579ApheresisAllogeneicHigh-Risk Myelodysplastic SyndromeHematology2024Standard TherapyPoland71
580ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyPoland27
581ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyPoland27
582ApheresisAllogeneicHodgkin DiseaseHematology2024Standard TherapyPoland28
583ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyPoland23
584ApheresisAllogeneicHypoplastic Myelodysplastic Syndrome/Acute Myelogenous LeukemiaHematology2024Standard TherapyPoland71
585ApheresisAllogeneicInfant Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland41
586ApheresisAllogeneicKutanes T-Zell-Lymphom, Mycosis FungoidesHematology2024Standard TherapyPoland72
587ApheresisAutologousMantle Cell LymphomaHematology2024Standard TherapyGermany51
588ApheresisAutologousMantle Cell LymphomaHematology2024Standard TherapyGermany64
589ApheresisAutologousMantle Cell LymphomaHematology2024Standard TherapyGermany66
590ApheresisAutologousMantle Cell LymphomaHematology2024Standard TherapyGermany52
591ApheresisAutologousMorbus HodgkinHematology2024Standard TherapyGermany63
592ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyPoland43
593ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany52
594ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany54
595ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany60
596ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany61
597ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
598ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
599ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
600ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
601ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany63
602ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany64
603ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany65
604ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany65
605ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany66
606ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany66
607ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany67
608ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany68
609ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany69
610ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany70
611ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany71
612ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany72
613ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany66
614ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
615ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany58
616ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany61
617ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany61
618ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
619ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany70
620ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany74
621ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany58
622ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany63
623ApheresisAllogeneicMyelodysplasticHematology2024Standard TherapyPoland68
624ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland20
625ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland22
626ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland54
627ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany58
628ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland60
629ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland62
630ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland65
631ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
632ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
633ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
634ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany69
635ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany69
636ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland70
637ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany71
638ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland73
639ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany60
640ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland53
641ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland69
642ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland59
643ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland60
644ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland49
645ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland52
646ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland63
647ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland66
648ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland58
649ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
650ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland65
651ApheresisAllogeneicMyelodysplastic Syndrome + MyelomaHematology2024Standard TherapyGermany67
652ApheresisAllogeneicMyelofibrosisHematology2024Standard TherapyPoland40
653ApheresisAllogeneicMyelofibrosisHematology2024Standard TherapyPoland58
654ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2024Standard TherapyPoland60
655ApheresisAllogeneicMyelofibrosis Post. Polycythemia VeraHematology2024Standard TherapyPoland66
656ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2024Standard TherapyPoland67
657ApheresisAllogeneicMyelomaHematology2024Standard TherapyGermany65
658ApheresisAllogeneicMyeloproliferative Neoplasms Hematology2024Standard TherapyPoland74
659ApheresisAllogeneicMyeloproliferative Neoplasms/Myelodysplastic SyndromeHematology2024Standard TherapyPoland68
660ApheresisAutologousNon-Hodgkin LymphomaHematology2024Standard TherapyGermany23
661ApheresisAutologousNon-Hodgkin LymphomaHematology2024Standard TherapyGermany50
662ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyPoland50
663ApheresisAutologousNon-Hodgkin LymphomaHematology2024Standard TherapyGermany67
664ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyPoland46
665ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyPoland65
666ApheresisAutologousNon-Hodgkin LymphomaHematology2024Standard TherapyGermany66
667ApheresisAutologousNon-Hodgkin Lymphoma - relapseHematology2024Standard TherapyGermany54
668ApheresisAutologousNonseminomaHematology2024Standard TherapyGermany38
669ApheresisAllogeneicOsteomyelitisHematology2024Standard TherapyPoland65
670ApheresisAllogeneicPost-Et-MyelofibrosisHematology2024Standard TherapyPoland59
671ApheresisAllogeneicPost-Pv-MyelofibrosisHematology2024Standard TherapyPoland64
672ApheresisAutologousPrimary Central Nervous System LymphomaHematology2024Standard TherapyGermany60
673ApheresisAllogeneicPrimary MyelofibrosisHematology2024Standard TherapyPoland52
674ApheresisAllogeneicPrimary MyelofibrosisHematology2024Standard TherapyPoland67
675ApheresisAllogeneicPrimary MyelofibrosisHematology2024Standard TherapyPoland70
676ApheresisAllogeneicRelapsed B-Cell Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland12
677ApheresisAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland15
678ApheresisAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland10
679ApheresisAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland60
680ApheresisAllogeneicSevere Aplastic Anemia Progressed To Myelodysplastic SyndromeHematology2024Standard TherapyPoland21
681ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany63
682ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany64
683ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany56
684ApheresisAutologousHodgkin LymphomaHematology2024Standard TherapyGermany56
685ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany64
686ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany56
687ApheresisAutologousFollicular lymphomaHematology2024Standard TherapyGermany58
688ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
689ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany47
690ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany69
691ApheresisAutologousHodgkin LymphomaHematology2024Standard TherapyGermany38
692ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
693ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany70
694ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany64
695ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany53
696ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany60
697ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany59
698ApheresisAutologousMantle cell lymphomaHematology2024Standard TherapyGermany45
699ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany66
700ApheresisAutologousHodgkin LymphomaHematology2024Standard TherapyGermany33
701ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany64
702ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany59
703ApheresisAllogeneicPrimary myelofibrosisHematology2024Standard TherapyGermany55
704ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany63
705ApheresisAllogeneicBlastic Plasmacytoid DendriticHematology2024Standard TherapyUSA57
706ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland32
707ApheresisAllogeneicMacrofocal multiple myeloma Hematology2024Standard TherapyUSA75
708ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUnited Kingdom62
709ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA52
710ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany48
711ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUnited Kingdom71
712ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyRomania35
713ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyLithuania47
714ApheresisAllogeneicDiffuse large B-cell lymphomaHematology2024Standard TherapyAustralia46
715ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA65
716ApheresisAllogeneicChronic lymphatic leukemiaHematology2024Standard TherapyNorway52
717ApheresisAllogeneicChronic myelogenous leukemiaHematology2024Standard TherapyPoland60
718ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyHungary32
719ApheresisAllogeneicMalignant histiocytosisHematology2024Standard TherapyBulgaria41
720ApheresisAllogeneicMyelodysplastic syndromeHematology2024Standard TherapyUSA78
721ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyHungary20
722ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly58
723ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPortugal67
724ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly63
725ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyLithuania19
726ApheresisAllogeneicHodgkin lymphomaHematology2024Standard TherapyRussia34
727ApheresisAllogeneicchronic lymphocytic leukemia Richters TransformationHematology2024Standard TherapyUnited Kingdom68
728ApheresisAllogeneicmyelodysplasiaHematology2024Standard TherapySweden66
729ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly52
730ApheresisAllogeneicmyelodysplasiaHematology2024Standard TherapyLithuania70
731ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany72
732ApheresisAllogeneicplasma cell leukemiaHematology2024Standard TherapyUSA59
733ApheresisAllogeneicFibrolamellar CarcinomaHematology2024Standard TherapyCzechia41
734ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly59
735ApheresisAllogeneicpost-ET MyelofibroseHematology2024Standard TherapyAustria61
736ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA55
737ApheresisAllogeneicMyeloma MultiplexHematology2024Standard TherapyPoland67
738ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapySpain45
739ApheresisAllogeneicMyelofibroseHematology2024Standard TherapySpain69
740ApheresisAllogeneicMyelofibroseHematology2024Standard TherapyPoland60
741ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyUSA53
742ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance35
743ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly69
744ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyNorway18
745ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany51
746ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland62
747ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyHungary56
748ApheresisAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyUSA19
749ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapySpain67
750ApheresisAllogeneicemophagocytic lymphohistiocytosisHematology2024Standard TherapyUnited Kingdom48
751ApheresisAllogeneicNon-Hodgkin's lymphomaHematology2024Standard TherapyNETHERLANDS61
752ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany29
753ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
754ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyIsrael63
755ApheresisAllogeneicETP-Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland35
756ApheresisAllogeneicHodgkin lymphomaHematology2024Standard TherapyPoland4
757ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany23
758ApheresisAllogeneicFanconi AnemiaHematology2024Standard TherapyUSA27
759ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA69
760ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA44
761ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland49
762ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA20
763ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance50
764ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA74
765ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyAustria49
766ApheresisAllogeneicPost-PV MyelofibroseHematology2024Standard TherapyGermany59
767ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA66
768ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland58
769ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany55
770ApheresisAllogeneicMyelofibrosisHematology2024Standard TherapyFrance70
771ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyFrance54
772ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA68
773ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland41
774ApheresisAllogeneicChronic myelogenous leukemiaHematology2024Standard TherapyUSA31
775ApheresisAllogeneicOther leukemiaHematology2024Standard TherapyItaly31
776ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapySweden42
777ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany43
778ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany52
779ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany64
780ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany60
781ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany70
782ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
783ApheresisAllogeneicPrimary myelofibrosisHematology2024Standard TherapyGermany55
784ApheresisAutologousAmyloid light-chain amyloidosisHematology2024Standard TherapyGermany55
785ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany61
786ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
787ApheresisAutologousEpstein–Barr virus positive diffuse large B-cell lymphomaHematology2024Standard TherapyGermany63
788ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany69
789ApheresisAutologousAngioimmunoblastic T-cell lymphomaHematology2024Standard TherapyGermany58
790ApheresisAllogeneicAcute lymphoblastic leukemiaHematology2024Standard TherapyGermany19
791ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany66
792ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany61
793ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyCanada16
794ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany61
795ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA75
796ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2024Standard TherapyUSA62
797ApheresisAllogeneicMyelodysplastic DisordersHematology2024Standard TherapyFrance66
798ApheresisAllogeneicB-Cell LymphomaHematology2024Standard TherapyCanada70
799ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly60
800ApheresisAllogeneicMyeloma MultiplexHematology2024Standard TherapyPoland57
801ApheresisAllogeneicDiffuse large B-cell lymphomaHematology2024Standard TherapyPoland17
802ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland48
803ApheresisAllogeneicChronic lymphocytic leukemiaHematology2024Standard TherapyGermany63
804ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland65
805ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA64
806ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA76
807ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland44
808ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
809ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyNETHERLANDS25
810ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyUSA42
811ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyCROATIA66
812ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA70
813ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapySwitzerland68
814ApheresisAllogeneicChronic Myelomonocytic LeukaemiaHematology2024Standard TherapyNETHERLANDS62
815ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyUSA58
816ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany62
817ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyBelarus54
818ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapySpain9
819ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland66
820ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance67
821ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance54
822ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapySouth Africa54
823ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany60
824ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapySweden60
825ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapySpain67
826ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany66
827ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany53
828ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
829ApheresisAutologousNon-Hodgkin lymphoma, rezidivHematology2024Standard TherapyGermany64
830ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany57
831ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany66
832ApheresisAllogeneicAcute lymphoblastic leukemiaHematology2024Standard TherapyGermany50
833ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany57
834ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA70
835ApheresisAllogeneicMultiple Organ Dysfunction SyndromeHematology2024Standard TherapyGermany42
836ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA32
837ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA76
838ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyItaly63
839ApheresisAllogeneicEarly T-cell precursor Acute Lymphoblastic LeukemiaHematology2024Standard TherapyAustralia43
840ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA72
841ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany72
842ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland52
843ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA73
844ApheresisAllogeneicMyelofibrosisHematology2024Standard TherapyPoland68
845ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly63
846ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyCzechia46
847ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance64
848ApheresisAllogeneicPrimary ImmunodeficienciesHematology2024Standard TherapyRussia7
849ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany68
850ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany62
851ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany48
852ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA63
853ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapySpain58
854ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland41
855ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2024Standard TherapyUSA73
856ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland15
857ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany65
858ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland38
859ApheresisAllogeneicPlasmacytomaHematology2024Standard TherapyPoland46
860ApheresisAutologousNo dataHematology2024Standard TherapyPortugal60
861ApheresisAutologousNo dataHematology2024Standard TherapyPortugal60
862Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2023Experimental TherapyPoland8
863Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2023Experimental TherapyPoland16
864Cord TissueAllogeneic - RelatedAgs (Autism + Epilepsy)Neurology2023Experimental TherapyPoland/Romania15
865Cord TissueAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania8,5
866Cord TissueAutologousAutismNeurology2023Experimental TherapyHungary10
867Cord TissueAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania4
868Cord TissueAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania10
869Cord TissueAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania3,2
870Cord TissueAutologousCerebral PalsyNeurology2023Experimental TherapyRomania2
871Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2023Experimental TherapyRomania3
872Cord TissueAllogeneic - UnrelatedDisorders Of Optic NerveOphthalmology2023Experimental TherapyPoland39,1
873Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2023Experimental TherapyPoland65,1
874Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2023Experimental TherapyPoland50,8
875Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2023Experimental TherapyPoland8 months
876Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2023Experimental TherapyPoland16,2
877Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2023Experimental TherapyPoland20,8
878Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2023Experimental TherapyPoland49,8
879Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2023Experimental TherapyPoland62,7
880Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2023Experimental TherapyPoland24,1
881Cord TissueAllogeneic - UnrelatedMucopolysaccharidosis Type IiHematology2023Experimental TherapyPoland4,7
882Cord TissueAllogeneic - UnrelatedNon-Inflammatory Diseases Of The Ovary, Fallopian Tube, And Broad Ligament Of The UterusGynecology2023Experimental TherapyPoland47
883Cord TissueAutologousOptic Nerve Atrophy, Tetraparesis, HydrocephalusNeurology2023Experimental TherapyRomania5,5
884Cord TissueAllogeneic - UnrelatedOvarian DysfunctionGynecology2023Experimental TherapyPoland44,8
885Cord TissueAllogeneic - UnrelatedOvarian DysfunctionGynecology2023Experimental TherapyPoland32,11
886Cord TissueAllogeneic - UnrelatedPolycystic Ovary SyndromeGynecology2023Experimental TherapyPoland39,4
887Cord TissueAllogeneic - RelatedRight Parietal Closed SchizencephalyNeurology2023Experimental TherapyRomania38
888Cord TissueAllogeneic - RelatedRp+ Usher SyndromeNeurology2023Experimental TherapyRomania10
889Cord TissueAllogeneic - RelatedSudden Sensorineural Hearing Loss (Ssnhl)Neurology2023Experimental TherapyRomania1
890Cord BloodAutologousAutismNeurology2023Experimental TherapyHungary10
891Cord BloodAllogeneicAutismNeurology2023Experimental TherapyPoland3,3
892Cord BloodAutologousAutismNeurology2023Experimental TherapyRomania3
893Cord BloodAutologousAutismNeurology2023Experimental TherapyRomania3
894Cord BloodAutologousAutismNeurology2023Experimental TherapyRomania10
895Cord BloodAutologousAutismNeurology2023Experimental TherapyPortugal7
896Cord BloodAutologousAutismNeurology2023Experimental TherapyPortugal5
897Cord BloodAutologousAutismNeurology2023Experimental TherapyHungary14
898Cord BloodAutologousAutismNeurology2023Experimental TherapyRomania10
899Cord BloodAutologousAutismNeurology2023Experimental TherapyHungary3
900Cord BloodAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania3,2
901Cord BloodAutologousAutismNeurology2023Experimental TherapyHungary5
902Cord BloodAllogeneic - RelatedBeta ThalassemiaHematology2023Standard TherapyUK8
903Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2023Experimental TherapyHungary5
904Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2023Standard TherapyUK2,5
905Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2023Standard TherapyUK2,5
906Cord BloodAutologousCerebral PalsyNeurology2023Experimental TherapyPoland2,1
907Cord BloodAllogeneic - RelatedCerebral Palsy Neurology2023Experimental TherapyRomania10
908Cord BloodAllogeneic - RelatedCerebral Palsy, Psychomotor Retard, Tetraparesis, MicrocephalyNeurology2023Experimental TherapyRomania9
909Cord BloodAutologousGlobal Developmental Delay Si Truncal AtaxiaNeurology2023Experimental TherapyRomania5
910Cord BloodAllogeneicNeuroblastomaHematology2023Standard TherapyTurkey2,1
911Cord BloodAllogeneic - RelatedNeuroblastomaHematology2023Standard TherapyTurkey2,1
912Cord BloodAutologousOptic Nerve Atrophy, Tetraparesis, HydrocephalusNeurology2023Experimental TherapyRomania5,5
913Cord BloodAutologousPervasive Developmental DisorderNeurology2023Experimental TherapyPoland3,11
914Cord BloodAutologousPervasive Developmental DisorderNeurology2023Experimental TherapyPoland8,1
915Cord BloodAllogeneic - RelatedSpasmodic TorticollisNeurology2023Experimental TherapyRomania41
916Cord BloodAllogeneicThalassemia MajorHematology2023Standard TherapyTurkey17,4
917Cord BloodAllogeneic - RelatedThalassemia MajorHematology2023Standard TherapyTurkey17,4
918Cord BloodAllogeneicWiskott-Aldrich SyndromeHematology2023Standard TherapyPoland5 months
919Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland42
920Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland41
921Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany35
922Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland59
923Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
924Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland51
925Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland59
926Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland42
927Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland21
928Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
929Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
930Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland39
931Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland53
932Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland42
933Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
934Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
935Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
936Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland43
937Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
938Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland56
939Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
940Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
941Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
942Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
943Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland47
944Bone Marrow FamilyAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland30
945Bone Marrow FamilyAllogeneicChronic Lymphocytic LeukemiaHematology2023Standard TherapyPoland69
946Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland60
947Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland70
948Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland76
949Bone Marrow FamilyAllogeneicLangerhans Cell SarcomaHematology2023Standard TherapyPoland66
950Bone Marrow FamilyAllogeneicMultiple MyelomaHematology2023Standard TherapyPoland63
951Bone Marrow FamilyAllogeneicMycosis FungoidesHematology2023Standard TherapyPoland71
952Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland71
953Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland68
954Bone Marrow FamilyAllogeneicMyelofibrosisHematology2023Standard TherapyPoland70
955Bone Marrow FamilyAllogeneicNo DataHematology2023Standard TherapyGermany70
956Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland55
957Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2023Standard TherapyPoland73
958Bone Marrow FamilyAllogeneicSecondary Chronic Myelomonocytic Leukemia To Acute Myeloid LeukemiaHematology2023Standard TherapyPoland62
959Bone Marrow FamilyAllogeneicSecondary Myelodysplastic Syndrome With Excess Of BlastsHematology2023Standard TherapyPoland15
960Bone Marrow FamilyAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland71
961Bone Marrow FamilyAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland5
962Bone MarrowAllogeneicAcute Leukemia Of Ambiguous Lineage Hematology2023Standard TherapyPoland1
963Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland11
964Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland5
965Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland16
966Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland28
967Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland14
968Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland1
969Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland25
970Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland7
971Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland4
972Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland8 months
973Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland12
974Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland63
975Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland5
976Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland12
977Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland3
978Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
979Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland14
980Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland47
981Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland11
982Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland13
983Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland17
984Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland32
985Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland43
986Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland12
987Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland59
988Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland38
989Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland14
990Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland1
991Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland75
992Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
993Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland13
994Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland6
995Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland17
996Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland34
997Bone MarrowAllogeneicAdrenoleukodystrophyHematology2023Standard TherapyPoland7
998Bone MarrowAllogeneicAdrenoleukodystrophy (Ald) - Siemerling-Creutzfeldt DiseaseHematology2023Standard TherapyPoland4
999Bone MarrowAllogeneicAmegakaryocytic ThrombocytopeniaHematology2023Standard TherapyPoland6 months
1000Bone MarrowAllogeneicAnemia FanconiHematology2023Standard TherapyPoland6
1001Bone MarrowAllogeneicAplastic AnemiaHematology2023Standard TherapyPoland18
1002Bone MarrowAllogeneicAplastic AnemiaHematology2023Standard TherapyPoland43
1003Bone MarrowAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland12
1004Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2023Standard TherapyPoland12
1005Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland55
1006Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland57
1007Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland40
1008Bone MarrowAllogeneicChronic Myeloid Leukemia Blast CrisisHematology2023Standard TherapyPoland21
1009Bone MarrowAllogeneicClippers SyndromeHematology2023Standard TherapyPoland49
1010Bone MarrowAllogeneicCongenital Amegakaryocytic Thrombocytopenia (Camt)Hematology2023Standard TherapyPoland6 months
1011Bone MarrowAllogeneicFanconi AnemiaHematology2023Standard TherapyPoland8
1012Bone MarrowAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2023Standard TherapyPoland2
1013Bone MarrowAllogeneicHodgkin’s LymphomaHematology2023Standard TherapyPoland23
1014Bone MarrowAllogeneicImmunodeficiency – Xlp1Hematology2023Standard TherapyPoland10
1015Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2023Standard TherapyPoland5
1016Bone MarrowAllogeneicMantle Cell LymphomaHematology2023Standard TherapyPoland68
1017Bone MarrowAllogeneicMetachromatic LeukodystrophyHematology2023Standard TherapyPoland22
1018Bone MarrowAllogeneicMitochondrial Neurogastrointestinal EncephalopathyHematology2023Standard TherapyPoland33
1019Bone MarrowAllogeneicMixed Lineage Acute Leukemia Hematology2023Standard TherapyPoland4
1020Bone MarrowAllogeneicMonocytopenia And Mycobacterial Infection (Monomac) Syndrome Hematology2023Standard TherapyPoland5
1021Bone MarrowAllogeneicMucopolysaccharidosis Type IHematology2023Standard TherapyPoland2
1022Bone MarrowAllogeneicMucopolysaccharidosis Type Ih (Hurler)Hematology2023Standard TherapyPoland8 months
1023Bone MarrowAllogeneicMucopolysaccharidosis Type Iv Hematology2023Standard TherapyPoland5
1024Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland51
1025Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland11
1026Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland14
1027Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland6
1028Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland7
1029Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland19
1030Bone MarrowAllogeneicNo DataHematology2023Standard TherapyPoland3
1031Bone MarrowAllogeneicNo DataHematology2023Standard TherapyPoland2
1032Bone MarrowAllogeneicNo DataHematology2023Standard TherapyPoland61
1033Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland20
1034Bone MarrowAllogeneicOther Immune SystemHematology2023Standard TherapyPoland6
1035Bone MarrowAllogeneicOther Immune SystemHematology2023Standard TherapyPoland6 months
1036Bone MarrowAllogeneicPrimary Combined Severe ImmunodeficiencyHematology2023Standard TherapyPoland14
1037Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2023Standard TherapyPoland3
1038Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2023Standard TherapyPoland4
1039Bone MarrowAllogeneicProlymphocytic LeukemiaHematology2023Standard TherapyPoland55
1040Bone MarrowAllogeneicRelapsed T Cell Acute Lymphoblastic Leukemia (T-All)Hematology2023Standard TherapyPoland5
1041Bone MarrowAllogeneicSecondary LeukemiaHematology2023Standard TherapyPoland20
1042Bone MarrowAllogeneicSecondary Myelofibrosis Post Polycythemia VeraHematology2023Standard TherapyPoland60
1043Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland11
1044Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland4
1045Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland31
1046Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland49
1047Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland8
1048Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland15
1049Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland17
1050Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland81
1051Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland29
1052Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland15
1053Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2023Standard TherapyPoland1
1054Bone MarrowAllogeneicSickle Cell Disease Hematology2023Standard TherapyPoland5
1055Bone MarrowAllogeneicT-Acute Lymphoblastic Leukemia, Ataxia TelangiectasiaHematology2023Standard TherapyPoland8
1056Bone MarrowAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland16
1057Bone MarrowAllogeneicThalassemia MajorHematology2023Standard TherapyPoland2
1058Bone MarrowAllogeneicVery Severe Aplastic AnemiaHematology2023Standard TherapyPoland21
1059Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2023Standard TherapyPoland1
1060Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2023Standard TherapyPoland3
1061ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany67
1062ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland37
1063ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland47
1064ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland16
1065ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland58
1066ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland64
1067ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland66
1068ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland11
1069ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland8
1070ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland52
1071ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland51
1072ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany54
1073ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland54
1074ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland40
1075ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany60
1076ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany40
1077ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland51
1078ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland35
1079ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland65
1080ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland47
1081ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany39
1082ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland54
1083ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland37
1084ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland54
1085ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland19
1086ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland20
1087ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland37
1088ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland42
1089ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland48
1090ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany47
1091ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany64
1092ApheresisAutologousAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany61
1093ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland20
1094ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland65
1095ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland40
1096ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland57
1097ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland44
1098ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland54
1099ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany31
1100ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland30
1101ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland60
1102ApheresisAllogeneicAcute Lymphoblastic Leukemia T-Cell; Myelodysplastic SyndromeHematology2023Standard TherapyPoland72
1103ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyGermany58
1104ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyGermany60
1105ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland32
1106ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland28
1107ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1108ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland70
1109ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1110ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland64
1111ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1112ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland41
1113ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1114ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1115ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland38
1116ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1117ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1118ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1119ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland87
1120ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1121ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1122ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland47
1123ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1124ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland56
1125ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1126ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland33
1127ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland53
1128ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1129ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1130ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland38
1131ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1132ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland1
1133ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland28
1134ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1135ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1136ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1137ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1138ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland31
1139ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1140ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1141ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland82
1142ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1143ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1144ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland59
1145ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland72
1146ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1147ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland41
1148ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1149ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
1150ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyGermany61
1151ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland58
1152ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
1153ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland51
1154ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1155ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1156ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland75
1157ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1158ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland7
1159ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland52
1160ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland28
1161ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland65
1162ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland37
1163ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland40
1164ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1165ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1166ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1167ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
1168ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
1169ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1170ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1171ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland1
1172ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1173ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland35
1174ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland48
1175ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1176ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1177ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1178ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland52
1179ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland74
1180ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland70
1181ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1182ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland65
1183ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland70
1184ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland32
1185ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
1186ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland20
1187ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1188ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1189ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland79
1190ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1191ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1192ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1193ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland43
1194ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1195ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland16
1196ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland44
1197ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland68
1198ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1199ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1200ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1201ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland53
1202ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland72
1203ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1204ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1205ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1206ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1207ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland36
1208ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1209ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1210ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland65
1211ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland1
1212ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1213ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1214ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland56
1215ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland11
1216ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1217ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland37
1218ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland40
1219ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland36
1220ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1221ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland53
1222ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1223ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland72
1224ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland22
1225ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1226ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland64
1227ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyGermany38
1228ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland44
1229ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1230ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1231ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1232ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1233ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland37
1234ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1235ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
1236ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland68
1237ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland43
1238ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1239ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1240ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1241ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland39
1242ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1243ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1244ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland47
1245ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland38
1246ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1247ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1248ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1249ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1250ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland65
1251ApheresisAutologousAnaplastic Lymphoma Kinase Positive Anaplastic Large-Cell LymphomaHematology2023Standard TherapyGermany37
1252ApheresisAllogeneicBare Lymphocyte Syndrome Type IiHematology2023Standard TherapyPoland3 months
1253ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland66
1254ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland49
1255ApheresisAutologousB-Cell LymphomaHematology2023Standard TherapyGermany66
1256ApheresisAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland53
1257ApheresisAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland27
1258ApheresisAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland51
1259ApheresisAllogeneicBeta Thalassemia MajorHematology2023Standard TherapyPoland4
1260ApheresisAllogeneicBlastic Plasmacytoid Dendritic Cell NeoplasmHematology2023Standard TherapyPoland66
1261ApheresisAllogeneicCell NeoplasmHematology2023Standard TherapyGermany47
1262ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2023Standard TherapyPoland61
1263ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland43
1264ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyGermany36
1265ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland62
1266ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland59
1267ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland37
1268ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland41
1269ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland54
1270ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland61
1271ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland54
1272ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyGermany28
1273ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland62
1274ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland65
1275ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland64
1276ApheresisAutologousComposite LymphomaHematology2023Standard TherapyGermany71
1277ApheresisAllogeneicCongenital Pulmonary Lymphangiectasia Hematology2023Standard TherapyPoland50
1278ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2023Standard TherapyGermany59
1279ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2023Standard TherapyPoland50
1280ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2023Standard TherapyGermany70
1281ApheresisAllogeneicEwing SarcomaHematology2023Standard TherapyPoland62
1282ApheresisAutologousFollicular LymphomaHematology2023Standard TherapyGermany62
1283ApheresisAllogeneicFollicular LymphomaHematology2023Standard TherapyPoland53
1284ApheresisAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2023Standard TherapyPoland4 months
1285ApheresisAutologousHodgkin - RelapseHematology2023Standard TherapyGermany43
1286ApheresisAllogeneicHuntington's Disease (Hd)Hematology2023Standard TherapyGermany36
1287ApheresisAllogeneicHypoplastic Myelodysplastic SyndromeHematology2023Standard TherapyPoland27
1288ApheresisAllogeneicImmunodeficiencyHematology2023Standard TherapyPoland4
1289ApheresisAllogeneicInherited Immune System DisorderHematology2023Standard TherapyPoland16
1290ApheresisAllogeneicLangerhans Cell SarcomaHematology2023Standard TherapyPoland66
1291ApheresisAutologousLight-Chain AmyloidosisHematology2023Standard TherapyGermany62
1292ApheresisAllogeneicMacrofocal Multiple Myeloma Hematology2023Standard TherapyPoland94
1293ApheresisAutologousMantle Cell LymphomaHematology2023Standard TherapyGermany54
1294ApheresisAutologousMantle Cell LymphomaHematology2023Standard TherapyGermany64
1295ApheresisAllogeneicMast Cell Sarcoma, Systemic Mastocytosis NrHematology2023Standard TherapyPoland51
1296ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2023Standard TherapyPoland64
1297ApheresisAutologousMorbus HodgkinHematology2023Standard TherapyGermany43
1298ApheresisAutologousMorbus HodgkinHematology2023Standard TherapyGermany57
1299ApheresisAllogeneicMucopolysaccharidosis /Myelodysplastic Syndrome OverlapHematology2023Standard TherapyPoland71
1300ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany47
1301ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany53
1302ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany65
1303ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany60
1304ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1305ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1306ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany72
1307ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany61
1308ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany68
1309ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany54
1310ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany67
1311ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany69
1312ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany61
1313ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1314ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1315ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany61
1316ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany64
1317ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany69
1318ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany58
1319ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany56
1320ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany66
1321ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1322ApheresisAllogeneicMultiple MyelomaHematology2023Standard TherapyPoland56
1323ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany53
1324ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany66
1325ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany59
1326ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany59
1327ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany64
1328ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1329ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany68
1330ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany60
1331ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany42
1332ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany62
1333ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany50
1334ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany59
1335ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany56
1336ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany64
1337ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany59
1338ApheresisAllogeneicMycosis FungoidesHematology2023Standard TherapyPoland62
1339ApheresisAllogeneicMyelodysplastic DisordersHematology2023Standard TherapyPoland57
1340ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland71
1341ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland64
1342ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland67
1343ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland56
1344ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland41
1345ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland70
1346ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland57
1347ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland70
1348ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland47
1349ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland29
1350ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland66
1351ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland68
1352ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland40
1353ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland56
1354ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland69
1355ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland59
1356ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland56
1357ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland68
1358ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland66
1359ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland63
1360ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland64
1361ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland64
1362ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland63
1363ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland65
1364ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland68
1365ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland44
1366ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland66
1367ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland48
1368ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland45
1369ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland67
1370ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland69
1371ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland72
1372ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland53
1373ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland71
1374ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland66
1375ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland57
1376ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland74
1377ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland72
1378ApheresisAllogeneicMyelodysplastic Syndrome Lb High RiskHematology2023Standard TherapyPoland58
1379ApheresisAllogeneicMyelodysplastic Syndrome With Multilineage DysplasiaHematology2023Standard TherapyPoland68
1380ApheresisAllogeneicMyelodysplastic Syndrome/Acute Myelogenous LeukemiaHematology2023Standard TherapyPoland42
1381ApheresisAllogeneicMyelodysplastic Syndrome-Eb1Hematology2023Standard TherapyPoland48
1382ApheresisAllogeneicMyelodysplastic Syndromes (Mds)Hematology2023Standard TherapyPoland73
1383ApheresisAllogeneicMyelodysplastic Syndromes (Mds)Hematology2023Standard TherapyPoland76
1384ApheresisAllogeneicMyelodysplastic Syndromes (Mds)Hematology2023Standard TherapyPoland70
1385ApheresisAllogeneicMyelodysplastic Syndromes (Mds)Hematology2023Standard TherapyPoland5
1386ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland65
1387ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland56
1388ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland70
1389ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland69
1390ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland61
1391ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland70
1392ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland68
1393ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2023Standard TherapyPoland50
1394ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2023Standard TherapyPoland54
1395ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2023Standard TherapyPoland60
1396ApheresisAllogeneicMyeloma MultiplexHematology2023Standard TherapyPoland63
1397ApheresisAutologousNo DataHematology2023Standard TherapyGermany69
1398ApheresisAutologousNo DataHematology2023Standard TherapyGermany53
1399ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland50
1400ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland23
1401ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland39
1402ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland2
1403ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland52
1404ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland61
1405ApheresisAutologousNo DataHematology2023Standard TherapyGermany60
1406ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland71
1407ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland44
1408ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland72
1409ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland66
1410ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland33
1411ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland42
1412ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland63
1413ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland19
1414ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland54
1415ApheresisAutologousNonseminoma, RelapseHematology2023Standard TherapyGermany48
1416ApheresisAllogeneicOrofacial Myofunctional Disorders (Omds), Primary Myelofibrosis (Pmf)Hematology2023Standard TherapyPoland69
1417ApheresisAllogeneicOsteomyelofibrosisHematology2023Standard TherapyPoland60
1418ApheresisAllogeneicOther Immune SystemHematology2023Standard TherapyPoland71
1419ApheresisAllogeneicOther MalignancyHematology2023Standard TherapyPoland49
1420ApheresisAllogeneicOther MyelofibrosisHematology2023Standard TherapyPoland56
1421ApheresisAllogeneicOther Non-Malignant DiseaseHematology2023Standard TherapyPoland70
1422ApheresisAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2023Standard TherapyPoland36
1423ApheresisAllogeneicPeripheral T-Cell LymphomaHematology2023Standard TherapyPoland47
1424ApheresisAutologousPlasma Cell LeukemiaHematology2023Standard TherapyGermany70
1425ApheresisAutologousPlasma Cell LeukemiaHematology2023Standard TherapyGermany56
1426ApheresisAutologousPlasmacytomaHematology2023Standard TherapyGermany63
1427ApheresisAllogeneicPost Therapeutic Myelodysplastic Syndrome /Acute Myelogenous Leukemia After Chronic Lymphocytic LeukemiaHematology2023Standard TherapyPoland60
1428ApheresisAllogeneicPost–Polycythemia Vera MyelofibrosisHematology2023Standard TherapyPoland38
1429ApheresisAllogeneicPra B-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland20
1430ApheresisAllogeneicPre-B-Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland41
1431ApheresisAllogeneicPre-B-Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland61
1432ApheresisAllogeneicPre-B-Acute Myelogenous LeukemiaHematology2023Standard TherapyPoland11
1433ApheresisAutologousPrimary Central Nervous System LymphomaHematology2023Standard TherapyGermany63
1434ApheresisAutologousPrimary Central Nervous System LymphomaHematology2023Standard TherapyGermany73
1435ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyGermany70
1436ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland68
1437ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland68
1438ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland31
1439ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland63
1440ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyGermany46
1441ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland68
1442ApheresisAllogeneicRelapsed B-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland11
1443ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1444ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland58
1445ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland36
1446ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland62
1447ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland9
1448ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland28
1449ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland17
1450ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2023Standard TherapyPoland1
1451ApheresisAllogeneicSystemic Mastocytosis Hematology2023Standard TherapyPoland63
1452ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland15
1453ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland28
1454ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland12
1455ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland65
1456ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland18
1457ApheresisAllogeneicT-Cell LymphomaHematology2023Standard TherapyPoland65
1458ApheresisAllogeneicThalassemia MajorHematology2023Standard TherapyPoland2
1459ApheresisAllogeneicTreatment-Related Myelodysplastic Syndrome Hematology2023Standard TherapyPoland67
1460ApheresisAllogeneicTreatment-Related Myelodysplastic Syndrome Hematology2023Standard TherapyPoland64
1461ApheresisAllogeneicWiskott-Aldrich SyndromeHematology2023Standard TherapyPoland2
1462Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2022Experimental TherapyPoland15
1463Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2022Experimental TherapyPoland6
1464Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2022Experimental TherapyPoland12
1465Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2022Experimental TherapyPoland7
1466Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2022Experimental TherapyPoland2
1467Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host Disease; Acute Lymphoblastic LeukemiaHematology2022Experimental TherapyPoland4,6
1468Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host Disease; Acute Lymphoblastic LeukemiaHematology2022Experimental TherapyPoland5,4
1469Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland42,8
1470Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland60,5
1471Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland69,7
1472Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland70,5
1473Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland54,2
1474Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland76,1
1475Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,3
1476Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland9,1
1477Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland3,9
1478Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,3
1479Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,8
1480Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7
1481Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland12,8
1482Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,1
1483Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland5,3
1484Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland4,8
1485Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyPoland7
1486Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyRomania14
1487Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland4,9
1488Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland2,6
1489Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,9
1490Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,6
1491Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland5,5
1492Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,4
1493Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,11
1494Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland3,5
1495Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyPoland/Romania6,7
1496Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,8
1497Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,8
1498Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyPoland/Romania8
1499Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland13,7
1500Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyPoland/Romania10,2
1501Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,4
1502Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,2
1503Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland12,4
1504Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland10,4
1505Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,11
1506Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland5,3
1507Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,5
1508Cord TissueAllogeneic - UnrelatedBone Marrow Transplant RejectionHematology2022Experimental TherapyPoland2,5
1509Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland8
1510Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland2,3
1511Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland12,3
1512Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,5
1513Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland2,6
1514Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland2,4
1515Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland7,5
1516Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland5,11
1517Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,4
1518Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,1
1519Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2022Experimental TherapyRomania3
1520Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,9
1521Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,8
1522Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland1,5
1523Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland2,4
1524Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,3
1525Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland11,8
1526Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland5
1527Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland7
1528Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland7,5
1529Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland1,8
1530Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2022Experimental TherapyPoland21,2
1531Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2022Experimental TherapyPoland51,4
1532Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2022Experimental TherapyPoland8,3
1533Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2022Experimental TherapyPoland18,4
1534Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2022Experimental TherapyPoland6,5
1535Cord TissueAllogeneic - UnrelatedEpilepsy; Global Developmental Delay; Hypoxic EncephalopathyNeurology2022Experimental TherapyPoland3,6
1536Cord TissueAllogeneic - UnrelatedEpileptic EncephalopathyNeurology2022Experimental TherapyPoland2,1
1537Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2022Experimental TherapyPoland10,2
1538Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2022Experimental TherapyPoland56,3
1539Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2022Experimental TherapyPoland38,7
1540Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2022Experimental TherapyPoland49,1
1541Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2022Experimental TherapyPoland1,1
1542Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2022Experimental TherapyPoland2,11
1543Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2022Experimental TherapyPoland16,1
1544Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland2,7
1545Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland11,7
1546Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland4,2
1547Cord TissueAllogeneic - RelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyRomania3
1548Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland2,1
1549Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland2,3
1550Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland4,7
1551Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland7,5
1552Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2022Experimental TherapyPoland47,1
1553Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2022Experimental TherapyPoland22,11
1554Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2022Experimental TherapyPoland49,1
1555Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2022Experimental TherapyPoland54,6
1556Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2022Experimental TherapyPoland62,9
1557Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2022Experimental TherapyPoland2,3
1558Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2022Experimental TherapyPoland1,4
1559Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2022Experimental TherapyPoland25,7
1560Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2022Experimental TherapyPoland14,1
1561Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2022Experimental TherapyPoland26,1
1562Cord TissueAllogeneic - UnrelatedOvarian DysfunctionGynecology2022Experimental TherapyPoland37,11
1563Cord TissueAllogeneic - UnrelatedPremature Ovarian Failure; Status After Oncological Treatment Of Breast CancerGynecology2022Experimental TherapyPoland45,2
1564Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2022Experimental TherapyPoland41,3
1565Cord TissueAllogeneic - UnrelatedSequelae Of Spinal Cord Injury; Condition After A Spinal Cord InjuryNeurology2022Experimental TherapyPoland23,9
1566Cord TissueAllogeneic - UnrelatedSpasmic Paralysis Of The LimbsNeurology2022Experimental TherapyPoland33,9
1567Cord TissueAllogeneic - UnrelatedSpastic Limb ParalysisNeurology2022Experimental TherapyPoland30,11
1568Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2022Experimental TherapyPoland12,11
1569Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2022Experimental TherapyPoland20
1570Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2022Experimental TherapyPoland39,11
1571Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2022Experimental TherapyPoland35,6
1572Cord BloodAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany46
1573Cord BloodAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland9
1574Cord BloodAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany2,5
1575Cord BloodAutologousAutismNeurology2022Experimental TherapyPoland7
1576Cord BloodAutologousAutismNeurology2022Experimental TherapyHungary13
1577Cord BloodAutologousAutismNeurology2022Experimental TherapyPoland8,8
1578Cord BloodAutologousAutismNeurology2022Experimental TherapyRomania5
1579Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2022Experimental TherapyUK11
1580Cord BloodAllogeneic - RelatedChronic Myelogenous LeukemiaHematology2022Standard TherapyTurkey19
1581Cord BloodAutologousHydrocephalusNeurology2022Experimental TherapyRomania6
1582Cord BloodAllogeneic - RelatedSickle Cell AnemiaHematology2022Standard TherapyTurkey7,7
1583Cord BloodAllogeneic - RelatedThalassemia MajorHematology2022Standard TherapyTurkey19,2
1584Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland3
1585Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland68
1586Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland1
1587Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland41
1588Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland64
1589Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland79
1590Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland23
1591Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
1592Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
1593Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland56
1594Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland46
1595Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland41
1596Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
1597Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland43
1598Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
1599Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
1600Bone Marrow FamilyAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland54
1601Bone Marrow FamilyAllogeneicBlastic Plasmacytoid Dendritic Cell NeoplasmHematology2022Standard TherapyPoland55
1602Bone Marrow FamilyAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland3
1603Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland60
1604Bone Marrow FamilyAllogeneicChronic Myelomonocytic Leukemia, Type 2Hematology2022Standard TherapyPoland68
1605Bone Marrow FamilyAllogeneicLeukocyte Adhesion DeficiencyHematology2022Standard TherapyPoland33
1606Bone Marrow FamilyAllogeneicMycosis FungoidesHematology2022Standard TherapyPoland62
1607Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
1608Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland66
1609Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland29
1610Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland67
1611Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
1612Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland69
1613Bone Marrow FamilyAllogeneicMyelofibrosisHematology2022Standard TherapyPoland64
1614Bone Marrow FamilyAllogeneicMyelofibrosis Post Essential ThrombocythemiaHematology2022Standard TherapyPoland64
1615Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2022Standard TherapyPoland49
1616Bone Marrow FamilyAllogeneicT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyPoland73
1617Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland3
1618Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland2
1619Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland37
1620Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland16
1621Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland9
1622Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland14
1623Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland18
1624Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland6
1625Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland38
1626Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland10
1627Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland10
1628Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland13
1629Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland4
1630Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland25
1631Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland8
1632Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland6
1633Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland20
1634Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland13
1635Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland13
1636Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland15
1637Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland11
1638Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland15
1639Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland11
1640Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland18
1641Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland11
1642Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland12
1643Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland44
1644Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland18
1645Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland75
1646Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
1647Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland41
1648Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland23
1649Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland36
1650Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland17
1651Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland63
1652Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland63
1653Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland12
1654Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland16
1655Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland58
1656Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1657Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland25
1658Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland30
1659Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland18
1660Bone MarrowAllogeneicAdenosine Deaminase Deficient Severe Combined Immunodeficiency (Ada-Scid) Hematology2022Standard TherapyPoland3 months
1661Bone MarrowAllogeneicAmyloidosisHematology2022Standard TherapyPoland9
1662Bone MarrowAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland19
1663Bone MarrowAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland49
1664Bone MarrowAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland10
1665Bone MarrowAllogeneicBone Marrow Failure Syndrome Hematology2022Standard TherapyPoland11
1666Bone MarrowAllogeneicChediak-Higashi-SyndromeHematology2022Standard TherapyPoland10
1667Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland37
1668Bone MarrowAllogeneicCombined ImmunodeficiencyHematology2022Standard TherapyPoland7
1669Bone MarrowAllogeneicCommon Variable Immunodeficiency With Granulomatous-Lymphocytic Interstitial Lung DiseaseHematology2022Standard TherapyPoland11
1670Bone MarrowAllogeneicDiamond Blackfan AnemiaHematology2022Standard TherapyPoland11
1671Bone MarrowAllogeneicDiamond Blackfan AnemiaHematology2022Standard TherapyPoland4
1672Bone MarrowAllogeneicDock8 DeficiencyHematology2022Standard TherapyPoland1
1673Bone MarrowAllogeneicEarly Isolated All Bm RelapseHematology2022Standard TherapyPoland6
1674Bone MarrowAllogeneicFanconi AnemiaHematology2022Standard TherapyPoland5
1675Bone MarrowAllogeneicFanconi AnemiaHematology2022Standard TherapyPoland7
1676Bone MarrowAllogeneicFanconi AnemiaHematology2022Standard TherapyPoland16
1677Bone MarrowAllogeneicGriscelli Syndrome Type 2Hematology2022Standard TherapyPoland2 months
1678Bone MarrowAllogeneicHemophagocytic LymphocytosisHematology2022Standard TherapyPoland1
1679Bone MarrowAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2022Standard TherapyPoland46
1680Bone MarrowAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland57
1681Bone MarrowAllogeneicInfant Acute Lymphoblastic Leukemia With Kmt2a Gene RearrangementHematology2022Standard TherapyPoland7 months
1682Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2022Standard TherapyPoland1
1683Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2022Standard TherapyPoland1
1684Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland49
1685Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland16
1686Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland63
1687Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland64
1688Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland14
1689Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland15
1690Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland51
1691Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland8
1692Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland12
1693Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
1694Bone MarrowAllogeneicMyelofibrosisHematology2022Standard TherapyPoland56
1695Bone MarrowAllogeneicMyelofibrosisHematology2022Standard TherapyPoland17
1696Bone MarrowAllogeneicNhl (Non-Hodgkin's Lymphoma)Hematology2022Standard TherapyPoland37
1697Bone MarrowAllogeneicNijmegen Breakage SyndromeHematology2022Standard TherapyPoland9
1698Bone MarrowAllogeneicNo DataHematology2022Standard TherapyPoland13
1699Bone MarrowAllogeneicNo DataHematology2022Standard TherapyPoland11
1700Bone MarrowAllogeneicNo DataHematology2022Standard TherapyPoland3
1701Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland53
1702Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland37
1703Bone MarrowAllogeneicOsteopetrosisHematology2022Standard TherapyPoland2
1704Bone MarrowAllogeneicOther Immune System DisordersHematology2022Standard TherapyPoland1
1705Bone MarrowAllogeneicOther Non-Malignant DiseaseHematology2022Standard TherapyPoland8
1706Bone MarrowAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2022Standard TherapyPoland17
1707Bone MarrowAllogeneicParoxysmal Nocturnal Hemoglobinuria With Marrow FailureHematology2022Standard TherapyPoland10
1708Bone MarrowAllogeneicPhiladelphia-Positive Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland18
1709Bone MarrowAllogeneicPre-B Acute Lymphoblastic Leukemia Hematology2022Standard TherapyPoland32
1710Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2022Standard TherapyPoland3
1711Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2022Standard TherapyPoland9 months
1712Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland46
1713Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland6
1714Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland15
1715Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland65
1716Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland12
1717Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland68
1718Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland15
1719Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland18
1720Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland11
1721Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland19
1722Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland6
1723Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland11
1724Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland35
1725Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland11
1726Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland5
1727Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland30
1728Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland14
1729Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland49
1730Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2022Standard TherapyPoland3 months
1731Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2022Standard TherapyPoland2 months
1732Bone MarrowAllogeneicShwachman-Diamond Syndrome – Sds Hematology2022Standard TherapyPoland7
1733Bone MarrowAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland1
1734Bone MarrowAllogeneicVery Severe Aplastic AnemiaHematology2022Standard TherapyPoland16
1735Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2022Standard TherapyPoland1
1736Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2022Standard TherapyPoland3
1737Bone MarrowAllogeneicX-Linked Congenital DyskeratosisHematology2022Standard TherapyPoland2
1738ApheresisAllogeneicAcute Biphenotypic LeukemiaHematology2022Standard TherapyPoland22
1739ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland41
1740ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland55
1741ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland4
1742ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland29
1743ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland59
1744ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland9
1745ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland57
1746ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland24
1747ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland36
1748ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland24
1749ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland47
1750ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland25
1751ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland29
1752ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland7
1753ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland13
1754ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland7
1755ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland8
1756ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland18
1757ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland35
1758ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland67
1759ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland69
1760ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland65
1761ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland10
1762ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland49
1763ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland75
1764ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland57
1765ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland14
1766ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland58
1767ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland54
1768ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland58
1769ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany29
1770ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany36
1771ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany57
1772ApheresisAllogeneicAcute MyelofibrosisHematology2022Standard TherapyPoland55
1773ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland69
1774ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland39
1775ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
1776ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland69
1777ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland30
1778ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
1779ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland74
1780ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland45
1781ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland50
1782ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
1783ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland78
1784ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland42
1785ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland52
1786ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland51
1787ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland69
1788ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland25
1789ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland57
1790ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
1791ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland55
1792ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland50
1793ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland37
1794ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland38
1795ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
1796ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
1797ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
1798ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1799ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland13
1800ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1801ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland46
1802ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland56
1803ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland11
1804ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland59
1805ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland44
1806ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland16
1807ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland49
1808ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
1809ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
1810ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland17
1811ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
1812ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland55
1813ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland31
1814ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland30
1815ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland58
1816ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland74
1817ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland43
1818ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
1819ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
1820ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
1821ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland53
1822ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland52
1823ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1824ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1825ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland77
1826ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland34
1827ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
1828ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1829ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1830ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland76
1831ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland50
1832ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
1833ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland41
1834ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
1835ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland55
1836ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland11
1837ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland43
1838ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland25
1839ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
1840ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
1841ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
1842ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland73
1843ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
1844ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland10
1845ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland39
1846ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland59
1847ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland45
1848ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland52
1849ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
1850ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland39
1851ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland53
1852ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
1853ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland58
1854ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
1855ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland71
1856ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland67
1857ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland67
1858ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
1859ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
1860ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland57
1861ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland70
1862ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
1863ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland71
1864ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland28
1865ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland88
1866ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1867ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland71
1868ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
1869ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
1870ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
1871ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland71
1872ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
1873ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland1
1874ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland67
1875ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
1876ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland56
1877ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
1878ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland36
1879ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland37
1880ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland26
1881ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland20
1882ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland74
1883ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland55
1884ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland56
1885ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
1886ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland13
1887ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
1888ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
1889ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland67
1890ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland52
1891ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland50
1892ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
1893ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland35
1894ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
1895ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland47
1896ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland34
1897ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
1898ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
1899ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
1900ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland64
1901ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland29
1902ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland63
1903ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland1
1904ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland39
1905ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland43
1906ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland63
1907ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland21
1908ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany58
1909ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany45
1910ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany63
1911ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany54
1912ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany48
1913ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany61
1914ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany27
1915ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany61
1916ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany66
1917ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2022Standard TherapyGermany47
1918ApheresisAllogeneicAcute Myeloid Leukemia; Myelodysplastic SyndromeHematology2022Standard TherapyGermany55
1919ApheresisAllogeneicAcute Promyelocytic LeukemiaHematology2022Standard TherapyPoland49
1920ApheresisAllogeneicAcute Promyelocytic LeukemiaHematology2022Standard TherapyPoland40
1921ApheresisAllogeneicAlk-Positive Anaplastic T-Cell LymphomaHematology2022Standard TherapyPoland15
1922ApheresisAutologousAnaplastic Large Cell LymphomaHematology2022Standard TherapyGermany22
1923ApheresisAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland22
1924ApheresisAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland16
1925ApheresisAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland17
1926ApheresisAllogeneicAplastic AnemiaHematology2022Standard TherapyGermany67
1927ApheresisAllogeneicAtypical Chronic Myeloid Leukemia Hematology2022Standard TherapyPoland62
1928ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland46
1929ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland18
1930ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany54
1931ApheresisAllogeneicBeta Thalassemia MajorHematology2022Standard TherapyPoland11
1932ApheresisAllogeneicC-All Rez (Acute Lymphoblastic Leukemia)Hematology2022Standard TherapyPoland66
1933ApheresisAllogeneicC-All Rez (Acute Lymphoblastic Leukemia)Hematology2022Standard TherapyPoland5
1934ApheresisAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland3
1935ApheresisAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland3
1936ApheresisAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland5
1937ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2022Standard TherapyPoland63
1938ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2022Standard TherapyPoland59
1939ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2022Standard TherapyGermany58
1940ApheresisAllogeneicChronic Lymphocytic Leukemia Richter Transformation 7/22Hematology2022Standard TherapyPoland44
1941ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland64
1942ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland67
1943ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland63
1944ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland59
1945ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland64
1946ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland60
1947ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland70
1948ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland54
1949ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland63
1950ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland54
1951ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland71
1952ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland67
1953ApheresisAllogeneicChronic Myelomonocytic Leukemia, Type 0 (Cmml-0)Hematology2022Standard TherapyPoland64
1954ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2022Standard TherapyPoland66
1955ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2022Standard TherapyPoland72
1956ApheresisAllogeneicCombined Immunodeficiency Syndrome With Hyper-IgmHematology2022Standard TherapyPoland6
1957ApheresisAllogeneicCongenital Dyserythropoietic AnemiaHematology2022Standard TherapyPoland2
1958ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany68
1959ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany65
1960ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany69
1961ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany50
1962ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany56
1963ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany65
1964ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany47
1965ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2022Standard TherapyGermany66
1966ApheresisAutologousDiffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany66
1967ApheresisAutologousGerm Cell TumorHematology2022Standard TherapyGermany39
1968ApheresisAutologousGerm Cell TumorHematology2022Standard TherapyGermany33
1969ApheresisAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2022Standard TherapyPoland12
1970ApheresisAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2022Standard TherapyPoland21
1971ApheresisAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland26
1972ApheresisAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland31
1973ApheresisAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland53
1974ApheresisAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland25
1975ApheresisAutologousHodgkin LymphomaHematology2022Standard TherapyGermany67
1976ApheresisAutologousHodgkin Lymphoma-RelapseHematology2022Standard TherapyGermany69
1977ApheresisAutologousHodgkin Lymphoma-RelapseHematology2022Standard TherapyGermany48
1978ApheresisAllogeneicHypoplastic Myelodysplastic SyndromeHematology2022Standard TherapyPoland26
1979ApheresisAllogeneicImmunodeficiencyHematology2022Standard TherapyPoland3
1980ApheresisAllogeneicJuvenile Myelomonocytic LeukemiaHematology2022Standard TherapyPoland5
1981ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany64
1982ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany61
1983ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany52
1984ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany44
1985ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany53
1986ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany49
1987ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany64
1988ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2022Standard TherapyPoland64
1989ApheresisAutologousMorbus HodgkinHematology2022Standard TherapyGermany36
1990ApheresisAutologousMorbus HodgkinHematology2022Standard TherapyGermany62
1991ApheresisAutologousMorbus Hodgkin-RelapseHematology2022Standard TherapyGermany63
1992ApheresisAllogeneicMucopolysaccharidosisHematology2022Standard TherapyPoland2
1993ApheresisAllogeneicMucopolysaccharidosis Type IHematology2022Standard TherapyPoland3
1994ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany58
1995ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany53
1996ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany57
1997ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany64
1998ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany50
1999ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany67
2000ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany55
2001ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany73
2002ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany63
2003ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany65
2004ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany58
2005ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany37
2006ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany47
2007ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany68
2008ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany53
2009ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany60
2010ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany60
2011ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany47
2012ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany59
2013ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany64
2014ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany59
2015ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany52
2016ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany73
2017ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany68
2018ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany63
2019ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany66
2020ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany50
2021ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany69
2022ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany57
2023ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany55
2024ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany61
2025ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany64
2026ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany71
2027ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany61
2028ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany62
2029ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany60
2030ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany33
2031ApheresisAllogeneicMultiple Myeloma - RelapseHematology2022Standard TherapyGermany43
2032ApheresisAutologousMultiple Myeloma Angioimmunoblastic T-Cell LymphomaHematology2022Standard TherapyGermany62
2033ApheresisAllogeneicMycosis FungoidesHematology2022Standard TherapyPoland64
2034ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2035ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland69
2036ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland76
2037ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland45
2038ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland63
2039ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland72
2040ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland70
2041ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland45
2042ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland73
2043ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland21
2044ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland46
2045ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland64
2046ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
2047ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland49
2048ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland62
2049ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland63
2050ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
2051ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland72
2052ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland33
2053ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland3
2054ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2055ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland16
2056ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland66
2057ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland64
2058ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
2059ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland62
2060ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland48
2061ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland62
2062ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland48
2063ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland73
2064ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland69
2065ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland79
2066ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland54
2067ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland44
2068ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland63
2069ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland56
2070ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2071ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland72
2072ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2073ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland64
2074ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2075ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland70
2076ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland66
2077ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland88
2078ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland67
2079ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland52
2080ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland57
2081ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland62
2082ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland36
2083ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland61
2084ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland11
2085ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyGermany61
2086ApheresisAllogeneicMyelodysplastic Syndrome - Raeb2Hematology2022Standard TherapyPoland62
2087ApheresisAllogeneicMyelodysplastic Syndrome RcHematology2022Standard TherapyPoland3
2088ApheresisAllogeneicMyelodysplastic Syndrome With Excess Blasts 1Hematology2022Standard TherapyPoland59
2089ApheresisAllogeneicMyelodysplastic Syndrome With Excess Blasts 2Hematology2022Standard TherapyPoland67
2090ApheresisAllogeneicMyelodysplastic Syndrome With FibrosisHematology2022Standard TherapyPoland72
2091ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland58
2092ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland69
2093ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland57
2094ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland64
2095ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland73
2096ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland67
2097ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland66
2098ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland69
2099ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland60
2100ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2022Standard TherapyPoland69
2101ApheresisAllogeneicMyelofibrosis Post Essential ThrombocythemiaHematology2022Standard TherapyPoland64
2102ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2022Standard TherapyPoland58
2103ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2022Standard TherapyPoland72
2104ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2022Standard TherapyPoland73
2105ApheresisAutologousMyelomaHematology2022Standard TherapyGermany54
2106ApheresisAllogeneicMyeloma MultiplexHematology2022Standard TherapyPoland31
2107ApheresisAllogeneicMyeloproliferative Neoplasms With Acute Myeloid LeukemiaHematology2022Standard TherapyGermany59
2108ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland50
2109ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland37
2110ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland64
2111ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland59
2112ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland21
2113ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland38
2114ApheresisAutologousNodular Lymphocyte Predominant Hodgkin LymphomaHematology2022Standard TherapyGermany31
2115ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland73
2116ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland61
2117ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland53
2118ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland18
2119ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland28
2120ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland55
2121ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland59
2122ApheresisAutologousNon-Hodgkin LymphomaHematology2022Standard TherapyGermany52
2123ApheresisAllogeneicOsteomyelofibrosisHematology2022Standard TherapyPoland59
2124ApheresisAllogeneicOsteomyelofibrosisHematology2022Standard TherapyPoland59
2125ApheresisAllogeneicOther Immune SystemHematology2022Standard TherapyPoland46
2126ApheresisAllogeneicOther MalignancyHematology2022Standard TherapyPoland72
2127ApheresisAllogeneicPeripheral T-Cell LymphomaHematology2022Standard TherapyPoland32
2128ApheresisAllogeneicPlasma Cell DisorderHematology2022Standard TherapyPoland56
2129ApheresisAllogeneicPlasma Cell LeukemiaHematology2022Standard TherapyPoland58
2130ApheresisAllogeneicPost-Essential Thrombocythemia-MyelofibrosisHematology2022Standard TherapyPoland64
2131ApheresisAllogeneicPost–Polycythemia Vera Myelofibrosis (Post-Pv Mf) Hematology2022Standard TherapyPoland48
2132ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany65
2133ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany65
2134ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany58
2135ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany39
2136ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany67
2137ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany37
2138ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany69
2139ApheresisAllogeneicPrimary MyelofibrosisHematology2022Standard TherapyPoland62
2140ApheresisAllogeneicPrimary MyelofibrosisHematology2022Standard TherapyPoland66
2141ApheresisAllogeneicPrimary MyelofibrosisHematology2022Standard TherapyPoland70
2142ApheresisAllogeneicPrimary Refractory T-Cell LymphomaHematology2022Standard TherapyPoland55
2143ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2022Standard TherapyPoland58
2144ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2022Standard TherapyGermany51
2145ApheresisAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland53
2146ApheresisAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland45
2147ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2022Standard TherapyPoland3 months
2148ApheresisAllogeneicSezary SyndromeHematology2022Standard TherapyPoland59
2149ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland6
2150ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2022Standard TherapyGermany37
2151ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2022Standard TherapyGermany30
2152ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2022Standard TherapyGermany46
2153ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyGermany52
2154ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyGermany51
2155ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyGermany52
2156ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyGermany60
2157ApheresisAutologousTesticular CancerHematology2022Standard TherapyGermany48
2158ApheresisAllogeneicThalassemia MajorHematology2022Standard TherapyPoland15
2159Adipose TissueAutologousGonarthrosisOrthopedy2022Experimental TherapyPoland60,11
2160Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2022Experimental TherapyPoland41,9
2161Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2022Experimental TherapyPoland30,1
2162Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2022Experimental TherapyPoland53
2163Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2021Experimental TherapyPoland7
2164Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2021Experimental TherapyPoland7,8
2165Cord TissueAllogeneic - UnrelatedAcute Myeloid Leukemia - Transplantation FailureHematology2021Experimental TherapyPoland13,5
2166Cord TissueAllogeneic - UnrelatedAgs (Autism + Epilepsy)Neurology2021Experimental TherapyPoland13,3
2167Cord TissueAllogeneic - UnrelatedAgs (Autism + Epilepsy)Neurology2021Experimental TherapyRomania13
2168Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland74,4
2169Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland64,11
2170Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland70,11
2171Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland59,2
2172Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland47,9
2173Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2174Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2175Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland66,8
2176Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland28,4
2177Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2178Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2179Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2180Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2181Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2182Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2183Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2184Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2185Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2186Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2187Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland54,11
2188Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2189Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2190Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2191Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2192Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland55,2
2193Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2194Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland70,5
2195Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland54,2
2196Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland58,11
2197Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2198Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2199Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2200Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland62,4
2201Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland74,6
2202Cord TissueAllogeneic - RelatedAutismNeurology2021Experimental TherapyPoland4
2203Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland9,2
2204Cord TissueAllogeneic - RelatedAutismNeurology2021Experimental TherapyPoland10
2205Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland4,6
2206Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland15,5
2207Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPolandno data
2208Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland7,11
2209Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland6,9
2210Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland4,9
2211Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland12,5
2212Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland12,1
2213Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland7,5
2214Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland8,7
2215Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland11,1
2216Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland5,3
2217Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland4,5
2218Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland8,11
2219Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland6,4
2220Cord TissueAllogeneic - UnrelatedBone Marrow Transplant Rejection; Graft Versus Host DiseaseHematology2021Experimental TherapyPoland6,8
2221Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2021Experimental TherapyPoland59
2222Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland3,1
2223Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland7,1
2224Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland5
2225Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland17
2226Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland6,6
2227Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland6,1
2228Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland1,9
2229Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland11
2230Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland7,11
2231Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland12
2232Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland1,9
2233Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland5,9
2234Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland7,9
2235Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland1,7
2236Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland4,1
2237Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland5,11
2238Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland11,4
2239Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland4,3
2240Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland4,1
2241Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland2,11
2242Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland11,6
2243Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland5,1
2244Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland2
2245Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland3,4
2246Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland9 months
2247Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland2,1
2248Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland23,3
2249Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland22,9
2250Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland3,11
2251Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland5,5
2252Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland8
2253Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyRomania11 months
2254Cord TissueAllogeneic - UnrelatedCerebral Palsy; Developmental DelayNeurology2021Experimental TherapyPoland12,2
2255Cord TissueAllogeneic - UnrelatedCerebral Palsy; Devic SyndromeNeurology2021Experimental TherapyPoland32,5
2256Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2021Experimental TherapyPoland2,6
2257Cord TissueAllogeneic - UnrelatedCondition After Cerebral InfarctionNeurology2021Experimental TherapyPoland42,7
2258Cord TissueAllogeneic - UnrelatedCondition After Knee InjuryOrthopedy2021Experimental TherapyPoland54,5
2259Cord TissueAllogeneic - UnrelatedCondition After Knee InjuryOrthopedy2021Experimental TherapyPoland40,4
2260Cord TissueAllogeneic - UnrelatedCoxarthrosisOrthopedy2021Experimental TherapyPoland69,4
2261Cord TissueAllogeneic - UnrelatedCoxarthrosisOrthopedy2021Experimental TherapyPoland55,2
2262Cord TissueAllogeneic - UnrelatedCoxarthrosisOrthopedy2021Experimental TherapyPoland50,2
2263Cord TissueAllogeneic - UnrelatedDegenerative Disease Of The SpineOrthopedy2021Experimental TherapyPoland51,2
2264Cord TissueAllogeneic - UnrelatedDegenerative Disease Of The SpineOrthopedy2021Experimental TherapyPoland56,2
2265Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2021Experimental TherapyPoland6,5
2266Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2021Experimental TherapyPoland27,2
2267Cord TissueAllogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Hematology2021Experimental TherapyTurkey25
2268Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2021Experimental TherapyPoland35,2
2269Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2021Experimental TherapyPoland2,4
2270Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2021Experimental TherapyPoland6,5
2271Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2272Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2273Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2274Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2275Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPoland21,11
2276Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2277Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2278Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2279Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2280Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2281Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2282Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2283Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2284Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2285Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2286Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2287Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2288Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2289Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2290Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2291Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2292Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland6,7
2293Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland9,8
2294Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland9,7
2295Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland2,11
2296Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland5,11
2297Cord TissueAllogeneic - UnrelatedEpileptic Encephalopathy; Global Developmental DelayNeurology2021Experimental TherapyPoland2,8
2298Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2021Experimental TherapyPoland5,7
2299Cord TissueAllogeneic - RelatedGlobal Developmental DelayNeurology2021Experimental TherapyPoland2
2300Cord TissueAllogeneic - UnrelatedGlobal Developmental Delay; EncephalopathyNeurology2021Experimental TherapyPoland2,9
2301Cord TissueAllogeneic - UnrelatedGlobal Developmental Delay; EncephalopathyNeurology2021Experimental TherapyPoland7,8
2302Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland59,11
2303Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland48,6
2304Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland53,6
2305Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland40
2306Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland62,11
2307Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland63
2308Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland72,5
2309Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland58,1
2310Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland46,3
2311Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland50,2
2312Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland51,2
2313Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland52,5
2314Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2021Experimental TherapyPoland4,7
2315Cord TissueAllogeneic - UnrelatedHemiparesisNeurology2021Experimental TherapyPoland37,3
2316Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2021Experimental TherapyPoland30,5
2317Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2021Experimental TherapyPoland7 months
2318Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2021Experimental TherapyPoland44,8
2319Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland5,7
2320Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland10,1
2321Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland5,5
2322Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland4
2323Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland2
2324Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland9,5
2325Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland4,5
2326Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland5
2327Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland5,6
2328Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland1,1
2329Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2021Experimental TherapyPoland1,6
2330Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2021Experimental TherapyPoland50,7
2331Cord TissueAllogeneic - UnrelatedNervous System DegenerationNeurology2021Experimental TherapyPoland56,9
2332Cord TissueAllogeneic - UnrelatedNon-Hodkin Lymphoma; Chronic Graft Versus Host DiseaseHematology2021Experimental TherapyPoland14,8
2333Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland13,7
2334Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland26,4
2335Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland45,1
2336Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland27,3
2337Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland22,2
2338Cord TissueAllogeneic - UnrelatedOsteoarthritisOrthopedy2021Experimental TherapyPoland57,2
2339Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2021Experimental TherapyPoland29,7
2340Cord TissueAllogeneic - UnrelatedSoft Tissue DiseasesOrthopedy2021Experimental TherapyPoland68,4
2341Cord TissueAllogeneic - UnrelatedSoft Tissue DiseasesOrthopedy2021Experimental TherapyPoland52,7
2342Cord TissueAllogeneic - UnrelatedSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2021Experimental TherapyPoland24,11
2343Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2021Experimental TherapyPoland24
2344Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2021Experimental TherapyPoland4,1
2345Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2021Experimental TherapyPoland30,8
2346Cord TissueAllogeneic - UnrelatedThermal InjuryDermatology2021Clinical Trial BIOOPAPolandno data
2347Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2348Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2349Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2350Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2351Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2352Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2353Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2354Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2355Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2356Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2357Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2358Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2359Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2360Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2361Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2362Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2363Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2364Cord BloodAutologousAutismNeurology2021Experimental TherapyPoland5,8
2365Cord BloodAutologousAutismNeurology2021Experimental TherapyPoland9,7
2366Cord BloodAllogeneic - RelatedAutismNeurology2021Experimental TherapyPoland7
2367Cord BloodAutologousAutismNeurology2021Experimental TherapyPoland4,1
2368Cord BloodAutologousAutismNeurology2021Experimental TherapyRomania3,9
2369Cord BloodAutologousAutismNeurology2021Experimental TherapyRomania5,2
2370Cord BloodAutologousAutismNeurology2021Experimental TherapyGermany7
2371Cord BloodAllogeneic - RelatedAutismNeurology2021Experimental TherapyGermany8
2372Cord BloodAutologousAutismNeurology2021Experimental TherapyGermany9
2373Cord BloodAutologousAutismNeurology2021Experimental TherapyGermany7
2374Cord BloodAutologousAutismNeurology2021Experimental TherapyGermany6
2375Cord BloodAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland9
2376Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland6
2377Cord BloodAllogeneic - RelatedDiamond Blackfan AnemiaHematology2021Standard TherapyTurkey3,12
2378Cord BloodAutologousFanconi AnemiaHematology2021Standard TherapyGermany7
2379Cord BloodAllogeneic - RelatedImmune Failure-Cd40 L DeficiencyHematology2021Standard TherapyTurkey12,4
2380Cord BloodAllogeneic - RelatedThalassemia MajorHematology2021Standard TherapyTurkey5,6
2381Cord BloodAllogeneic - RelatedThalassemia MajorHematology2021Standard TherapyTurkey16,6
2382Cord BloodAllogeneic - RelatedThalassemia MajorHematology2021Standard TherapyTurkey7,3
2383Cord BloodAllogeneic - RelatedThalassemia MajorHematology2021Standard TherapyTurkey16
2384Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland58
2385Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland33
2386Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2387Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2388Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2389Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2390Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland74
2391Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2392Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland67
2393Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2394Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2395Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland48
2396Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2397Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland47
2398Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland74
2399Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2400Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2401Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland34
2402Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland64
2403Bone Marrow FamilyAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland36
2404Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland39
2405Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland71
2406Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland64
2407Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
2408Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2409Bone Marrow FamilyAllogeneicMyelofibrosisHematology2021Standard TherapyPoland52
2410Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2021Standard TherapyPoland48
2411Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland50
2412Bone Marrow FamilyAllogeneicRefractory CytopeniaHematology2021Standard TherapyPoland45
2413Bone Marrow FamilyAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland2
2414Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland11
2415Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland17
2416Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland1
2417Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland8
2418Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland1
2419Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland11
2420Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland4
2421Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland6
2422Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland1
2423Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland47
2424Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2425Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland6
2426Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2427Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland2
2428Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2429Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland2
2430Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2431Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland31
2432Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland4
2433Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland15
2434Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2435Bone MarrowAllogeneicAdrenoleukodystrophyMetabolic2021Standard TherapyPoland8
2436Bone MarrowAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland32
2437Bone MarrowAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland19
2438Bone MarrowAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland49
2439Bone MarrowAllogeneicAplastic Anemia; Paroxysmal Nocturnal HemoglobinuriaHematology2021Standard TherapyPoland32
2440Bone MarrowAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland16
2441Bone MarrowAllogeneicBcr-Abl Pos. AllHematology2021Standard TherapyPoland51
2442Bone MarrowAllogeneicBeta Thalassemia MajorHematology2021Standard TherapyPoland14
2443Bone MarrowAllogeneicCartilage Hair HypoplasiaHematology2021Standard TherapyPoland7
2444Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland2
2445Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland1
2446Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland2
2447Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland44
2448Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland64
2449Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland47
2450Bone MarrowAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland53
2451Bone MarrowAllogeneicCombined ImmunodeficiencyHematology2021Standard TherapyPoland1
2452Bone MarrowAllogeneicCombined Immunodeficiency Syndrome With Hyper-IgmHematology2021Standard TherapyPoland5
2453Bone MarrowAllogeneicFanconi AnemiaHematology2021Standard TherapyPoland4
2454Bone MarrowAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2021Standard TherapyPoland3
2455Bone MarrowAllogeneicHurler SyndromeHematology2021Standard TherapyPoland3
2456Bone MarrowAllogeneicImmunodeficiencyHematology2021Standard TherapyPoland2
2457Bone MarrowAllogeneicInherited Immune System DisorderHematology2021Standard TherapyPoland1
2458Bone MarrowAllogeneicIpex- Other ImmuneHematology2021Standard TherapyPoland20
2459Bone MarrowAllogeneicLeukemia Lymphoblastic AcutaHematology2021Standard TherapyPoland6
2460Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2461Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland10
2462Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland2
2463Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland30
2464Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland67
2465Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland59
2466Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland59
2467Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland69
2468Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland55
2469Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland14
2470Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland41
2471Bone MarrowAllogeneicOsteopetrosisHematology2021Standard TherapyPoland7
2472Bone MarrowAllogeneicOther Leukemia SpecifyHematology2021Standard TherapyPoland35
2473Bone MarrowAllogeneicOther MyelofibrosisHematology2021Standard TherapyPoland72
2474Bone MarrowAllogeneicRefractory CytopeniaHematology2021Standard TherapyPoland7
2475Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland23
2476Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland53
2477Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland12
2478Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland5
2479Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland13
2480Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland12
2481Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland32
2482Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland1
2483Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland1
2484Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2021Standard TherapyPoland9 months
2485ApheresisAllogeneicAcute Biphenotypic LeukemiaHematology2021Standard TherapyPoland28
2486ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland17
2487ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland73
2488ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland38
2489ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland31
2490ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland24
2491ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland27
2492ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland54
2493ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland51
2494ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland65
2495ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland47
2496ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland10
2497ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland23
2498ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland5
2499ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland28
2500ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland58
2501ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland13
2502ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland55
2503ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland42
2504ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland20
2505ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland58
2506ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland52
2507ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland68
2508ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland32
2509ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland19
2510ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland61
2511ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland42
2512ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland3
2513ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland29
2514ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland8
2515ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland54
2516ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland20
2517ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland6
2518ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland61
2519ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland24
2520ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland66
2521ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland38
2522ApheresisAllogeneicAcute Lymphoblastic Leukemia - RelapseHematology2021Standard TherapyPoland38
2523ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland40
2524ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2525ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland23
2526ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2527ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2528ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland73
2529ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2530ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland48
2531ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2532ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland24
2533ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland50
2534ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2535ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2536ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland46
2537ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2538ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland47
2539ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland45
2540ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland70
2541ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2542ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland70
2543ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2544ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland37
2545ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland21
2546ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2547ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland20
2548ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland43
2549ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland56
2550ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2551ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2552ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2553ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2554ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland56
2555ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2556ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland61
2557ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2558ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2559ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2560ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland73
2561ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2562ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland32
2563ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2564ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2565ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2566ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2567ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland38
2568ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland40
2569ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2570ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2571ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2572ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland28
2573ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland48
2574ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland52
2575ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland40
2576ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2577ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2578ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland45
2579ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2580ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland71
2581ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2582ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland29
2583ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2584ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland30
2585ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland47
2586ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2587ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2588ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2589ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2590ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland30
2591ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2592ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland44
2593ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2594ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2595ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2596ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland47
2597ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2598ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland42
2599ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2600ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2601ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland37
2602ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland67
2603ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2604ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2605ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland12
2606ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland70
2607ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland38
2608ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2609ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland46
2610ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland39
2611ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2612ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2613ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2614ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2615ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2616ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2617ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland48
2618ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2619ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2620ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2621ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland57
2622ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2623ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland49
2624ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2625ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2626ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2627ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland40
2628ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2629ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland73
2630ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland56
2631ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland46
2632ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland3
2633ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland25
2634ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2635ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland61
2636ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland51
2637ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland50
2638ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2639ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2640ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland35
2641ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2642ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland14
2643ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland49
2644ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland80
2645ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2646ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland31
2647ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland32
2648ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland61
2649ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2650ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland10
2651ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland67
2652ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland57
2653ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2654ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2655ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland61
2656ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland17
2657ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland46
2658ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland34
2659ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland39
2660ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2661ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2662ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland22
2663ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland56
2664ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland42
2665ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2666ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland52
2667ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland13
2668ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany32
2669ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany61
2670ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany72
2671ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany55
2672ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany57
2673ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany62
2674ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany46
2675ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany63
2676ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany65
2677ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany71
2678ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany53
2679ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany57
2680ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany50
2681ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany32
2682ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany71
2683ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2021Standard TherapyGermany65
2684ApheresisAutologousAmyloidosisHematology2021Standard TherapyGermany63
2685ApheresisAllogeneicAnaplastic Large Cell LymphomaHematology2021Standard TherapyGermany56
2686ApheresisAutologousAngioimmunoblastic T-Cell LymphomaHematology2021Standard TherapyGermany62
2687ApheresisAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland54
2688ApheresisAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland7
2689ApheresisAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland40
2690ApheresisAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland14
2691ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland36
2692ApheresisAutologousB-Cell LymphomaHematology2021Standard TherapyGermany59
2693ApheresisAutologousB-Cell LymphomaHematology2021Standard TherapyGermany33
2694ApheresisAutologousB-Cell LymphomaHematology2021Standard TherapyGermany63
2695ApheresisAutologousB-Cell LymphomaHematology2021Standard TherapyGermany49
2696ApheresisAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland28
2697ApheresisAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland11
2698ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2021Standard TherapyPoland62
2699ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2021Standard TherapyPoland60
2700ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2021Standard TherapyPoland63
2701ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland52
2702ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland45
2703ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland37
2704ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland62
2705ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland64
2706ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland74
2707ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland31
2708ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland63
2709ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland18
2710ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland68
2711ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland59
2712ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland67
2713ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland62
2714ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland34
2715ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland70
2716ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland71
2717ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2021Standard TherapyGermany67
2718ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2021Standard TherapyPoland62
2719ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2021Standard TherapyPoland50
2720ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2021Standard TherapyGermany68
2721ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2021Standard TherapyGermany63
2722ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2021Standard TherapyGermany65
2723ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2021Standard TherapyGermany65
2724ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2021Standard TherapyGermany71
2725ApheresisAllogeneicFarber DiseaseHematology2021Standard TherapyPoland9
2726ApheresisAllogeneicFollicular LymphomaHematology2021Standard TherapyPoland54
2727ApheresisAutologousFollicular LymphomaHematology2021Standard TherapyGermany55
2728ApheresisAutologousFollicular LymphomaHematology2021Standard TherapyGermany64
2729ApheresisAutologousFollicular LymphomaHematology2021Standard TherapyGermany50
2730ApheresisAutologousGerm Cell TumorHematology2021Standard TherapyGermany28
2731ApheresisAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2021Standard TherapyPoland23
2732ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland41
2733ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland40
2734ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland27
2735ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland19
2736ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland26
2737ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland32
2738ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyGermany21
2739ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyGermany37
2740ApheresisAutologousHodgkin LymphomaHematology2021Standard TherapyGermany30
2741ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyGermany47
2742ApheresisAutologousHodgkin LymphomaHematology2021Standard TherapyGermany36
2743ApheresisAutologousHodgkin LymphomaHematology2021Standard TherapyGermany30
2744ApheresisAllogeneicHurler SyndromeHematology2021Standard TherapyPoland2
2745ApheresisAllogeneicImmunodeficiencyHematology2021Standard TherapyPoland12
2746ApheresisAllogeneicLeukemiaHematology2021Standard TherapyPoland63
2747ApheresisAllogeneicLymphomaHematology2021Standard TherapyPoland58
2748ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany66
2749ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany57
2750ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany66
2751ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany57
2752ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany63
2753ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany56
2754ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany65
2755ApheresisAllogeneicMetachromatic LeukodystrophyHematology2021Standard TherapyPoland60
2756ApheresisAutologousMorbus HodgkinHematology2021Standard TherapyGermany36
2757ApheresisAutologousMorbus HodgkinHematology2021Standard TherapyGermany50
2758ApheresisAutologousMorbus HodgkinHematology2021Standard TherapyGermany21
2759ApheresisAllogeneicMucopolysaccharidosisHematology2021Standard TherapyPoland2
2760ApheresisAllogeneicMultiple MyelomaHematology2021Standard TherapyPoland44
2761ApheresisAllogeneicMultiple MyelomaHematology2021Standard TherapyPoland60
2762ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany70
2763ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany71
2764ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany53
2765ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany51
2766ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
2767ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany65
2768ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany62
2769ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany57
2770ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany66
2771ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany50
2772ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany65
2773ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany50
2774ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany47
2775ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany43
2776ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany66
2777ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany56
2778ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany65
2779ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany51
2780ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
2781ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany62
2782ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany68
2783ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany70
2784ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany70
2785ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany38
2786ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
2787ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany63
2788ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany71
2789ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany52
2790ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany63
2791ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany57
2792ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany68
2793ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
2794ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany58
2795ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany57
2796ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany60
2797ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany58
2798ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany67
2799ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany62
2800ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany42
2801ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
2802ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany67
2803ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany57
2804ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany68
2805ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland68
2806ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland41
2807ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland60
2808ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland8
2809ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland61
2810ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland62
2811ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland68
2812ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
2813ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland56
2814ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland62
2815ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland57
2816ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland47
2817ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
2818ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland29
2819ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland66
2820ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2821ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2822ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland59
2823ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland50
2824ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland59
2825ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland28
2826ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland68
2827ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
2828ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland54
2829ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland66
2830ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland52
2831ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2832ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland75
2833ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland72
2834ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland62
2835ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland40
2836ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
2837ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland67
2838ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland72
2839ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland64
2840ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland64
2841ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland53
2842ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland53
2843ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland73
2844ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2845ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland8
2846ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland66
2847ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland26
2848ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland56
2849ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland63
2850ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland61
2851ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2852ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland66
2853ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyGermany48
2854ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyGermany58
2855ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyGermany59
2856ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland62
2857ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland63
2858ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland64
2859ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland66
2860ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland65
2861ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland56
2862ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland75
2863ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland65
2864ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland51
2865ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland63
2866ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland75
2867ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland64
2868ApheresisAllogeneicMyeloma MultiplexHematology2021Standard TherapyPoland48
2869ApheresisAllogeneicMyeloma MultiplexHematology2021Standard TherapyPoland53
2870ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2021Standard TherapyPoland67
2871ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2021Standard TherapyPoland58
2872ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2021Standard TherapyGermany51
2873ApheresisAllogeneicNo DataHematology2021Standard TherapyPoland64
2874ApheresisAllogeneicNo DataHematology2021Standard TherapyPoland57
2875ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland30
2876ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland51
2877ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland58
2878ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland56
2879ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland58
2880ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland50
2881ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland53
2882ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland20
2883ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland64
2884ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland66
2885ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyGermany62
2886ApheresisAutologousNon-Hodgkin LymphomaHematology2021Standard TherapyGermany61
2887ApheresisAutologousNon-Hodgkin LymphomaHematology2021Standard TherapyGermany49
2888ApheresisAllogeneicNon-Hodgkin-Lymphoma-RelapseHematology2021Standard TherapyGermany62
2889ApheresisAllogeneicOsteomyelitisHematology2021Standard TherapyPoland47
2890ApheresisAllogeneicOsteomyelofibrosisHematology2021Standard TherapyPoland69
2891ApheresisAllogeneicOsteomyelofibrosisHematology2021Standard TherapyPoland43
2892ApheresisAutologousOsteosclerotic MyelomaHematology2021Standard TherapyGermany54
2893ApheresisAllogeneicOther Myelodysplastic SyndromesHematology2021Standard TherapyPoland65
2894ApheresisAllogeneicOther MyelofibrosisHematology2021Standard TherapyPoland68
2895ApheresisAllogeneicOther MyelofibrosisHematology2021Standard TherapyPoland70
2896ApheresisAllogeneicOther MyelofibrosisHematology2021Standard TherapyPoland72
2897ApheresisAllogeneicOther Plasma Cell DisorderHematology2021Standard TherapyPoland67
2898ApheresisAllogeneicPeripheral T-Cell LymphomaHematology2021Standard TherapyPoland45
2899ApheresisAllogeneicPhiladelphia-Positive Acute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland61
2900ApheresisAllogeneicPolycythemia VeraHematology2021Standard TherapyPoland65
2901ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany71
2902ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany66
2903ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany62
2904ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany53
2905ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany44
2906ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany54
2907ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany65
2908ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany65
2909ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany60
2910ApheresisAllogeneicPrimary MyelofibrosisHematology2021Standard TherapyPoland66
2911ApheresisAllogeneicPrimary MyelofibrosisHematology2021Standard TherapyPoland63
2912ApheresisAllogeneicPrimary MyelofibrosisHematology2021Standard TherapyPoland62
2913ApheresisAllogeneicPrimary MyelofibrosisHematology2021Standard TherapyPoland64
2914ApheresisAllogeneicProlymphocytic LeukemiaHematology2021Standard TherapyPoland68
2915ApheresisAllogeneicProlymphocytic LeukemiaHematology2021Standard TherapyPoland64
2916ApheresisAllogeneicRefractory CytopeniaHematology2021Standard TherapyPoland6
2917ApheresisAllogeneicSecondary Acute Lymphoblastic Leukemia From Chronic Myeloid LeukemiaHematology2021Standard TherapyPoland58
2918ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2021Standard TherapyGermany70
2919ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2021Standard TherapyGermany64
2920ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2021Standard TherapyGermany39
2921ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2021Standard TherapyGermany60
2922ApheresisAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland35
2923ApheresisAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland58
2924ApheresisAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland41
2925ApheresisAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland38
2926ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland1
2927ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland1
2928ApheresisAllogeneicT-Cell Lymphoblastic LymphomaHematology2021Standard TherapyGermany26
2929ApheresisAllogeneicT-Cell Lymphoblastic LymphomaHematology2021Standard TherapyGermany37
2930ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2021Standard TherapyGermany54
2931ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2021Standard TherapyGermany66
2932ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2021Standard TherapyGermany66
2933ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2021Standard TherapyGermany29
2934ApheresisAllogeneicT-Cell-LymphomaHematology2021Standard TherapyPoland45
2935ApheresisAutologousTesticular CancerHematology2021Standard TherapyGermany33
2936ApheresisAllogeneicΒ - ThalassemiaHematology2021Standard TherapyPoland17
2937Adipose TissueAutologousGonarthrosisOrthopedy2021Experimental TherapyPoland51,1
2938Adipose TissueAutologousGonarthrosisOrthopedy2021Experimental TherapyPoland44,4
2939Adipose TissueAutologousGonarthrosisOrthopedy2021Experimental TherapyPoland35,8
2940Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2021Experimental TherapyPoland40.9
2941Adipose TissueAutologousSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2021Experimental TherapyPoland27,5
2942Placenta bloodAutologousCerebral PalsyNeurology2020Experimental TherapyPoland2,6
2943Cord TissueAllogeneic - Unrelated Covid-19Pulmonology2020Experimental TherapyPoland84,5
2944Cord TissueAllogeneic - UnrelatedAcquired Epileptic AphasiaNeurology2020Experimental TherapyPoland4,11
2945Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2020Experimental TherapyPoland8,11
2946Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2020Experimental TherapyPoland8
2947Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2020Experimental TherapyPoland2,4
2948Cord TissueAllogeneic - UnrelatedAcute Respiratory Distress Syndrome; Covid-19Pulmonology2020Experimental TherapyPoland53
2949Cord TissueAllogeneic - UnrelatedAcute Respiratory Distress Syndrome; Covid-19Pulmonology2020Experimental TherapyPoland66,11
2950Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophyNeurology2020Experimental TherapyPoland8,1
2951Cord TissueAllogeneic - UnrelatedAlopecia AreataDermatology2020Experimental TherapyPoland36,6
2952Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland53,2
2953Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland54,4
2954Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland48,1
2955Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland64,11
2956Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland62,9
2957Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland69,1
2958Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland52,11
2959Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland58
2960Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland59,7
2961Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland52,7
2962Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland62,5
2963Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland59,6
2964Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland59,1
2965Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland58,1
2966Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland4,3
2967Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland7,1
2968Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland8,7
2969Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland7,6
2970Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland9,11
2971Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland4,9
2972Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland6,1
2973Cord TissueAllogeneic - RelatedAutismNeurology2020Experimental TherapyPoland8
2974Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland7,1
2975Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland7,1
2976Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland5,1
2977Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland9,4
2978Cord TissueAllogeneic - RelatedAutismNeurology2020Experimental TherapyRomania13
2979Cord TissueAllogeneic - RelatedAutismNeurology2020Experimental TherapyPoland10
2980Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland6,5
2981Cord TissueAllogeneic - UnrelatedBone Marrow Transplant RejectionHematology2020Experimental TherapyPoland14,2
2982Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2020Experimental TherapyPoland57,11
2983Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland17,2
2984Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,4
2985Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,7
2986Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland5
2987Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,7
2988Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland8,7
2989Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland15,6
2990Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2020Experimental TherapyPoland6
2991Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland3,1
2992Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,7
2993Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland13
2994Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland2,9
2995Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,1
2996Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland8,3
2997Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland7,11
2998Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland4,4
2999Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2020Experimental TherapyPoland4
3000Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,11
3001Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland4,11
3002Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland18,2
3003Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland5,8
3004Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland10,9
3005Cord TissueAllogeneic - UnrelatedCerebral Palsy; Developmental DelayNeurology2020Experimental TherapyPoland5,9
3006Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2020Experimental TherapyPoland9,8
3007Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2020Experimental TherapyPoland1,7
3008Cord TissueAllogeneic - UnrelatedChondromalaciaOrthopedy2020Experimental TherapyPoland61,7
3009Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2020Experimental TherapyPoland4,7
3010Cord TissueAllogeneic - UnrelatedCondition After Knee InjuryOrthopedy2020Experimental TherapyPoland42,1
3011Cord TissueAllogeneic - UnrelatedCovid-19Pulmonology2020Experimental TherapyPoland74,5
3012Cord TissueAllogeneic - UnrelatedCovid-19Pulmonology2020Experimental TherapyPoland76,2
3013Cord TissueAllogeneic - UnrelatedCovid-19; Severe Pneumonia; Acute Respiratory FailurePulmonology2020Experimental TherapyPoland59,5
3014Cord TissueAllogeneic - UnrelatedCoxarthrosisOrthopedy2020Experimental TherapyPoland46,4
3015Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2020Experimental TherapyPoland5,8
3016Cord TissueAllogeneic - RelatedDevelopmental DelayNeurology2020Experimental TherapyRomania13
3017Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2020Experimental TherapyPoland6
3018Cord TissueAllogeneic - UnrelatedDisorder Of Brain, Unspecified; AdrenoleukodystrophyNeurology2020Experimental TherapyPoland11,9
3019Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2020Experimental TherapyPoland26,6
3020Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland35,6
3021Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland44
3022Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland35,3
3023Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland29,3
3024Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland30,9
3025Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland5,3
3026Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland17,11
3027Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland21,5
3028Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2020Experimental TherapyPoland10,9
3029Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2020Experimental TherapyPoland2,1
3030Cord TissueAllogeneic - UnrelatedEpilepsy; Developmental DelayNeurology2020Experimental TherapyPoland15,8
3031Cord TissueAllogeneic - UnrelatedEpilepsy; Encephalopathy; Developmental DelayNeurology2020Experimental TherapyPoland7,1
3032Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2020Experimental TherapyPoland40,5
3033Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2020Experimental TherapyPoland6,4
3034Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland61,8
3035Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland62,8
3036Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland62,11
3037Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland60,1
3038Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland73,6
3039Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland63,8
3040Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland60,3
3041Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland64,8
3042Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland57,5
3043Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland53,9
3044Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland56,9
3045Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland63,7
3046Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland49,9
3047Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland58
3048Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland61,4
3049Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland60,2
3050Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland50,8
3051Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2020Experimental TherapyPortugal18
3052Cord TissueAllogeneic - UnrelatedGraft Versus Host Disease; Transplantation FailureHematology2020Experimental TherapyPoland2,9
3053Cord TissueAllogeneic - UnrelatedGuillain-Barré SyndromeNeurology2020Experimental TherapyPoland43,5
3054Cord TissueAllogeneic - UnrelatedHead InjuryNeurology2020Experimental TherapyPoland16,3
3055Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2020Experimental TherapyPoland2,11
3056Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2020Experimental TherapyPoland5,4
3057Cord TissueAllogeneic - UnrelatedHypoxic Encephalopathy; Drug-Resistant EpilepsyNeurology2020Experimental TherapyPoland20,9
3058Cord TissueAllogeneic - UnrelatedLimb UlcerationDermatology2020Experimental TherapyPoland82,7
3059Cord TissueAllogeneic - UnrelatedMacular DegenerationOphthalmology2020Experimental TherapyPoland20,8
3060Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2020Experimental TherapyPoland56,4
3061Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2020Experimental TherapyPoland8,11
3062Cord TissueAllogeneic - UnrelatedMyelomeningocele; Arnold-Chiari MalformationNeurology2020Experimental TherapyPoland2,5
3063Cord TissueAllogeneic - UnrelatedMyelomeningocele; HydrocephalusNeurology2020Experimental TherapyPoland2,11
3064Cord TissueAllogeneic - UnrelatedMyoclonic Epilepsy With Ragged Red FibersNeurology2020Experimental TherapyPoland23,4
3065Cord TissueAllogeneic - UnrelatedNo Bone AdhesionOrthopedy2020Experimental TherapyPoland69,5
3066Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland16,3
3067Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland66,3
3068Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland23,11
3069Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland27,1
3070Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland31,9
3071Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland58,3
3072Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland41,2
3073Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2020Experimental TherapyPoland41,2
3074Cord TissueAllogeneic - UnrelatedOsteoarthritisOrthopedy2020Experimental TherapyPoland56,5
3075Cord TissueAllogeneic - UnrelatedOther Specific Cartilage DiseasesOrthopedy2020Experimental TherapyPoland39,4
3076Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2020Experimental TherapyPoland4,1
3077Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System - Global Development Delay And MicrocephalyNeurology2020Experimental TherapyPoland2,11
3078Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; Congenital Genetic DefectNeurology2020Experimental TherapyPoland2,6
3079Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; Congenital Genetic DefectNeurology2020Experimental TherapyPoland5,2
3080Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; Cornelia De Lange SyndromeNeurology2020Experimental TherapyPoland4,4
3081Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; Hypoxia-Ischemic EncephalopathyNeurology2020Experimental TherapyPoland4,3
3082Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; LissencephalyNeurology2020Experimental TherapyPoland6,4
3083Cord TissueAllogeneic - UnrelatedOther Sphingolipidoses; Krabbe's LeukodystrophyNeurology2020Experimental TherapyPoland4
3084Cord TissueAllogeneic - UnrelatedOther Spinal Muscular Atrophy And Related Syndromes; Bulbar PalsyNeurology2020Experimental TherapyPolandno data
3085Cord TissueAllogeneic - UnrelatedPolyneuropathyNeurology2020Experimental TherapyPoland43,11
3086Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2020Experimental TherapyPoland33,7
3087Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2020Experimental TherapyPoland61,5
3088Cord TissueAllogeneic - UnrelatedSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2020Experimental TherapyPoland59,6
3089Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2020Experimental TherapyPoland11 months
3090Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2020Experimental TherapyPoland1,3
3091Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2020Experimental TherapyPoland33,2
3092Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2020Experimental TherapyPoland37,11
3093Cord TissueAllogeneic - UnrelatedState After EncephalitisNeurology2020Experimental TherapyPoland3,8
3094Cord TissueAllogeneic - UnrelatedTendon InjuryOrthopedy2020Experimental TherapyPoland29
3095Cord TissueAllogeneic - UnrelatedTransplantation Failure; Coexisting Viral InfectionsHematology2020Experimental TherapyPoland13,1
3096Cord BloodAutologousAutismNeurology2020Experimental TherapyPolandno data
3097Cord BloodAutologousAutismNeurology2020Experimental TherapyGermany9
3098Cord BloodAutologousAutismNeurology2020Experimental TherapyGermany5
3099Cord BloodAutologousB-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyUK5
3100Cord BloodAutologousCerebral PalsyNeurology2020Experimental TherapyPoland2,2
3101Cord BloodAutologousCerebral PalsyNeurology2020Experimental TherapyPoland2,9
3102Cord BloodAutologousCerebral PalsyNeurology2020Experimental TherapyPoland2,4
3103Cord BloodAllogeneic - RelatedSevere Aplastic AnemiaHematology2020Standard TherapyPolandno data
3104Cord BloodAllogeneic - RelatedThalassemia MajorHematology2020Standard TherapyTurkey3,4
3105Cord BloodAllogeneic - RelatedThalassemia MajorHematology2020Standard TherapyTurkey3,4
3106Cord BloodAllogeneic - RelatedThalassemia MajorHematology2020Standard TherapyTurkey4,4
3107Cord BloodAllogeneic - RelatedThalassemia MajorHematology2020Standard TherapyTurkey4,4
3108Bone Marrow FamilyAllogeneicAcute Lymphoblastic Leukemia - RelapseHematology2020Standard TherapyGermany57
3109Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland69
3110Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland48
3111Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3112Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland72
3113Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3114Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland38
3115Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3116Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany76
3117Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia - RelapseHematology2020Standard TherapyGermany61
3118Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia - RelapseHematology2020Standard TherapyGermany68
3119Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2020Standard TherapyPoland63
3120Bone Marrow FamilyAllogeneicHodgkin LymphomaHematology2020Standard TherapyPoland35
3121Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland71
3122Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland31
3123Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland62
3124Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland59
3125Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland67
3126Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3127Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland70
3128Bone Marrow FamilyAllogeneicT-Cell Lymphoblastic LeukemiaHematology2020Standard TherapyGermany24
3129Bone Marrow (Apheresismily donor)AllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland68
3130Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland14
3131Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland1
3132Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland52
3133Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland66
3134Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland4
3135Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland15
3136Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland5
3137Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland3
3138Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland62
3139Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland47
3140Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland1
3141Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland16
3142Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland43
3143Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland9
3144Bone MarrowAllogeneicAplastic AnemiaHematology2020Standard TherapyPoland10
3145Bone MarrowAllogeneicAplastic AnemiaHematology2020Standard TherapyPoland27
3146Bone MarrowAllogeneicAplastic AnemiaHematology2020Standard TherapyPoland23
3147Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2020Standard TherapyPoland6
3148Bone MarrowAllogeneicCongenital NeutropeniaHematology2020Standard TherapyPoland2
3149Bone MarrowAllogeneicFamilial Hemophagocytic Lymphohistiocytosis Type 2Hematology2020Standard TherapyPoland8
3150Bone MarrowAllogeneicFanconi AnemiaHematology2020Standard TherapyPoland11
3151Bone MarrowAllogeneicFanconi AnemiaHematology2020Standard TherapyPoland6
3152Bone MarrowAllogeneicImmune Deficiency; NeutropeniaHematology2020Standard TherapyPoland4
3153Bone MarrowAllogeneicMetachromatic LeukodystrophyHematology2020Standard TherapyPoland6
3154Bone MarrowAllogeneicMucopolysaccharidosis Type IHematology2020Standard TherapyPoland2
3155Bone MarrowAllogeneicMucopolysaccharidosis Type IiHematology2020Standard TherapyPoland1
3156Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland52
3157Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland54
3158Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland3
3159Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland28
3160Bone MarrowAllogeneicNo DataHematology2020Standard TherapyPoland1
3161Bone MarrowAllogeneicNo DataHematology2020Standard TherapyPoland10
3162Bone MarrowAllogeneicOsteopetrosisHematology2020Standard TherapyPoland1
3163Bone MarrowAllogeneicPrimary Immunodeficiency With Severe Mds AssociatedHematology2020Standard TherapyPoland14
3164Bone MarrowAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3165Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland5
3166Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland57
3167Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland27
3168Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland43
3169Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland10
3170Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland34
3171Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland11
3172Bone MarrowAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland12
3173Bone MarrowAllogeneicX-Linked Chronic Granulomatous DiseaseHematology2020Standard TherapyPoland5
3174Bone MarrowAllogeneicΒ - Thalassemia MajorHematology2020Standard TherapyPoland13
3175Bone MarrowAllogeneicΒ - Thalassemia MajorHematology2020Standard TherapyPoland17
3176Bone MarrowAllogeneicΒ - Thalassemia MajorHematology2020Standard TherapyPoland6
3177ApheresisAllogeneicAcute Biphenotypic LeukemiaHematology2020Standard TherapyPoland71
3178ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland54
3179ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland72
3180ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland41
3181ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland14
3182ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland59
3183ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland60
3184ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland9
3185ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland23
3186ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland40
3187ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland51
3188ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland71
3189ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland34
3190ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland67
3191ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland50
3192ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland18
3193ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland69
3194ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland12
3195ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland13
3196ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland12
3197ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland44
3198ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland34
3199ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland36
3200ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland54
3201ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland56
3202ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland44
3203ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland36
3204ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland25
3205ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland44
3206ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyGermany52
3207ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyGermany48
3208ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3209ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3210ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland72
3211ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3212ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland54
3213ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3214ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland67
3215ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland37
3216ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3217ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland70
3218ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland46
3219ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland65
3220ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3221ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland73
3222ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland27
3223ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland29
3224ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland52
3225ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3226ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland43
3227ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland67
3228ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3229ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3230ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland66
3231ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland60
3232ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland32
3233ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland66
3234ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland44
3235ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland40
3236ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3237ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland65
3238ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland38
3239ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland49
3240ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland65
3241ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3242ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3243ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3244ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland73
3245ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland54
3246ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3247ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland70
3248ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3249ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland68
3250ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3251ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland60
3252ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland55
3253ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland54
3254ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland56
3255ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland54
3256ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland44
3257ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland55
3258ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland67
3259ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland53
3260ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3261ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland30
3262ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland34
3263ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3264ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland66
3265ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland35
3266ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland5
3267ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland65
3268ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3269ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland49
3270ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3271ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3272ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland39
3273ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland45
3274ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3275ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3276ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3277ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3278ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland1
3279ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland53
3280ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland14
3281ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland15
3282ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3283ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland66
3284ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3285ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland72
3286ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland51
3287ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland53
3288ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland39
3289ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland42
3290ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland52
3291ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland55
3292ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland69
3293ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3294ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3295ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3296ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland37
3297ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland72
3298ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany64
3299ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany45
3300ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany67
3301ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany67
3302ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany61
3303ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany36
3304ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany34
3305ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany48
3306ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany60
3307ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany48
3308ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany35
3309ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany42
3310ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany59
3311ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany20
3312ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany58
3313ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany44
3314ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany30
3315ApheresisAllogeneicAcute Myeloid Leukemia; Myelodysplastic SyndromeHematology2020Standard TherapyPoland64
3316ApheresisAllogeneicAcute Undifferentiated LeukemiaHematology2020Standard TherapyPoland31
3317ApheresisAutologousAmyloid Light-Chain AmyloidosisHematology2020Standard TherapyGermany62
3318ApheresisAutologousAmyloidosisHematology2020Standard TherapyGermany58
3319ApheresisAllogeneicAnaplastic Large Cell LymphomaHematology2020Standard TherapyPoland8
3320ApheresisAllogeneicAplastic AnemiaHematology2020Standard TherapyPoland12
3321ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland29
3322ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyGermany58
3323ApheresisAutologousB-Cell LymphomaHematology2020Standard TherapyGermany68
3324ApheresisAutologousB-Cell LymphomaHematology2020Standard TherapyGermany70
3325ApheresisAutologousB-Cell Lymphoma - Second Primary Central Nervous System LymphomaHematology2020Standard TherapyGermany70
3326ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany57
3327ApheresisAutologousBone TumorHematology2020Standard TherapyGermany28
3328ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2020Standard TherapyPoland49
3329ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2020Standard TherapyPoland74
3330ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2020Standard TherapyPoland67
3331ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2020Standard TherapyPoland58
3332ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland61
3333ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland56
3334ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland47
3335ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland73
3336ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland62
3337ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland57
3338ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland44
3339ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland62
3340ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2020Standard TherapyPoland66
3341ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2020Standard TherapyGermany31
3342ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2020Standard TherapyPoland63
3343ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany68
3344ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany51
3345ApheresisAllogeneicDyskeratosis CongenitaHematology2020Standard TherapyPoland19
3346ApheresisAllogeneicErdheim-Chester DiseaseHematology2020Standard TherapyPoland4
3347ApheresisAutologousEwing SarcomaHematology2020Standard TherapyGermany30
3348ApheresisAllogeneicFanconi AnemiaHematology2020Standard TherapyPoland1
3349ApheresisAllogeneicFanconi AnemiaHematology2020Standard TherapyPoland29
3350ApheresisAutologousGerm Cell TumorHematology2020Standard TherapyGermany30
3351ApheresisAutologousHodgkin LymphomaHematology2020Standard TherapyGermany48
3352ApheresisAutologousHodgkin LymphomaHematology2020Standard TherapyGermany22
3353ApheresisAutologousHodgkin Lymphoma-RelapseHematology2020Standard TherapyGermany66
3354ApheresisAllogeneicLymphoblastic LymphomaHematology2020Standard TherapyPoland24
3355ApheresisAllogeneicMantle Cell LymphomaHematology2020Standard TherapyPoland56
3356ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany56
3357ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany48
3358ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany53
3359ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany59
3360ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany65
3361ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany58
3362ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany49
3363ApheresisAllogeneicMast Cell LeukemiaHematology2020Standard TherapyGermany55
3364ApheresisAutologousMorbus HodgkinHematology2020Standard TherapyGermany68
3365ApheresisAutologousMorbus HodgkinHematology2020Standard TherapyGermany53
3366ApheresisAutologousMorbus Hodgkin-RelapseHematology2020Standard TherapyGermany18
3367ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany54
3368ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany66
3369ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany56
3370ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3371ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany70
3372ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany41
3373ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany56
3374ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany61
3375ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany55
3376ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany67
3377ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany52
3378ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany69
3379ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany64
3380ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany46
3381ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany55
3382ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany60
3383ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3384ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany51
3385ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany55
3386ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany63
3387ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3388ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany55
3389ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3390ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3391ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3392ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany42
3393ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany59
3394ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany66
3395ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3396ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany67
3397ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3398ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany60
3399ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3400ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany63
3401ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3402ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany63
3403ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany62
3404ApheresisAllogeneicMultiple MyelomaHematology2020Standard TherapyGermany49
3405ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany45
3406ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3407ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany45
3408ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany66
3409ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany40
3410ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany53
3411ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany54
3412ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany44
3413ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3414ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany48
3415ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3416ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany66
3417ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3418ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany54
3419ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland67
3420ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland59
3421ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland60
3422ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland62
3423ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland55
3424ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland70
3425ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland66
3426ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland51
3427ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland56
3428ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland64
3429ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland63
3430ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland73
3431ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland63
3432ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland37
3433ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland59
3434ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland70
3435ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland74
3436ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland66
3437ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland22
3438ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland64
3439ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland70
3440ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland70
3441ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland67
3442ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland60
3443ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland68
3444ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland58
3445ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland67
3446ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland47
3447ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland56
3448ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland55
3449ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland64
3450ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland66
3451ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland65
3452ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland63
3453ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland69
3454ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland63
3455ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyGermany73
3456ApheresisAllogeneicMyelofibrosisHematology2020Standard TherapyPoland63
3457ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland69
3458ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland70
3459ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland63
3460ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland62
3461ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland43
3462ApheresisAllogeneicMyeloma MultiplexHematology2020Standard TherapyPoland63
3463ApheresisAllogeneicMyeloma MultiplexHematology2020Standard TherapyPoland52
3464ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2020Standard TherapyPoland68
3465ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2020Standard TherapyPoland40
3466ApheresisAllogeneicNo DataHematology2020Standard TherapyPoland71
3467ApheresisAllogeneicNo DataHematology2020Standard TherapyPoland64
3468ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland65
3469ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland58
3470ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland63
3471ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland58
3472ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland62
3473ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland53
3474ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland57
3475ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland69
3476ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland62
3477ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland34
3478ApheresisAutologousNon-Hodgkin LymphomaHematology2020Standard TherapyGermany42
3479ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyGermany62
3480ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2020Standard TherapyGermany56
3481ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2020Standard TherapyGermany67
3482ApheresisAllogeneicOsteomyelofibrosisHematology2020Standard TherapyPoland68
3483ApheresisAllogeneicOsteomyelofibrosisHematology2020Standard TherapyPoland52
3484ApheresisAllogeneicOsteomyelofibrosisHematology2020Standard TherapyPoland64
3485ApheresisAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2020Standard TherapyPoland57
3486ApheresisAllogeneicPerforin DeficiencyHematology2020Standard TherapyPoland2
3487ApheresisAutologousPrimary Central Nervous System LymphomaHematology2020Standard TherapyGermany59
3488ApheresisAutologousPrimary Cerebral Diffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany66
3489ApheresisAutologousPrimary Cerebral Diffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany59
3490ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland63
3491ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland61
3492ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland51
3493ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland66
3494ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland61
3495ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyGermany54
3496ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyGermany58
3497ApheresisAllogeneicPurine Nucleoside Phosphorylase DeficiencyHematology2020Standard TherapyPoland1
3498ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland43
3499ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland76
3500ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland57
3501ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyGermany66
3502ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyGermany56
3503ApheresisAutologousSecondary B-Cell Non-Hodgkin-LymphomaHematology2020Standard TherapyGermany73
3504ApheresisAutologousSecondary Diffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany54
3505ApheresisAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland9
3506ApheresisAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland53
3507ApheresisAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland52
3508ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2020Standard TherapyPoland2
3509ApheresisAllogeneicSezary SyndromeHematology2020Standard TherapyPoland44
3510ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland14
3511ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany57
3512ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany29
3513ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany64
3514ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany63
3515ApheresisAllogeneicT-Cell-LymphomaHematology2020Standard TherapyPoland29
3516ApheresisAutologousT-Cell-LymphomaHematology2020Standard TherapyGermany51
3517ApheresisAutologousT-Cell-LymphomaHematology2020Standard TherapyGermany60
3518ApheresisAllogeneicT-Cell-Prolymphocytic LeukemiaHematology2020Standard TherapyPoland55
3519ApheresisAllogeneicT-Cell-Prolymphocytic LeukemiaHematology2020Standard TherapyPoland74
3520ApheresisAllogeneicΒ - ThalassemiaHematology2020Standard TherapyPoland6
3521ApheresisAllogeneicΒ - Thalassemia MajorHematology2020Standard TherapyPoland17
3522Adipose TissueAutologousAlopeciaDermatology2020Experimental TherapyPoland68,5
3523Adipose TissueAutologousChondromalaciaOrthopedy2020Experimental TherapyPoland45,9
3524Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland52,8
3525Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland63,4
3526Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland41,1
3527Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland34,8
3528Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland48,1
3529Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland57,11
3530Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland59,8
3531Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland35,1
3532Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland61,8
3533Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland56,5
3534Adipose TissueAutologousGonarthrosis; Shoulder OsteoarthritisOrthopedy2020Experimental TherapyPoland42,5
3535Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2020Experimental TherapyPoland53,6
3536Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2020Experimental TherapyPoland49,2
3537Adipose TissueAutologousOmarthrosisOrthopedy2020Experimental TherapyPoland70,1
3538Adipose TissueAutologousOther Acquired Deformities Of The Ankle And FootOrthopedy2020Experimental TherapyPoland41,6
3539Adipose TissueAutologousScarDermatology2020Clinical TrialPolandno data
3540Adipose TissueAutologousSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2020Experimental TherapyPoland61,1
3541Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2019Experimental TherapyPoland5,3
3542Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland1,9
3543Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland6,1
3544Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland2,2
3545Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland10,1
3546Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland18,2
3547Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland10,2
3548Cord TissueAllogeneic - UnrelatedAgenesis Of Corpus Callosum; Atrophy Of The Optic NervesNeurology2019Experimental TherapyPoland7,3
3549Cord TissueAllogeneic - UnrelatedAlopecia AreataDermatology2019Experimental TherapyPoland47,11
3550Cord TissueAllogeneic - UnrelatedAlopecia AreataDermatology2019Experimental TherapyPoland57,9
3551Cord TissueAllogeneic - UnrelatedAlopecia AreataDermatology2019Experimental TherapyPoland43,3
3552Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland54,9
3553Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland58,7
3554Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland65,5
3555Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland60,11
3556Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland38,2
3557Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland61,9
3558Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland70,11
3559Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland73,1
3560Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland58,1
3561Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland65,1
3562Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland39,8
3563Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland46,1
3564Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland59,1
3565Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland61
3566Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland66,2
3567Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland44,1
3568Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland65,1
3569Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland65
3570Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland41,5
3571Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland59,8
3572Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland32,2
3573Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland56,1
3574Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland61,5
3575Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland49,7
3576Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland67,11
3577Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland59,3
3578Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPolandno data
3579Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland57,7
3580Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland62,4
3581Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland67,8
3582Cord TissueAllogeneic - UnrelatedAngelman Syndrome; Cerebral PalsyNeurology2019Experimental TherapyPoland13,5
3583Cord TissueAllogeneic - UnrelatedArthrogryposis Multiplex Congenita; MyopathyNeurology2019Experimental TherapyPoland3,11
3584Cord TissueAllogeneic - UnrelatedArthrosis Of The Knee Joint - ChondromalaciaOrthopedy2019Experimental TherapyPoland51,4
3585Cord TissueAllogeneic - UnrelatedAsperger SyndromeNeurology2019Experimental TherapyPoland10,8
3586Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2019Experimental TherapyPoland38,7
3587Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland5,6
3588Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland2,6
3589Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland11,6
3590Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland3,7
3591Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,9
3592Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,2
3593Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,8
3594Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,2
3595Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland9
3596Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland11,1
3597Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland4,8
3598Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland13,4
3599Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland5,11
3600Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland2,7
3601Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,1
3602Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,2
3603Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,9
3604Cord TissueAllogeneic - RelatedAutismNeurology2019Experimental TherapyPoland4
3605Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,3
3606Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,5
3607Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,3
3608Cord TissueAllogeneic - RelatedAutismNeurology2019Experimental TherapyPoland7
3609Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland4,2
3610Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland5,3
3611Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland4,6
3612Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland3,8
3613Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland9,5
3614Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,11
3615Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland3,8
3616Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland3,8
3617Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPolandno data
3618Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland5,2
3619Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,6
3620Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,1
3621Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,7
3622Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,7
3623Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland9,11
3624Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland12,4
3625Cord TissueAllogeneic - UnrelatedAutism; Diabetes Mellitus Type 1Neurology2019Experimental TherapyPoland8,1
3626Cord TissueAllogeneic - UnrelatedAutism; MicrocephalyNeurology2019Experimental TherapyPoland7,8
3627Cord TissueAllogeneic - UnrelatedBest DiseaseOphthalmology2019Experimental TherapyPoland56,4
3628Cord TissueAllogeneic - UnrelatedBirth AsphyxiaNeurology2019Experimental TherapyPoland5,4
3629Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2019Experimental TherapyPoland50,1
3630Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2019Experimental TherapyPoland37,7
3631Cord TissueAllogeneic - UnrelatedCerebellar Syndrome; Multiple System AtrophyNeurology2019Experimental TherapyPoland57,2
3632Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6
3633Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland9,11
3634Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland11 months
3635Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,5
3636Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,4
3637Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland11,1
3638Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland4,2
3639Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,3
3640Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,5
3641Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,6
3642Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland9,1
3643Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland4
3644Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland2,2
3645Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland4,3
3646Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,9
3647Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland2
3648Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland1,6
3649Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland15,5
3650Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland2,7
3651Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland9,9
3652Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland4,11
3653Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,1
3654Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland5,6
3655Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland2,6
3656Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland1,1
3657Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland5,3
3658Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland22,8
3659Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland28,2
3660Cord TissueAllogeneic - Unrelated & RelatedCerebral PalsyNeurology2019Experimental TherapyPoland/Romania7,5
3661Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland9,7
3662Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland10
3663Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6,8
3664Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,3
3665Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland10,8
3666Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,1
3667Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,8
3668Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland14,9
3669Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6,9
3670Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland52,7
3671Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6,7
3672Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland2,9
3673Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6,11
3674Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland16,1
3675Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland5,1
3676Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland5,7
3677Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland3
3678Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland3
3679Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3
3680Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland11,6
3681Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,8
3682Cord TissueAllogeneic - UnrelatedCerebral Palsy; AutismNeurology2019Experimental TherapyPoland5,5
3683Cord TissueAllogeneic - UnrelatedCerebral Palsy; Dandy-Walker MalformationNeurology2019Experimental TherapyPoland7,3
3684Cord TissueAllogeneic - UnrelatedCerebral Palsy; Developmental DelayNeurology2019Experimental TherapyPoland18,9
3685Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland3,7
3686Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland3
3687Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland5,5
3688Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland5,11
3689Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland10,1
3690Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland7,11
3691Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland5,3
3692Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland8,5
3693Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland6,3
3694Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland5,6
3695Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland15,7
3696Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland6
3697Cord TissueAllogeneic - UnrelatedCerebral Palsy; Epilepsy; Developmental DelayNeurology2019Experimental TherapyPoland1,11
3698Cord TissueAllogeneic - UnrelatedCerebral Palsy; Epilepsy; MicrocephaliaNeurology2019Experimental TherapyPoland9,3
3699Cord TissueAllogeneic - UnrelatedCerebral Palsy; HydrocephalusNeurology2019Experimental TherapyPoland2,2
3700Cord TissueAllogeneic - UnrelatedCerebral Palsy; HydrocephalusNeurology2019Experimental TherapyPoland4,2
3701Cord TissueAllogeneic - UnrelatedCerebral Palsy; Hydrocephalus; EpilepsyNeurology2019Experimental TherapyPoland3,7
3702Cord TissueAllogeneic - UnrelatedCerebral Palsy; Wolf-Hirschhorn SyndromeNeurology2019Experimental TherapyPoland10,1
3703Cord TissueAllogeneic - UnrelatedChondrocalcinosis; Moderate GonarthrosisOrthopedy2019Experimental TherapyPoland79,1
3704Cord TissueAllogeneic - UnrelatedChondromalaciaOrthopedy2019Experimental TherapyPoland60,9
3705Cord TissueAllogeneic - UnrelatedChoroideremiaOphthalmology2019Experimental TherapyPoland24,5
3706Cord TissueAllogeneic - UnrelatedChoroideremiaOphthalmology2019Experimental TherapyPoland30,1
3707Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2019Experimental TherapyPoland10,5
3708Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host Disease; Condition After Bone Marrow Transplantation Due To Severe Aplastic AnemiaHematology2019Experimental TherapyPoland9
3709Cord TissueAllogeneic - UnrelatedCondition After Bilateral Optic Nerve InflammationOphthalmology2019Experimental TherapyPoland46,11
3710Cord TissueAllogeneic - UnrelatedCondition After Sympathetic Inflammation Of The Left EyeOphthalmology2019Experimental TherapyPoland23,1
3711Cord TissueAllogeneic - RelatedCoxarthrosisOrthopedy2019Experimental TherapyPoland57
3712Cord TissueAllogeneic - UnrelatedDandy-Walker Malformation; Trisomy 9Neurology2019Experimental TherapyPoland10,8
3713Cord TissueAllogeneic - UnrelatedDegeneration Of The Cartilage Of The Knee JointOrthopedy2019Experimental TherapyPoland44,7
3714Cord TissueAllogeneic - UnrelatedDegenerative Disease Of The SpineOrthopedy2019Experimental TherapyPoland86,11
3715Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; Chiari MalformationNeurology2019Experimental TherapyPoland4,6
3716Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; Congenital CytomegalovirusNeurology2019Experimental TherapyPoland8,3
3717Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; EpilepsyNeurology2019Experimental TherapyPoland2,1
3718Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3719Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3720Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3721Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3722Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3723Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3724Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3725Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3726Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3727Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3728Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Experimental TherapyPoland2,11
3729Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Experimental TherapyPoland37,5
3730Cord TissueAllogeneic - UnrelatedDravet's SyndromeNeurology2019Experimental TherapyPoland19,7
3731Cord TissueAllogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Neurology2019Experimental TherapyPoland15
3732Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2019Experimental TherapyPoland7,8
3733Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2019Experimental TherapyPoland7,7
3734Cord TissueAllogeneic - RelatedEncephalopathy; Cerebral PalsyNeurology2019Experimental TherapyPoland6
3735Cord TissueAllogeneic - UnrelatedEncephalopathy; EpilepsyNeurology2019Experimental TherapyPoland17,1
3736Cord TissueAllogeneic - UnrelatedEncephalopathy; EpilepsyNeurology2019Experimental TherapyPoland3,6
3737Cord TissueAllogeneic - UnrelatedEncephalopathy; Epilepsy; Delayed Psychomotor DevelopmentNeurology2019Experimental TherapyPoland13,1
3738Cord TissueAllogeneic - UnrelatedEncephalopathy; Epilepsy; Delayed Psychomotor DevelopmentNeurology2019Experimental TherapyPoland2,5
3739Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2019Experimental TherapyPoland4,4
3740Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2019Experimental TherapyPoland5,8
3741Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2019Experimental TherapyPoland7,4
3742Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2019Experimental TherapyPoland7,4
3743Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2019Experimental TherapyPoland51,1
3744Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2019Experimental TherapyPoland8,1
3745Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2019Experimental TherapyPoland13,9
3746Cord TissueAllogeneic - UnrelatedEpilepsy; Developmental DelayNeurology2019Experimental TherapyPoland9,4
3747Cord TissueAllogeneic - UnrelatedEpilepsy; Developmental DelayNeurology2019Experimental TherapyPoland3,2
3748Cord TissueAllogeneic - UnrelatedEpilepsy; EncephalopathyNeurology2019Experimental TherapyPoland8,1
3749Cord TissueAllogeneic - UnrelatedEpileptic Encephalopathy; EpilepsyNeurology2019Experimental TherapyPoland16,2
3750Cord TissueAllogeneic - UnrelatedEpileptic Encephalopathy; EpilepsyNeurology2019Experimental TherapyPoland2,11
3751Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2019Experimental TherapyPoland39,1
3752Cord TissueAllogeneic - UnrelatedFragile X Syndrome; Pervasive Developmental DisorderNeurology2019Experimental TherapyPoland4
3753Cord TissueAllogeneic - UnrelatedFriedreich's AtaxiaNeurology2019Experimental TherapyPoland59,6
3754Cord TissueAllogeneic - UnrelatedGeneral HypotoniaNeurology2019Experimental TherapyPoland2,1
3755Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2019Experimental TherapyPoland6,7
3756Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland70,8
3757Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland78,7
3758Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland84,1
3759Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland48,7
3760Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland34,2
3761Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland63,7
3762Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland64,8
3763Cord TissueAllogeneic - UnrelatedHyperacute Graft Versus Host Disease; Condition After Bone Marrow Transplantation Due To Severe Congenital NeutropeniaHematology2019Experimental TherapyPoland8 months
3764Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2019Experimental TherapyPoland2,2
3765Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2019Experimental TherapyPoland2,5
3766Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2019Experimental TherapyPoland4,8
3767Cord TissueAllogeneic - UnrelatedIschemic StrokeNeurology2019Experimental TherapyPoland40,7
3768Cord TissueAllogeneic - UnrelatedIschemic StrokeNeurology2019Experimental TherapyPolandno data
3769Cord TissueAllogeneic - UnrelatedKrabbe DiseaseNeurology2019Experimental TherapyPoland3,3
3770Cord TissueAllogeneic - UnrelatedMacular DegenerationOphthalmology2019Experimental TherapyPoland15,2
3771Cord TissueAllogeneic - UnrelatedMicrocephalia; Cerebellar Syndrome; Delayed Psychomotor DevelopmentNeurology2019Experimental TherapyPoland7,7
3772Cord TissueAllogeneic - UnrelatedMultiple System AtrophyNeurology2019Experimental TherapyPoland54,1
3773Cord TissueAllogeneic - UnrelatedMultiple System AtrophyNeurology2019Experimental TherapyPoland71,11
3774Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2019Experimental TherapyPoland46,1
3775Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2019Experimental TherapyPoland17,3
3776Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2019Experimental TherapyPoland13,1
3777Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland2,2
3778Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland19,11
3779Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland2,1
3780Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland1,11
3781Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland4,11
3782Cord TissueAllogeneic - UnrelatedNon-Adhesion Left Tibia Shank Fracture; Neurofibromatosis T. IOrthopedy2019Experimental TherapyPoland18,4
3783Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland43,9
3784Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland68,4
3785Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland72,5
3786Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland33,3
3787Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland26
3788Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland23,9
3789Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland35,1
3790Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland38,3
3791Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland24,5
3792Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland12,1
3793Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland9,8
3794Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland41,3
3795Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland34,7
3796Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland59,4
3797Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland53,2
3798Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland12,3
3799Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2019Experimental TherapyPoland26,8
3800Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2019Experimental TherapyPoland71,3
3801Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2019Experimental TherapyPoland49,8
3802Cord TissueAllogeneic - UnrelatedOther Disorders Of The Central Nervous System; Genetic Defect; Suspected AutismNeurology2019Experimental TherapyPoland6,7
3803Cord TissueAllogeneic - UnrelatedOther Disorders Of The Central Nervous System; Genetic Defect; Suspected AutismNeurology2019Experimental TherapyPoland6,7
3804Cord TissueAllogeneic - UnrelatedOther Disorders Of The Optic DiscNeurology2019Experimental TherapyPoland3
3805Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland1,7
3806Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland4,1
3807Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland11 months
3808Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland3,1
3809Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland3,6
3810Cord TissueAllogeneic - UnrelatedOther Vascular And Retinal DisordersOphthalmology2019Experimental TherapyPoland34,2
3811Cord TissueAllogeneic - UnrelatedParkinson SyndromeNeurology2019Experimental TherapyPoland51,2
3812Cord TissueAllogeneic - UnrelatedParoxysmal DystoniaNeurology2019Experimental TherapyPoland3,7
3813Cord TissueAllogeneic - UnrelatedPolyneuropathyNeurology2019Experimental TherapyPoland60,8
3814Cord TissueAllogeneic - UnrelatedProgressive Supranuclear AtrophyNeurology2019Experimental TherapyPoland62,4
3815Cord TissueAllogeneic - UnrelatedPropionic AciduriaNeurology2019Experimental TherapyPoland10,7
3816Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland19,1
3817Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland35
3818Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland21,6
3819Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland67,2
3820Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland63,4
3821Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland69
3822Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2019Experimental TherapyPoland62,7
3823Cord TissueAllogeneic - RelatedSclerosis MultiplexNeurology2019Experimental TherapyPoland61
3824Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2019Experimental TherapyPoland61,6
3825Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2019Experimental TherapyPoland59,7
3826Cord TissueAllogeneic - UnrelatedSecondary Progressive Multiple SclerosisNeurology2019Experimental TherapyPoland22,9
3827Cord TissueAllogeneic - UnrelatedSecondary Progressive Multiple SclerosisNeurology2019Experimental TherapyPoland64
3828Cord TissueAllogeneic - UnrelatedSecondary Progressive Multiple SclerosisNeurology2019Experimental TherapyPoland54,6
3829Cord TissueAllogeneic - UnrelatedSecondary Progressive Multiple SclerosisNeurology2019Experimental TherapyPoland59,5
3830Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2019Experimental TherapyPoland5,11
3831Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2019Experimental TherapyPoland10 months
3832Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2019Experimental TherapyPoland10 months
3833Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2019Experimental TherapyPoland5,11
3834Cord TissueAllogeneic - UnrelatedSpina Bifida; EpilepsyNeurology2019Experimental TherapyPoland2,2
3835Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2019Experimental TherapyPoland33
3836Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2019Experimental TherapyPolandno data
3837Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2019Experimental TherapyPoland27,5
3838Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2019Experimental TherapyPoland26,9
3839Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2019Experimental TherapyPoland38,6
3840Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2019Experimental TherapyPoland27,8
3841Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2019Experimental TherapyPoland41,1
3842Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2019Experimental TherapyPoland11
3843Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2019Experimental TherapyPoland40
3844Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2019Experimental TherapyPoland26,1
3845Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2019Experimental TherapyPoland54,11
3846Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2019Experimental TherapyPoland37
3847Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2019Experimental TherapyPoland30,5
3848Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2019Experimental TherapyPoland40
3849Cord TissueAllogeneic - UnrelatedStatus After Meningitis And Encephalitis; EncephalopathyNeurology2019Experimental TherapyPoland4
3850Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2019Standard TherapyTurkey2
3851Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany6
3852Cord BloodAutologousAutismNeurology2019Experimental TherapyPoland3,6
3853Cord BloodAutologousAutismNeurology2019Experimental TherapyPoland10,5
3854Cord BloodAutologousAutismNeurology2019Experimental TherapyGermany4
3855Cord BloodAutologousBrain DamageNeurology2019Experimental TherapyGermany11 months
3856Cord BloodAutologousBrain DamageNeurology2019Experimental TherapyGermany1,5
3857Cord BloodAllogeneic - RelatedBrain DamageNeurology2019Experimental TherapyGermany7
3858Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyUK3
3859Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland4,5
3860Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland8,8
3861Cord BloodAllogeneic - RelatedFanconi AnemiaHematology2019Standard TherapyTurkey12,4
3862Cord BloodAutologousSevere Aplastic AnemiaHematology2019Standard TherapyPortugal4
3863Cord BloodAllogeneic - RelatedSevere Chronic NeutropeniaHematology2019Standard TherapyGermany6
3864Cord BloodAllogeneic - RelatedThalassemiaHematology2019Standard TherapyTurkey5,5
3865Cord BloodAllogeneic - RelatedThalassemiaHematology2019Standard TherapyTurkey5,11
3866Cord BloodAllogeneic - RelatedThalassemia MajorHematology2019Standard TherapyTurkey5,1
3867Cord BloodAllogeneic - RelatedThalassemia MajorHematology2019Standard TherapyTurkey3,5
3868Cord BloodAllogeneic - RelatedThalassemia MajorHematology2019Standard TherapyTurkey12
3869Cord BloodAllogeneic - RelatedThalassemia MajorHematology2019Standard TherapyTurkey16
3870Bone Marrow FamilyAllogeneicActivated Pi3k Delta Syndrome (Apds)Hematology2019Standard TherapyPoland20
3871Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland59
3872Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
3873Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland73
3874Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland61
3875Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
3876Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
3877Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
3878Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
3879Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
3880Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
3881Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland23
3882Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
3883Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
3884Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland23
3885Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland55
3886Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland5
3887Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
3888Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland14
3889Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland42
3890Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
3891Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia - RelapseHematology2019Standard TherapyGermany61
3892Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia - RelapseHematology2019Standard TherapyGermany22
3893Bone Marrow FamilyAllogeneicGlanzmann ThrombastheniaHematology2019Standard TherapyPoland11
3894Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland58
3895Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland78
3896Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
3897Bone Marrow FamilyAllogeneicMyelofibrosisHematology2019Standard TherapyPoland60
3898Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2019Standard TherapyPoland48
3899Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2019Standard TherapyPoland56
3900Bone Marrow FamilyAllogeneicNo DataHematology2019Standard TherapyPoland66
3901Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland58
3902Bone Marrow FamilyAllogeneicRefractory Anemia With Blast Excess RelapseHematology2019Standard TherapyGermany53
3903Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2019Standard TherapyPoland27
3904Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland52
3905Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland5
3906Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland21
3907Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland17
3908Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland42
3909Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland15
3910Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland64
3911Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland2
3912Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland17
3913Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland11
3914Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland51
3915Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland8
3916Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland20
3917Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland3
3918Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland10
3919Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland13
3920Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland15
3921Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland5
3922Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland3
3923Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland66
3924Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland14
3925Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
3926Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland10
3927Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland4
3928Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland47
3929Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
3930Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland5
3931Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
3932Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland47
3933Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland59
3934Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
3935Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland12
3936Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland20
3937Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland48
3938Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland30
3939Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland3
3940Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland32
3941Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland14
3942Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland47
3943Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland1
3944Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland3
3945Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland16
3946Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland42
3947Bone MarrowAllogeneicAdrenoleukodystrophyMetabolic2019Standard TherapyPoland3
3948Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland18
3949Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland8
3950Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland10
3951Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland25
3952Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland30
3953Bone MarrowAllogeneicC-Hhyp Cartilage-Hair HypoplasiaHematology2019Standard TherapyPoland2
3954Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2019Standard TherapyPoland7
3955Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland9
3956Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland35
3957Bone MarrowAllogeneicCongenital Amegakaryocytic Thrombocytopenia (Camt)Hematology2019Standard TherapyPoland1
3958Bone MarrowAllogeneicDiamond Blackfan AnemiaHematology2019Standard TherapyPoland2
3959Bone MarrowAllogeneicFanconi AnemiaHematology2019Standard TherapyPoland6
3960Bone MarrowAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland62
3961Bone MarrowAllogeneicHurler SyndromeHematology2019Standard TherapyPoland2
3962Bone MarrowAllogeneicHurler SyndromeHematology2019Standard TherapyPoland3
3963Bone MarrowAllogeneicImmunodeficiencyHematology2019Standard TherapyPoland1
3964Bone MarrowAllogeneicMucopolysaccharidosis Type IMetabolic2019Standard TherapyPoland2
3965Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland75
3966Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland57
3967Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland63
3968Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland8
3969Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland14
3970Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland75
3971Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
3972Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland27
3973Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland67
3974Bone MarrowAllogeneicMyeloproliferative SyndromeHematology2019Standard TherapyPoland2
3975Bone MarrowAllogeneicNijmegen Breakage SyndromeHematology2019Standard TherapyPoland6
3976Bone MarrowAllogeneicNijmegen Breakage SyndromeHematology2019Standard TherapyPoland16
3977Bone MarrowAllogeneicNo DataHematology2019Standard TherapyPoland59
3978Bone MarrowAllogeneicNo DataHematology2019Standard TherapyPoland3
3979Bone MarrowAllogeneicNo DataHematology2019Standard TherapyPoland1
3980Bone MarrowAllogeneicNo DataHematology2019Standard TherapyPoland64
3981Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland43
3982Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland55
3983Bone MarrowAllogeneicOhis - Other Histiocytic DisordersHematology2019Standard TherapyPoland5
3984Bone MarrowAllogeneicOsteopetrosisMetabolic2019Standard TherapyPoland1
3985Bone MarrowAllogeneicOsteopetrosisMetabolic2019Standard TherapyPoland5 months
3986Bone MarrowAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2019Standard TherapyPoland14
3987Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2019Standard TherapyPoland2
3988Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2019Standard TherapyPoland22
3989Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland11
3990Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland12
3991Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland5
3992Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland17
3993Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland4
3994Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland22
3995Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland11
3996Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland14
3997Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland3
3998Bone MarrowAllogeneicShwachman Diamond AnemiaHematology2019Standard TherapyPoland20
3999Bone MarrowAllogeneicThalassemia MajorHematology2019Standard TherapyPoland13
4000Bone MarrowAllogeneicThalassemia MajorHematology2019Standard TherapyPoland5
4001Bone MarrowAllogeneicThalassemia MajorHematology2019Standard TherapyPoland10
4002Bone MarrowAllogeneicVery Severe Aplastic AnemiaHematology2019Standard TherapyPoland13
4003ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland4
4004ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland27
4005ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland47
4006ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland67
4007ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland65
4008ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland63
4009ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland18
4010ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland20
4011ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland15
4012ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland43
4013ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland51
4014ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland7
4015ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland59
4016ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland46
4017ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland48
4018ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland63
4019ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland28
4020ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland36
4021ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland36
4022ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland63
4023ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland43
4024ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany32
4025ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany44
4026ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland63
4027ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4028ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland39
4029ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland53
4030ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland66
4031ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4032ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland37
4033ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland54
4034ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland36
4035ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland53
4036ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
4037ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland38
4038ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4039ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4040ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4041ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland70
4042ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland55
4043ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4044ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4045ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4046ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4047ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4048ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4049ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland52
4050ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4051ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland37
4052ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland56
4053ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4054ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland45
4055ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland45
4056ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4057ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland54
4058ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland55
4059ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4060ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4061ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland42
4062ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4063ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4064ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland59
4065ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland52
4066ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4067ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4068ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland53
4069ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland68
4070ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4071ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland61
4072ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland70
4073ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland54
4074ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4075ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland70
4076ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4077ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4078ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland55
4079ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4080ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland48
4081ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland38
4082ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland45
4083ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland51
4084ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland68
4085ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4086ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4087ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4088ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4089ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland11
4090ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4091ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4092ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland40
4093ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland25
4094ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland63
4095ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland44
4096ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4097ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland38
4098ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland52
4099ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland27
4100ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4101ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland61
4102ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4103ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland52
4104ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4105ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland61
4106ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4107ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4108ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4109ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4110ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4111ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4112ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland68
4113ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland15
4114ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4115ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland59
4116ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4117ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4118ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland23
4119ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland39
4120ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland25
4121ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland71
4122ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland25
4123ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland48
4124ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland45
4125ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4126ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4127ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland31
4128ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
4129ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland3
4130ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4131ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4132ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland46
4133ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany57
4134ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany58
4135ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany31
4136ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany47
4137ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany64
4138ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany46
4139ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany40
4140ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany60
4141ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany65
4142ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany68
4143ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany65
4144ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany26
4145ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany52
4146ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany38
4147ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany56
4148ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2019Standard TherapyGermany51
4149ApheresisAutologousAmyloidosisHematology2019Standard TherapyGermany60
4150ApheresisAllogeneicAplasiaHematology2019Standard TherapyPoland51
4151ApheresisAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland16
4152ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland8
4153ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany46
4154ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany21
4155ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany28
4156ApheresisAllogeneicB-Cell Chronic Lymphoblastic LeukemiaHematology2019Standard TherapyPoland66
4157ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany66
4158ApheresisAllogeneicChronic Granulomatous DiseaseHematology2019Standard TherapyPoland2
4159ApheresisAllogeneicChronic Granulomatous DiseaseHematology2019Standard TherapyPoland16
4160ApheresisAllogeneicChronic Granulomatous DiseaseHematology2019Standard TherapyPoland3
4161ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland58
4162ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland65
4163ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland69
4164ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland65
4165ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland60
4166ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland69
4167ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland23
4168ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland34
4169ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland37
4170ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland56
4171ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland58
4172ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland56
4173ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland31
4174ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland54
4175ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland46
4176ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2019Standard TherapyPoland54
4177ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2019Standard TherapyPoland65
4178ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2019Standard TherapyPoland73
4179ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2019Standard TherapyPoland62
4180ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2019Standard TherapyGermany66
4181ApheresisAutologousEmbryonal Cell Carcinoma Of The TesticleHematology2019Standard TherapyGermany29
4182ApheresisAllogeneicExtracranial Malignant Germ Cell TumorsHematology2019Standard TherapyPoland53
4183ApheresisAllogeneicGlanzmann ThrombastheniaHematology2019Standard TherapyPoland11
4184ApheresisAllogeneicHigh-Risk Myelodysplastic SyndromeHematology2019Standard TherapyPoland61
4185ApheresisAllogeneicHistiocytosis XHematology2019Standard TherapyPoland14
4186ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland65
4187ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland58
4188ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland28
4189ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland44
4190ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland1
4191ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland32
4192ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland34
4193ApheresisAllogeneicMantle Cell LymphomaHematology2019Standard TherapyPoland62
4194ApheresisAllogeneicMantle Cell LymphomaHematology2019Standard TherapyPoland69
4195ApheresisAllogeneicMantle Cell LymphomaHematology2019Standard TherapyPoland65
4196ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany66
4197ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany63
4198ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany59
4199ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany68
4200ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany65
4201ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany54
4202ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany64
4203ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany59
4204ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany59
4205ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany71
4206ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany63
4207ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2019Standard TherapyPoland59
4208ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2019Standard TherapyPoland49
4209ApheresisAutologousMonoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline MyopathyHematology2019Standard TherapyGermany36
4210ApheresisAutologousMorbus HodgkinHematology2019Standard TherapyGermany66
4211ApheresisAllogeneicMucopolysaccharidosis Type IMetabolic2019Standard TherapyPoland1
4212ApheresisAllogeneicMucopolysaccharidosis Type IiMetabolic2019Standard TherapyPoland2
4213ApheresisAllogeneicMucopolysaccharidosis Type IiMetabolic2019Standard TherapyPoland2
4214ApheresisAllogeneicMultiple MyelomaHematology2019Standard TherapyPoland52
4215ApheresisAllogeneicMultiple MyelomaHematology2019Standard TherapyPoland55
4216ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4217ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany58
4218ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany58
4219ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany69
4220ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany58
4221ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4222ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany52
4223ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany56
4224ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany54
4225ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany51
4226ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany57
4227ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany52
4228ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany61
4229ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4230ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany59
4231ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany64
4232ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany39
4233ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany52
4234ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany59
4235ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany63
4236ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany40
4237ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany57
4238ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany53
4239ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany64
4240ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany70
4241ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4242ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany56
4243ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany63
4244ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany35
4245ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany70
4246ApheresisAllogeneicMultiple MyelomaHematology2019Standard TherapyGermany57
4247ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany41
4248ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany60
4249ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4250ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4251ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany63
4252ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4253ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany66
4254ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany57
4255ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4256ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany67
4257ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany64
4258ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany70
4259ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany64
4260ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany66
4261ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4262ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany58
4263ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany59
4264ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany72
4265ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4266ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4267ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland55
4268ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4269ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland14
4270ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4271ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4272ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland75
4273ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland45
4274ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland70
4275ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland72
4276ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland69
4277ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland45
4278ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland40
4279ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland65
4280ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland72
4281ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland50
4282ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland59
4283ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4284ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4285ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland42
4286ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland68
4287ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland65
4288ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland56
4289ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland63
4290ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4291ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland64
4292ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland42
4293ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland68
4294ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4295ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland68
4296ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4297ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4298ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4299ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland67
4300ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland4
4301ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland56
4302ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4303ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4304ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4305ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4306ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland63
4307ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland44
4308ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland45
4309ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland33
4310ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4311ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland65
4312ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland49
4313ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland69
4314ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland71
4315ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland25
4316ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland42
4317ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland46
4318ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland65
4319ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany49
4320ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany66
4321ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany64
4322ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany67
4323ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany66
4324ApheresisAllogeneicMyelodysplastic Syndrome - RaebHematology2019Standard TherapyPoland21
4325ApheresisAllogeneicMyelodysplastic Syndrome - RaebHematology2019Standard TherapyPoland16
4326ApheresisAllogeneicMyelodysplastic Syndrome; Myeloproliferative Neoplasms OverlapHematology2019Standard TherapyGermany64
4327ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland46
4328ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland62
4329ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland47
4330ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland33
4331ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland45
4332ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland43
4333ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland66
4334ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland69
4335ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland63
4336ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland61
4337ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland61
4338ApheresisAllogeneicMyeloma MultiplexHematology2019Standard TherapyPoland45
4339ApheresisAllogeneicMyeloma MultiplexHematology2019Standard TherapyPoland62
4340ApheresisAutologousMyeloma; AmyloidosisHematology2019Standard TherapyGermany47
4341ApheresisAutologousNatural Killer / T-Cell-Non-Hodgkin-LymphomaHematology2019Standard TherapyGermany32
4342ApheresisAllogeneicNo DataHematology2019Standard TherapyPoland43
4343ApheresisAllogeneicNo DataHematology2019Standard TherapyPoland20
4344ApheresisAllogeneicNo DataHematology2019Standard TherapyPoland58
4345ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland68
4346ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland28
4347ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland58
4348ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland67
4349ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland51
4350ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland65
4351ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland42
4352ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland55
4353ApheresisAutologousNon-Hodgkin LymphomaHematology2019Standard TherapyGermany56
4354ApheresisAutologousNon-Hodgkin LymphomaHematology2019Standard TherapyGermany59
4355ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2019Standard TherapyGermany63
4356ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2019Standard TherapyGermany69
4357ApheresisAllogeneicOsteomyelofibrosis - OtherHematology2019Standard TherapyPoland63
4358ApheresisAllogeneicOther MyelofibrosisHematology2019Standard TherapyPoland70
4359ApheresisAllogeneicOther MyelofibrosisHematology2019Standard TherapyPoland61
4360ApheresisAllogeneicOther MyelofibrosisHematology2019Standard TherapyPoland50
4361ApheresisAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2019Standard TherapyPoland24
4362ApheresisAllogeneicPlasma Cell LeukemiaHematology2019Standard TherapyPoland35
4363ApheresisAllogeneicPolycythemia Vera-MyelofibrosisHematology2019Standard TherapyGermany58
4364ApheresisAllogeneicPost–Polycythemia Vera MyelofibrosisHematology2019Standard TherapyGermany70
4365ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany65
4366ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany63
4367ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany69
4368ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany64
4369ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany56
4370ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany57
4371ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany63
4372ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany67
4373ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany78
4374ApheresisAllogeneicPrimary ImmunodeficiencyHematology2019Standard TherapyPoland21
4375ApheresisAllogeneicPrimary ImmunodeficiencyHematology2019Standard TherapyPoland19
4376ApheresisAllogeneicPrimary MediastinalHematology2019Standard TherapyPoland33
4377ApheresisAllogeneicPrimary MyelofibrosisHematology2019Standard TherapyPoland46
4378ApheresisAllogeneicPrimary MyelofibrosisHematology2019Standard TherapyPoland45
4379ApheresisAllogeneicPrimary MyelofibrosisHematology2019Standard TherapyGermany55
4380ApheresisAllogeneicRelapsed Peripheral T Cell LymphomaHematology2019Standard TherapyPoland65
4381ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2019Standard TherapyPoland59
4382ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2019Standard TherapyGermany64
4383ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2019Standard TherapyGermany60
4384ApheresisAllogeneicSecondary Acute Myeloid Leukemia At Myeloproliferative NeoplasmsHematology2019Standard TherapyGermany56
4385ApheresisAutologousSecondary Primary Central Nervous System LymphomaHematology2019Standard TherapyGermany66
4386ApheresisAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland12
4387ApheresisAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland11
4388ApheresisAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland55
4389ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2019Standard TherapyPoland1
4390ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland44
4391ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany55
4392ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany59
4393ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany67
4394ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany45
4395ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany72
4396ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany61
4397ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany61
4398ApheresisAutologousTesticular Cancer RelapseHematology2019Standard TherapyGermany29
4399ApheresisAllogeneicThalassemia MajorHematology2019Standard TherapyPoland20
4400ApheresisAllogeneicWiskott-Aldrich SyndromeHematology2019Standard TherapyPoland1
4401ApheresisAllogeneicΒ - ThalassemiaHematology2019Standard TherapyPoland13
4402Adipose TissueAutologousChondromalaciaOrthopedy2019Experimental TherapyPoland48,8
4403Adipose TissueAutologousChondromalaciaOrthopedy2019Experimental TherapyPoland38,6
4404Adipose TissueAutologousCoxarthrosisOrthopedy2019Experimental TherapyPoland34
4405Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4406Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4407Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4408Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4409Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4410Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4411Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4412Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4413Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4414Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4415Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4416Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4417Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4418Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4419Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4420Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4421Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4422Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4423Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4424Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4425Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4426Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4427Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4428Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland44,11
4429Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland65,3
4430Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland68,6
4431Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland36,1
4432Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland54,3
4433Adipose TissueAutologousMild ArthritisOrthopedy2019Experimental TherapyPoland21,2
4434Adipose TissueAutologousMild ArthritisOrthopedy2019Experimental TherapyPoland68,5
4435Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland52,8
4436Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland44,8
4437Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland52,5
4438Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland54,5
4439Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland55,11
4440Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4441Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4442Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4443Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4444Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4445Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4446Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4447Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4448Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4449Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4450Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4451Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4452Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4453Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4454Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4455Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4456Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4457Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4458Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4459Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4460Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4461Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4462Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4463Adipose TissueAutologousShoulder OsteoarthritisOrthopedy2019Experimental TherapyPoland47,1
4464Adipose TissueAutologousSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2019Experimental TherapyPoland45,3
4465Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2018Experimental TherapyPoland7
4466Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2018Experimental TherapyPolandno data
4467Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2018Experimental TherapyPoland4,7
4468Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2018Experimental TherapyPoland46,7
4469Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2018Experimental TherapyPoland20,6
4470Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2018Experimental TherapyPoland82,11
4471Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland61,11
4472Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland67,1
4473Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland41,8
4474Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland52,3
4475Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland66,3
4476Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland46,2
4477Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland65,2
4478Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland47,3
4479Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland52,11
4480Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland40
4481Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland54,2
4482Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland67,11
4483Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland41,9
4484Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland80,3
4485Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland65,7
4486Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland65,2
4487Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland60,2
4488Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland67,9
4489Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland49,2
4490Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland64,5
4491Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland63,7
4492Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland62,1
4493Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland55,6
4494Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland38,8
4495Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland69,5
4496Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland37,11
4497Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland56,8
4498Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland71,1
4499Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland64,3
4500Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland68,5
4501Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland78,2
4502Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland70,9
4503Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland62,4
4504Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland61,8
4505Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland41,7
4506Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland38,1
4507Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland62,7
4508Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland44,3
4509Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland55,11
4510Cord TissueAllogeneic - UnrelatedArthrogryposis Multiplex Congenita; EpilepsiaNeurology2018Experimental TherapyPoland6,3
4511Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2018Experimental TherapyPoland18,11
4512Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,5
4513Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland9
4514Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,3
4515Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,1
4516Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland9,5
4517Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5,11
4518Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,3
4519Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,1
4520Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland11,11
4521Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,7
4522Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5,5
4523Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5
4524Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,3
4525Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5,3
4526Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,4
4527Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,9
4528Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5,1
4529Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland11,4
4530Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,11
4531Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,1
4532Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6
4533Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland9,2
4534Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland9,6
4535Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,5
4536Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,11
4537Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5
4538Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,9
4539Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,7
4540Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland15
4541Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,3
4542Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,3
4543Cord TissueAllogeneic - RelatedAutismNeurology2018Experimental TherapyPoland4
4544Cord TissueAllogeneic - UnrelatedAutism - Delayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland6
4545Cord TissueAllogeneic - RelatedAutism; Congenital CytomegalovirusNeurology2018Experimental TherapyPoland6
4546Cord TissueAllogeneic - UnrelatedBilateral Edema Of The Optic NervesOphthalmology2018Experimental TherapyPoland12,4
4547Cord TissueAllogeneic - UnrelatedBrain Disorder, UnspecifiedNeurology2018Experimental TherapyPoland10,1
4548Cord TissueAllogeneic - UnrelatedCartilage DamageOrthopedy2018Experimental TherapyPoland56
4549Cord TissueAllogeneic - UnrelatedCerebellar Syndrome; Delayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland3,7
4550Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland16,7
4551Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,8
4552Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,11
4553Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,11
4554Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland9,4
4555Cord TissueAllogeneic - Unrelated & RelatedCerebral PalsyNeurology2018Experimental TherapyPoland13,1
4556Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,4
4557Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,1
4558Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,5
4559Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,11
4560Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,6
4561Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland11,6
4562Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,9
4563Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,2
4564Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,1
4565Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,3
4566Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,6
4567Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,2
4568Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland16,5
4569Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,1
4570Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,6
4571Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,9
4572Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,5
4573Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,4
4574Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,3
4575Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland1,11
4576Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,1
4577Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland7,8
4578Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland1,1
4579Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,4
4580Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland8,5
4581Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland12,4
4582Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,7
4583Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland10 months
4584Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland8,9
4585Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,2
4586Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland15,7
4587Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,2
4588Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland13,5
4589Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,1
4590Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland7,4
4591Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,6
4592Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,1
4593Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,2
4594Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,9
4595Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,1
4596Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland1,9
4597Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,5
4598Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland7,1
4599Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,3
4600Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,11
4601Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland13,2
4602Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland7,3
4603Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland1,2
4604Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland16
4605Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,4
4606Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland12,2
4607Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,9
4608Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2018Experimental TherapyPoland10
4609Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2
4610Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,2
4611Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,6
4612Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland9,5
4613Cord TissueAllogeneic - UnrelatedCerebral Palsy; EncephalopathyNeurology2018Experimental TherapyPoland1,11
4614Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland3,7
4615Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland9,2
4616Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland2,4
4617Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland10,9
4618Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland7,4
4619Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland3,6
4620Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland3,1
4621Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland2
4622Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland2,4
4623Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland8,3
4624Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland10,11
4625Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland2,3
4626Cord TissueAllogeneic - UnrelatedCerebral Palsy; Epilepsy; Developmental DelayNeurology2018Experimental TherapyPoland8,11
4627Cord TissueAllogeneic - UnrelatedCongenital MyastheniaNeurology2018Experimental TherapyPoland6,4
4628Cord TissueAllogeneic - UnrelatedCongenital MyastheniaNeurology2018Experimental TherapyPoland3,3
4629Cord TissueAllogeneic - UnrelatedDamage To The Intercondylar Fissure Of The Right KneeOrthopedy2018Experimental TherapyPoland40
4630Cord TissueAllogeneic - UnrelatedDegeneration Of The Cartilage Of The Knee JointOrthopedy2018Experimental TherapyPoland34
4631Cord TissueAllogeneic - UnrelatedDegeneration Of The Cartilage Of The Knee JointOrthopedy2018Experimental TherapyPoland57
4632Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland6,2
4633Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland5,4
4634Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland4,8
4635Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland7,11
4636Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland4,7
4637Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland4,2
4638Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; Atrophy Of The Optic NervesNeurology2018Experimental TherapyPoland2
4639Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; EpilepsyNeurology2018Experimental TherapyPoland4,5
4640Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2018Experimental TherapyPoland14
4641Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2018Experimental TherapyPoland7,11
4642Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2018Experimental TherapyPoland5,2
4643Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4644Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4645Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4646Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4647Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4648Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4649Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4650Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4651Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4652Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2018Experimental TherapyPoland8,8
4653Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2018Experimental TherapyPoland54,8
4654Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2018Experimental TherapyPoland11,4
4655Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2018Experimental TherapyPoland24,5
4656Cord TissueAllogeneic - UnrelatedEncephalopathy; Cerebral PalsyNeurology2018Experimental TherapyPoland22,1
4657Cord TissueAllogeneic - UnrelatedEncephalopathy; EpilepsyNeurology2018Experimental TherapyPoland21,2
4658Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland20,9
4659Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland13,3
4660Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland7,6
4661Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland4
4662Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland3,9
4663Cord TissueAllogeneic - UnrelatedEpilepsy; Agenesis Of Corpus CallosumNeurology2018Experimental TherapyPoland2
4664Cord TissueAllogeneic - UnrelatedFriedreich's AtaxiaNeurology2018Experimental TherapyPoland27,6
4665Cord TissueAllogeneic - UnrelatedFriedreich's AtaxiaNeurology2018Experimental TherapyPoland31,5
4666Cord TissueAllogeneic - UnrelatedFriedreich's AtaxiaNeurology2018Experimental TherapyPoland22,4
4667Cord TissueAllogeneic - UnrelatedGeneral HypotoniaNeurology2018Experimental TherapyPoland2,5
4668Cord TissueAllogeneic - UnrelatedGeneral HypotoniaNeurology2018Experimental TherapyPoland9,11
4669Cord TissueAllogeneic - UnrelatedGeneral HypotoniaNeurology2018Experimental TherapyPoland7,3
4670Cord TissueAllogeneic - UnrelatedGeneral Hypotonia; AutismNeurology2018Experimental TherapyPoland8,4
4671Cord TissueAllogeneic - UnrelatedGenetic Syndrome - Deletion Of Part Of Chromosome 3Neurology2018Experimental TherapyPoland8,1
4672Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland44,11
4673Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland46,1
4674Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland28,11
4675Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland66
4676Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland48
4677Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland43
4678Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland48
4679Cord TissueAllogeneic - UnrelatedHoloprosencephalyNeurology2018Experimental TherapyPoland12,2
4680Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical Development, UnspecifiedNeurology2018Experimental TherapyPoland10,2
4681Cord TissueAllogeneic - UnrelatedLeber's Hereditary Optic NeuropathyOphthalmology2018Experimental TherapyPoland18,11
4682Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2018Experimental TherapyPoland5,2
4683Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2018Experimental TherapyPoland7,5
4684Cord TissueAllogeneic - UnrelatedMicrocephaliaNeurology2018Experimental TherapyPoland12,1
4685Cord TissueAllogeneic - UnrelatedMultiple System AtrophyNeurology2018Experimental TherapyPoland47,8
4686Cord TissueAllogeneic - UnrelatedMultiple System AtrophyNeurology2018Experimental TherapyPoland61,8
4687Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland28,1
4688Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland21,7
4689Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland22,6
4690Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland29,9
4691Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland21,8
4692Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland66,2
4693Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2018Experimental TherapyPoland1
4694Cord TissueAllogeneic - UnrelatedMyelomeningocele; HydrocephalusNeurology2018Experimental TherapyPoland2,9
4695Cord TissueAllogeneic - UnrelatedMyopathyNeurology2018Experimental TherapyPoland57,3
4696Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2018Experimental TherapyPoland27,4
4697Cord TissueAllogeneic - UnrelatedNeuropathyNeurology2018Experimental TherapyPoland47,6
4698Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland68,5
4699Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland31,11
4700Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland55,4
4701Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland36,6
4702Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland34,11
4703Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland27,2
4704Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland59,3
4705Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland50,8
4706Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland38,6
4707Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland55,8
4708Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland62,5
4709Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland35
4710Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland57,8
4711Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland75,5
4712Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland54,4
4713Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland80,5
4714Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland40,9
4715Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland70,11
4716Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland47,1
4717Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland38,2
4718Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland67,1
4719Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland64,7
4720Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland55,8
4721Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland27,5
4722Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland38,7
4723Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland23,7
4724Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland50,1
4725Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland70,5
4726Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland66,7
4727Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland22
4728Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland69,8
4729Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland78
4730Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland30
4731Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland73,8
4732Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland30,7
4733Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland49,7
4734Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland34,9
4735Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland46,5
4736Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland53,7
4737Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland56,7
4738Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland54,9
4739Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland42,4
4740Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland44,6
4741Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland60,3
4742Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland42,2
4743Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland52
4744Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2018Experimental TherapyPoland15,8
4745Cord TissueAllogeneic - UnrelatedOther Reduction Deformities Of Brain; SchizencephalyNeurology2018Experimental TherapyPoland5,7
4746Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland1,11
4747Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland1,9
4748Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland16,1
4749Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland5
4750Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland6
4751Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland11 months
4752Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland4,5
4753Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland1,2
4754Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland2,1
4755Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System - Syndrome Pierre-RobinNeurology2018Experimental TherapyPoland2,7
4756Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System- Pitt Hopkins SyndromeNeurology2018Experimental TherapyPoland10,1
4757Cord TissueAllogeneic - UnrelatedParalysisNeurology2018Experimental TherapyPoland14,11
4758Cord TissueAllogeneic - UnrelatedPhelan-Mcdermid SyndromeNeurology2018Experimental TherapyPoland17,1
4759Cord TissueAllogeneic - UnrelatedProgressive Supranuclear AtrophyNeurology2018Experimental TherapyPoland62
4760Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland25,5
4761Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland36,3
4762Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland48,11
4763Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland44,3
4764Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland52,8
4765Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland32,3
4766Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland46,7
4767Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland47,8
4768Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland51,9
4769Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland38,1
4770Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland30,4
4771Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland34,2
4772Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland28,6
4773Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland83,5
4774Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland57,5
4775Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland45,11
4776Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland28,6
4777Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland61,3
4778Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland20,8
4779Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland76,1
4780Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland35,1
4781Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland31,2
4782Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland64,4
4783Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland66,2
4784Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland75,7
4785Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland62
4786Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland44
4787Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland48,1
4788Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland47,11
4789Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland44,2
4790Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland42,6
4791Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland64,9
4792Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland85,1
4793Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland61,9
4794Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland64,3
4795Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland51,6
4796Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland40,11
4797Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland50,4
4798Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland49,2
4799Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland33,5
4800Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland54,7
4801Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland36,7
4802Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland59,1
4803Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland66,8
4804Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland39,5
4805Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland44,2
4806Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland39,1
4807Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland47,3
4808Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland58,2
4809Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland42
4810Cord TissueAllogeneic - UnrelatedSpastic TetraparesisNeurology2018Experimental TherapyPoland12
4811Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland2,6
4812Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland3,1
4813Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland4,11
4814Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland4,4
4815Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1
4816Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland2
4817Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1,5
4818Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1,1
4819Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1,4
4820Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland2,8
4821Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland2,6
4822Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland3,2
4823Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1,6
4824Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland33,11
4825Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland30,9
4826Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland25,9
4827Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland25,9
4828Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland34,3
4829Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland18,5
4830Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland26,6
4831Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland18,2
4832Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland38
4833Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2018Experimental TherapyPoland64,1
4834Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2018Experimental TherapyPoland34,1
4835Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2018Experimental TherapyPoland22,4
4836Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2018Experimental TherapyPoland34
4837Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2018Experimental TherapyPoland39,2
4838Cord TissueAllogeneic - UnrelatedState After Encephalitis; EpilepsyNeurology2018Experimental TherapyPoland44,11
4839Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland70,1
4840Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland53,4
4841Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland67,3
4842Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland42,3
4843Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland60,9
4844Cord TissueAllogeneic - UnrelatedTetraparesisOrthopedy2018Experimental TherapyPoland32,2
4845Cord TissueAllogeneic - UnrelatedVisual Pathway DysfunctionOphthalmology2018Experimental TherapyPoland48,9
4846Cord TissueAllogeneic - UnrelatedWolf-Hirschhorn SyndromeNeurology2018Experimental TherapyPoland1,8
4847Cord BloodAllogeneic - RelatedAlpha-MannosidosisNeurology2018Experimental TherapyGermany8
4848Cord BloodAutologousAplastic AnemiaHematology2018Standard TherapyPoland3,5
4849Cord BloodAutologousAutismNeurology2018Experimental TherapyPortugal6
4850Cord BloodAutologousAutismNeurology2018Experimental TherapyPortugal8
4851Cord BloodAllogeneic - RelatedAutismNeurology2018Experimental TherapyPoland3,9
4852Cord BloodAutologousAutismNeurology2018Experimental TherapyUK5,4
4853Cord BloodAutologousBrain DamageNeurology2018Experimental TherapyGermany3
4854Cord BloodAutologousCerebral PalsyNeurology2018Experimental TherapyPoland1,7
4855Cord BloodAutologousCerebral PalsyNeurology2018Experimental TherapyUK3,4
4856Cord BloodAllogeneicImmunodeficiencyHematology2018Standard TherapyGermany3 months
4857Cord BloodAllogeneic - RelatedSickle Cell AnemiaHematology2018Standard TherapyTurkey10,1
4858Cord BloodAllogeneic - RelatedSickle Cell AnemiaHematology2018Standard TherapyTurkey6
4859Cord BloodAllogeneicSphingolipidosisNeurology2018Experimental TherapyGermany4
4860Cord BloodAutologousStrokeNeurology2018Experimental TherapyGermany8 months
4861Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey8,6
4862Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey4,3
4863Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey3,1
4864Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey5
4865Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey10,9
4866Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey3
4867Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyGermany5
4868Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
4869Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland3
4870Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
4871Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland32
4872Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland27
4873Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland63
4874Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland28
4875Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland33
4876Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
4877Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
4878Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland64
4879Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
4880Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland25
4881Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland42
4882Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
4883Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland52
4884Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland20
4885Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland34
4886Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland63
4887Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany34
4888Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia In First Complete RemissionHematology2018Standard TherapyPoland61
4889Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland62
4890Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland66
4891Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland23
4892Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland45
4893Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland57
4894Bone Marrow FamilyAllogeneicNo DataHematology2018Standard TherapyPoland70
4895Bone Marrow FamilyAllogeneicNo DataHematology2018Standard TherapyPoland64
4896Bone Marrow FamilyAllogeneicNo DataHematology2018Standard TherapyPoland3
4897Bone Marrow FamilyAllogeneicNo DataHematology2018Standard TherapyPoland58
4898Bone Marrow FamilyAllogeneicRelapsed Peripheral T Cell LymphomaHematology2018Standard TherapyPoland44
4899Bone Marrow FamilyAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland9
4900Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland3
4901Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland9 months
4902Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland12
4903Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
4904Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland11
4905Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland14
4906Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
4907Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland7
4908Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
4909Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland14
4910Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland6
4911Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland59
4912Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland12
4913Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland6
4914Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland18
4915Bone MarrowAllogeneicAcute Lymphoblastic Leukemia - RelapseHematology2018Standard TherapyPoland14
4916Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
4917Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland49
4918Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
4919Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland36
4920Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland20
4921Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland1
4922Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland8
4923Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland3
4924Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
4925Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland41
4926Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland32
4927Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland17
4928Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland25
4929Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
4930Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland70
4931Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland8
4932Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland72
4933Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland40
4934Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland22
4935Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
4936Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland53
4937Bone MarrowAllogeneicAplastic AnemiaHematology2018Standard TherapyPoland24
4938Bone MarrowAllogeneicBilineal Leukemia - Acute Lymphoblastic Leukemia; Acute Myeloid LeukemiaHematology2018Standard TherapyPoland2
4939Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland1
4940Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland3
4941Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland2
4942Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland2
4943Bone MarrowAllogeneicCongenital Hypoplastic AnemiaHematology2018Standard TherapyPoland2
4944Bone MarrowAllogeneicDiffuse Large B-Cell LymphomaHematology2018Standard TherapyPoland68
4945Bone MarrowAllogeneicFanconi AnemiaHematology2018Standard TherapyPoland3
4946Bone MarrowAllogeneicFanconi AnemiaHematology2018Standard TherapyPoland3
4947Bone MarrowAllogeneicHodgkin LymphomaHematology2018Standard TherapyPoland31
4948Bone MarrowAllogeneicHurler SyndromeHematology2018Standard TherapyPoland2
4949Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2018Standard TherapyPoland11
4950Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland4
4951Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland12
4952Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland2
4953Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland70
4954Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland4
4955Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland4
4956Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland31
4957Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland37
4958Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland16
4959Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland48
4960Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland52
4961Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland1
4962Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland1
4963Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland62
4964Bone MarrowAllogeneicOther Non-Malignant DiseaseHematology2018Standard TherapyPoland29
4965Bone MarrowAllogeneicPrimary Myelofibrosis Grade IiiHematology2018Standard TherapyGermany73
4966Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland19
4967Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland14
4968Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland27
4969Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland18
4970Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland2
4971Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland20
4972Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland6
4973Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyGermany54
4974Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland2
4975Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland1
4976Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland7 months
4977Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland21
4978Bone MarrowAllogeneicT-Cell Leukemia/LymphomaHematology2018Standard TherapyPoland10
4979Bone MarrowAllogeneicThalassemia MajorHematology2018Standard TherapyPoland14
4980Bone MarrowAllogeneicThalassemia MajorHematology2018Standard TherapyPoland12
4981ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland29
4982ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland63
4983ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland65
4984ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland48
4985ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
4986ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland33
4987ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland61
4988ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland42
4989ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland47
4990ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland62
4991ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
4992ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
4993ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland49
4994ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland59
4995ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland20
4996ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland27
4997ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland1
4998ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland61
4999ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland33
5000ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland33
5001ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland21
5002ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland39
5003ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
5004ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland7 months
5005ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland25
5006ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland64
5007ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland36
5008ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland49
5009ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland20
5010ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland44
5011ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland59
5012ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland55
5013ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland30
5014ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland34
5015ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland48
5016ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland40
5017ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland45
5018ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland9
5019ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
5020ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland47
5021ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland24
5022ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany52
5023ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany43
5024ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany52
5025ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany59
5026ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany24
5027ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland26
5028ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland35
5029ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland59
5030ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland42
5031ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5032ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
5033ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5034ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland34
5035ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland72
5036ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland45
5037ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland45
5038ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5039ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland30
5040ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5041ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland56
5042ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5043ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland51
5044ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland64
5045ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5046ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland64
5047ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5048ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5049ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland76
5050ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland38
5051ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland58
5052ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5053ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5054ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5055ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland68
5056ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland37
5057ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland65
5058ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5059ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland33
5060ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5061ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland73
5062ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5063ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland52
5064ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
5065ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland57
5066ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland35
5067ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5068ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland42
5069ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland72
5070ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland55
5071ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5072ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland70
5073ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland40
5074ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5075ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland58
5076ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland39
5077ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland53
5078ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5079ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland59
5080ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5081ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland31
5082ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5083ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5084ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland38
5085ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland45
5086ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland32
5087ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5088ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland69
5089ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5090ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland28
5091ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland52
5092ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5093ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland55
5094ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5095ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland47
5096ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland29
5097ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland37
5098ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland57
5099ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland6
5100ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland56
5101ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5102ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland31
5103ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland58
5104ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland45
5105ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5106ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland32
5107ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5108ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland68
5109ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5110ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland59
5111ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland57
5112ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland59
5113ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland25
5114ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland75
5115ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland43
5116ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland72
5117ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland37
5118ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland55
5119ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5120ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland55
5121ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland56
5122ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland62
5123ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5124ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland41
5125ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland14
5126ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland62
5127ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
5128ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5129ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland38
5130ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany20
5131ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany47
5132ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany58
5133ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany31
5134ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany68
5135ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany60
5136ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany59
5137ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany67
5138ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany62
5139ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany58
5140ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany69
5141ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany62
5142ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany60
5143ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany65
5144ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany19
5145ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany68
5146ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany62
5147ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany67
5148ApheresisAllogeneicAcute Myeloid Leukemia; Myeloproliferative SyndromeHematology2018Standard TherapyGermany62
5149ApheresisAutologousAmyloidosisHematology2018Standard TherapyGermany72
5150ApheresisAutologousAmyloidosisHematology2018Standard TherapyGermany75
5151ApheresisAllogeneicAplastic AnemiaHematology2018Standard TherapyGermany61
5152ApheresisAutologousApoplexyHematology2018Standard TherapyGermany3
5153ApheresisAllogeneicAtypical Chronic Myeloid Leukemia Hematology2018Standard TherapyPoland58
5154ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland41
5155ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
5156ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland34
5157ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland34
5158ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland52
5159ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland46
5160ApheresisAllogeneicB-Cell Chronic Lymphoblastic LeukemiaHematology2018Standard TherapyPoland65
5161ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany69
5162ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany43
5163ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany66
5164ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany32
5165ApheresisAllogeneicBlastic Nk Cell LymphomaHematology2018Standard TherapyPoland65
5166ApheresisAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland15
5167ApheresisAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland2
5168ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2018Standard TherapyPoland49
5169ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2018Standard TherapyPoland38
5170ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyPoland63
5171ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyPoland48
5172ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyPoland25
5173ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyPoland41
5174ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyGermany44
5175ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyGermany54
5176ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland39
5177ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland63
5178ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland56
5179ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland71
5180ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland51
5181ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland67
5182ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland67
5183ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland49
5184ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland60
5185ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2018Standard TherapyPoland54
5186ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2018Standard TherapyGermany71
5187ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2018Standard TherapyGermany71
5188ApheresisAllogeneicFanconi AnemiaHematology2018Standard TherapyPoland9
5189ApheresisAllogeneicFollicular LymphomaHematology2018Standard TherapyPoland44
5190ApheresisAutologousFollicular LymphomaHematology2018Standard TherapyGermany65
5191ApheresisAllogeneicFollicular Lymphoma (Non-Hodgkin Lymphoma)Hematology2018Standard TherapyPoland56
5192ApheresisAutologousGerm Cell TumorHematology2018Standard TherapyGermany23
5193ApheresisAutologousGerm Cell TumorHematology2018Standard TherapyGermany31
5194ApheresisAllogeneicHodgkin LymphomaHematology2018Standard TherapyPoland38
5195ApheresisAllogeneicHodgkin LymphomaHematology2018Standard TherapyPoland27
5196ApheresisAllogeneicHypoplastic Mds-Eb2 With Incipient SamlHematology2018Standard TherapyPoland63
5197ApheresisAutologousLarge B-Cell Non-Hodgkin-LymphomaHematology2018Standard TherapyGermany66
5198ApheresisAllogeneicLeukemiaHematology2018Standard TherapyPoland34
5199ApheresisAllogeneicLymphomatoid GranulomatosisHematology2018Standard TherapyGermany36
5200ApheresisAutologousMantle Cell LymphomaHematology2018Standard TherapyGermany66
5201ApheresisAutologousMantle Cell LymphomaHematology2018Standard TherapyGermany64
5202ApheresisAutologousMantle Cell LymphomaHematology2018Standard TherapyGermany44
5203ApheresisAutologousMantle Cell LymphomaHematology2018Standard TherapyGermany66
5204ApheresisAutologousMorbus HodgkinHematology2018Standard TherapyGermany65
5205ApheresisAutologousMorbus HodgkinHematology2018Standard TherapyGermany31
5206ApheresisAllogeneicMorbus Hodgkin-RelapseHematology2018Standard TherapyGermany35
5207ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany67
5208ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany61
5209ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany61
5210ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany66
5211ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany57
5212ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany53
5213ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany57
5214ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5215ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany47
5216ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany60
5217ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany66
5218ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5219ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany67
5220ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5221ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany54
5222ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany58
5223ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany51
5224ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany69
5225ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany52
5226ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5227ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5228ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5229ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5230ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany64
5231ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany63
5232ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany55
5233ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany60
5234ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany61
5235ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5236ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany64
5237ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany55
5238ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5239ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany64
5240ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany52
5241ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany61
5242ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany69
5243ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany73
5244ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany42
5245ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany60
5246ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5247ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany66
5248ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany66
5249ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5250ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany51
5251ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany69
5252ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany50
5253ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany67
5254ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany50
5255ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany64
5256ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany56
5257ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland74
5258ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5259ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland72
5260ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland59
5261ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland50
5262ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland62
5263ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland68
5264ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland54
5265ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5266ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland22
5267ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland64
5268ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland77
5269ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland66
5270ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland60
5271ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland68
5272ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland39
5273ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland62
5274ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland56
5275ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland63
5276ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland63
5277ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland27
5278ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland70
5279ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland39
5280ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland71
5281ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland32
5282ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland59
5283ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland59
5284ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland63
5285ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5286ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland65
5287ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland66
5288ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland48
5289ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland60
5290ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland57
5291ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland46
5292ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland49
5293ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland4
5294ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5295ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland69
5296ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland63
5297ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland8
5298ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland58
5299ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland61
5300ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5301ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyGermany61
5302ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyGermany65
5303ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyGermany57
5304ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyGermany27
5305ApheresisAllogeneicMyelodysplastic Syndrome - RaebHematology2018Standard TherapyPoland61
5306ApheresisAllogeneicMyelodysplastic Syndrome Refractory Anemia With Blast Proliferation IiHematology2018Standard TherapyGermany57
5307ApheresisAllogeneicMyelodysplastic Syndrome; Acute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany65
5308ApheresisAllogeneicMyelodysplastic Syndrome; Acute Myelogenous LeukemiaHematology2018Standard TherapyPoland74
5309ApheresisAllogeneicMyelodysplastic Syndrome; Myeloproliferative NeoplasmsHematology2018Standard TherapyGermany62
5310ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland49
5311ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland60
5312ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland56
5313ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland58
5314ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland64
5315ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland68
5316ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland72
5317ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland53
5318ApheresisAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland56
5319ApheresisAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland57
5320ApheresisAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland55
5321ApheresisAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland52
5322ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2018Standard TherapyPoland61
5323ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland69
5324ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland70
5325ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland38
5326ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland22
5327ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland60
5328ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland19
5329ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland65
5330ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland22
5331ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland67
5332ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland46
5333ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland23
5334ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland69
5335ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland70
5336ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland17
5337ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland31
5338ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland66
5339ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland17
5340ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland58
5341ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland11
5342ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland64
5343ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland30
5344ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland54
5345ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany72
5346ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany54
5347ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany58
5348ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany63
5349ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany48
5350ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany62
5351ApheresisAllogeneicNon-Hodgkin Lymphoma; Diffuse Large B-Cell LymphomaHematology2018Standard TherapyPoland62
5352ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2018Standard TherapyGermany51
5353ApheresisAllogeneicOther MalignancyHematology2018Standard TherapyPoland59
5354ApheresisAllogeneicOther Myelodysplastic SyndromesHematology2018Standard TherapyPoland67
5355ApheresisAllogeneicOther MyelofibrosisHematology2018Standard TherapyPoland57
5356ApheresisAllogeneicPeripheral T-Cell LymphomaHematology2018Standard TherapyPoland50
5357ApheresisAllogeneicPlasma Cell DisorderHematology2018Standard TherapyPoland64
5358ApheresisAllogeneicPlasma Cell DisorderHematology2018Standard TherapyPoland57
5359ApheresisAutologousPlasma Cell LeukemiaHematology2018Standard TherapyGermany52
5360ApheresisAllogeneicPost-Essential Thrombocythemia-MyelofibrosisHematology2018Standard TherapyGermany53
5361ApheresisAutologousPrimary Central Nervous System LymphomaHematology2018Standard TherapyGermany67
5362ApheresisAutologousPrimary Central Nervous System LymphomaHematology2018Standard TherapyGermany69
5363ApheresisAutologousPrimary Central Nervous System LymphomaHematology2018Standard TherapyGermany66
5364ApheresisAutologousPrimary Central Nervous System Lymphoma RelapseHematology2018Standard TherapyGermany63
5365ApheresisAllogeneicPrimary ImmunodeficiencyHematology2018Standard TherapyPoland3
5366ApheresisAllogeneicPrimary Myelofibrosis; Secondary Acute Myelogenous LeukemiaHematology2018Standard TherapyPoland53
5367ApheresisAllogeneicProlymphocytic LeukemiaHematology2018Standard TherapyPoland62
5368ApheresisAutologousRefractory Diffuse Large B-Cell LymphomaHematology2018Standard TherapyGermany36
5369ApheresisAllogeneicRefractory Diffuse Large B-Cell LymphomaHematology2018Standard TherapyGermany50
5370ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2018Standard TherapyPoland58
5371ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2018Standard TherapyGermany68
5372ApheresisAllogeneicSecondary Acute Myeloid Leukemia At Primary MyelofibrosisHematology2018Standard TherapyGermany56
5373ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland18
5374ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland74
5375ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland24
5376ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland70
5377ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland6
5378ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland13
5379ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland2
5380ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland7
5381ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland13
5382ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland45
5383ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland40
5384ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany67
5385ApheresisAutologousT-Cell-LymphomaHematology2018Standard TherapyGermany67
5386ApheresisAllogeneicT-Cell-LymphomaHematology2018Standard TherapyGermany23
5387ApheresisAllogeneicThalassemia MajorHematology2018Standard TherapyPoland5
5388ApheresisAllogeneicTherapy-Related Myelodysplastic SyndromesHematology2018Standard TherapyPoland65
5389Adipose TissueAutologousCondition After Injury Of The Left Knee JointOrthopedy2018Experimental TherapyPoland33
5390Adipose TissueAutologousCoxarthrosisOrthopedy2018Experimental TherapyPoland53
5391Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5392Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5393Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5394Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5395Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5396Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5397Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5398Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5399Adipose TissueAutologousGonarthrosisOrthopedy2018Experimental TherapyPoland69
5400Adipose TissueAutologousGonarthrosisOrthopedy2018Experimental TherapyPoland42
5401Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5402Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5403Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5404Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5405Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5406Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5407Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5408Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5409Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5410Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5411Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5412Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland44,2
5413Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland25,8
5414Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland38,5
5415Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland26,1
5416Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland37,11
5417Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland62,5
5418Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland35,4
5419Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland31,3
5420Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland13
5421Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland11,1
5422Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland2,4
5423Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland8,1
5424Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland7,6
5425Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2017Experimental TherapyPoland33,4
5426Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland67,11
5427Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland37,9
5428Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland71,7
5429Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPolandno data
5430Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland47,6
5431Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland56,7
5432Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland48,11
5433Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland46,3
5434Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland45,9
5435Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland75,9
5436Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland51,3
5437Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland59,8
5438Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland64,9
5439Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland56,7
5440Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland40,11
5441Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland69,1
5442Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland52
5443Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland35,1
5444Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland77,2
5445Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland35,6
5446Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland33,5
5447Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland51,6
5448Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland46
5449Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland54,1
5450Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland63,2
5451Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland43,8
5452Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland64,7
5453Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland51,6
5454Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland70,11
5455Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland65,1
5456Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland51,3
5457Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland68,1
5458Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland59,3
5459Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland49,1
5460Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland60,1
5461Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland56,7
5462Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland58,7
5463Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland63
5464Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland62,9
5465Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland57,9
5466Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland59,11
5467Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland46,5
5468Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland53,9
5469Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland55,2
5470Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland54,6
5471Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland78,6
5472Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland44
5473Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland78,7
5474Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland60,1
5475Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland28,7
5476Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland78,5
5477Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland54,2
5478Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland45,3
5479Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland48,2
5480Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland71,8
5481Cord TissueAllogeneic - UnrelatedAnterior Ischemic Optic NeuropathyOphthalmology2017Experimental TherapyPoland67,7
5482Cord TissueAllogeneic - UnrelatedArthrogryposis Multiplex CongenitaNeurology2017Experimental TherapyPoland1,7
5483Cord TissueAllogeneic - UnrelatedArthrogryposis Multiplex CongenitaNeurology2017Experimental TherapyPoland3,5
5484Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2017Experimental TherapyPoland23,9
5485Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2017Experimental TherapyPoland35,5
5486Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland7,11
5487Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland13,4
5488Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland11,11
5489Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland9,1
5490Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland6,3
5491Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland7,11
5492Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland10,2
5493Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland4,8
5494Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland6,8
5495Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland7
5496Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland4,8
5497Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland10,8
5498Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland13,1
5499Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland4,11
5500Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland4,8
5501Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland12,2
5502Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland5,1
5503Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland6,5
5504Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland7,8
5505Cord TissueAllogeneic - UnrelatedAutism; EncephalopathyNeurology2017Experimental TherapyPoland7,11
5506Cord TissueAllogeneic - UnrelatedCartilage DamageOrthopedy2017Experimental TherapyPoland61
5507Cord TissueAllogeneic - UnrelatedCartilage DamageOrthopedy2017Experimental TherapyPoland46
5508Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2017Experimental TherapyPoland33
5509Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland11,5
5510Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland60,5
5511Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland52,6
5512Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland60,11
5513Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland46,5
5514Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland18,7
5515Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland15,4
5516Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,11
5517Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland31,9
5518Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,7
5519Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2017Experimental TherapyPoland12
5520Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,9
5521Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,3
5522Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland6,1
5523Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland13,6
5524Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland8,2
5525Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,7
5526Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland8,4
5527Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland15,1
5528Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland18,4
5529Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland7,9
5530Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,5
5531Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,7
5532Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,5
5533Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,1
5534Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,4
5535Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,3
5536Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,7
5537Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,2
5538Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,7
5539Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,11
5540Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland15,3
5541Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland13,6
5542Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,4
5543Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,3
5544Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,3
5545Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,2
5546Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3
5547Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,9
5548Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland7,8
5549Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland6,2
5550Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland10
5551Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,6
5552Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland1,11
5553Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,2
5554Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland24,8
5555Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland8,1
5556Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland1,6
5557Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,8
5558Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland10,9
5559Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland17
5560Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,6
5561Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,9
5562Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,8
5563Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland8,6
5564Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland6,2
5565Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland1,6
5566Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,5
5567Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland6,2
5568Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2017Experimental TherapyPoland5,8
5569Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2017Experimental TherapyPoland3,6
5570Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2017Experimental TherapyPoland2,1
5571Cord TissueAllogeneic - UnrelatedCerebral Palsy; Neonatal Cerebral LeukomalaciaNeurology2017Experimental TherapyPoland1,9
5572Cord TissueAllogeneic - UnrelatedChronic Myelogenous LeukemiaHematology2017Experimental TherapyPoland5,11
5573Cord TissueAllogeneic - UnrelatedCondition After EncephalitisNeurology2017Experimental TherapyPoland19,7
5574Cord TissueAllogeneic - UnrelatedCondition After MyelitisNeurology2017Experimental TherapyPoland34,11
5575Cord TissueAllogeneic - UnrelatedCongenital Fiber-Type Disproportion MyopathyNeurology2017Experimental TherapyPoland1,1
5576Cord TissueAllogeneic - UnrelatedCongenital Malformations Of The Nervous System, UnspecifiedNeurology2017Experimental TherapyPoland8,2
5577Cord TissueAllogeneic - UnrelatedCranium BifidumNeurology2017Experimental TherapyPoland5,2
5578Cord TissueAllogeneic - UnrelatedCri Du Chat SyndromeNeurology2017Experimental TherapyPoland8,6
5579Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland3,5
5580Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland6,3
5581Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland5
5582Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland7,9
5583Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland8,3
5584Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; EpilepsyNeurology2017Experimental TherapyPoland11,8
5585Cord TissueAllogeneic - UnrelatedDevic’s DiseaseNeurology2017Experimental TherapyPoland45,2
5586Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland28,6
5587Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland28,11
5588Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland23,9
5589Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland9,1
5590Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland14,5
5591Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2017Experimental TherapyPoland21,1
5592Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2017Experimental TherapyPoland5
5593Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2017Experimental TherapyPoland5,5
5594Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2017Experimental TherapyPoland1,6
5595Cord TissueAllogeneic - UnrelatedEncephalopathy; Cerebral PalsyNeurology2017Experimental TherapyPoland4,4
5596Cord TissueAllogeneic - UnrelatedEncephalopathy; Cerebral PalsyNeurology2017Experimental TherapyPoland1,5
5597Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland3,1
5598Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland16,4
5599Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland9,11
5600Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland12,11
5601Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland15,9
5602Cord TissueAllogeneic - UnrelatedEpilepsy; AutismNeurology2017Experimental TherapyPoland6
5603Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland22,1
5604Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland31,6
5605Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland32,3
5606Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland33,4
5607Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland42,1
5608Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland22,4
5609Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2017Experimental TherapyPoland4,7
5610Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2017Experimental TherapyPoland7,11
5611Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2017Experimental TherapyPoland58
5612Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2017Experimental TherapyPoland65,6
5613Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2017Experimental TherapyPoland66
5614Cord TissueAllogeneic - UnrelatedHydrocephalus; Neonatal Cerebral LeukomalaciaNeurology2017Experimental TherapyPoland2,3
5615Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2017Experimental TherapyPoland1,9
5616Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2017Experimental TherapyPoland1,1
5617Cord TissueAllogeneic - UnrelatedIschemia Within The Optic NerveOphthalmology2017Experimental TherapyPoland37,11
5618Cord TissueAllogeneic - UnrelatedKrabbe DiseaseNeurology2017Experimental TherapyPoland6,3
5619Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2017Experimental TherapyPoland7,1
5620Cord TissueAllogeneic - UnrelatedMoyamoya DiseaseNeurology2017Experimental TherapyPoland17,7
5621Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland26,11
5622Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland34,1
5623Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland6,7
5624Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland12,1
5625Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland10,8
5626Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland8
5627Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland29,8
5628Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland7,4
5629Cord TissueAllogeneic - UnrelatedMyopathy Of Congenital Fiber Type Disproportion; Damage To The Central Nervous SystemNeurology2017Experimental TherapyPoland2,2
5630Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2017Experimental TherapyPoland37,7
5631Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2017Experimental TherapyPoland41,11
5632Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2017Experimental TherapyPoland3,2
5633Cord TissueAllogeneic - UnrelatedNo Bone AdhesionOrthopedy2017Experimental TherapyPoland14,1
5634Cord TissueAllogeneic - UnrelatedNo Bone AdhesionOrthopedy2017Experimental TherapyPoland17,11
5635Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland39
5636Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland30,9
5637Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland37,7
5638Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland66,11
5639Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland31,5
5640Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland39,7
5641Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland76,1
5642Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland77,5
5643Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland30,6
5644Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland85,7
5645Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland52,8
5646Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland37,1
5647Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland59
5648Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland66,1
5649Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2017Experimental TherapyPoland56,4
5650Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2017Experimental TherapyPoland30,11
5651Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2017Experimental TherapyPoland74,5
5652Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2017Experimental TherapyPoland7,11
5653Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2017Experimental TherapyPoland2,1
5654Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2017Experimental TherapyPoland2,4
5655Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland58,1
5656Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland49
5657Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland56,8
5658Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland65,2
5659Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland43,4
5660Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland42,11
5661Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland41
5662Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland52,1
5663Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland61,5
5664Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland48,1
5665Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland31,1
5666Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland52,11
5667Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland36,11
5668Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland63,11
5669Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland31,9
5670Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland45,5
5671Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland49,1
5672Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland26,9
5673Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland65,4
5674Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland43,11
5675Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland22,1
5676Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland61,3
5677Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland61,7
5678Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland65,1
5679Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland43,1
5680Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland36,9
5681Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland48,8
5682Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland52,9
5683Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland47,2
5684Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland46,9
5685Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland38
5686Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland25,2
5687Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland53,1
5688Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland47,6
5689Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland32,9
5690Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland69,2
5691Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland64,3
5692Cord TissueAllogeneic - UnrelatedSpastic TetraparesisNeurology2017Experimental TherapyPoland29,4
5693Cord TissueAllogeneic - UnrelatedSpastic Tetraparesis; EpilepsyNeurology2017Experimental TherapyPoland2,8
5694Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland1,11
5695Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland6,4
5696Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland6,3
5697Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland1,1
5698Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland4,1
5699Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland3,6
5700Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland3,4
5701Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland2,11
5702Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland5,8
5703Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland6,1
5704Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland2,8
5705Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland2,3
5706Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland18,5
5707Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland5,1
5708Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland11,1
5709Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland10,3
5710Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland9 months
5711Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland34,11
5712Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland34,1
5713Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland24,9
5714Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland39
5715Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland6,4
5716Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPolandno data
5717Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPolandno data
5718Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland27,3
5719Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland33,8
5720Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland3,4
5721Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland38,4
5722Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland14,4
5723Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland57,1
5724Cord TissueAllogeneic - UnrelatedSpinal Cord Injury; TetraparesisOrthopedy2017Experimental TherapyPoland42,9
5725Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland10,6
5726Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland41,4
5727Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland12,11
5728Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland8,5
5729Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland24,9
5730Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2017Experimental TherapyPoland44,1
5731Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2017Experimental TherapyPoland24,6
5732Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2017Experimental TherapyPoland35,9
5733Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2017Experimental TherapyPoland24,6
5734Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland37,4
5735Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland31,6
5736Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland30
5737Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland23,7
5738Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland27,11
5739Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland45,4
5740Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland48,1
5741Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland37,8
5742Cord TissueAllogeneic - UnrelatedSyndrome IfapHematology2017Experimental TherapyPoland3,5
5743Cord TissueAllogeneic - UnrelatedSyringomyeliaNeurology2017Experimental TherapyPoland42,6
5744Cord TissueAllogeneic - UnrelatedTetraparesisOrthopedy2017Experimental TherapyPoland27,11
5745Cord TissueAllogeneic - UnrelatedTransverse MyelitisNeurology2017Experimental TherapyPoland8,3
5746Cord TissueAllogeneic - UnrelatedTraumatic Brain InjuryNeurology2017Experimental TherapyPoland9,4
5747Cord BloodAutologousAutismNeurology2017Experimental TherapyPoland4,11
5748Cord BloodAutologousAutismNeurology2017Experimental TherapyPoland6,2
5749Cord BloodAutologousAutismNeurology2017Experimental TherapyPoland7,3
5750Cord BloodAutologousAutismNeurology2017Experimental TherapyRomania5,4
5751Cord BloodAutologousAutismNeurology2017Experimental TherapyRomania4,1
5752Cord BloodAutologousAutismNeurology2017Experimental TherapyRomania4,1
5753Cord BloodAllogeneic - RelatedCd40 Ligand DeficiencyHematology2017Standard TherapyTurkey9,7
5754Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapySpain 7
5755Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyPoland2,2
5756Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyPoland5,4
5757Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyPoland10,3
5758Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyPoland6,8
5759Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyUK7
5760Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyUK3,4
5761Cord BloodAllogeneic - RelatedChronic Granulomatous DiseaseHematology2017Standard TherapyTurkey3,9
5762Cord Bloodno dataLymphoblastic LeukemiaHematology2017Standard TherapyUK3
5763Cord BloodAllogeneic - RelatedRelapse Of Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7,3
5764Cord BloodAllogeneic - RelatedThalassemia MajorHematology2017Standard TherapyTurkey4,1
5765Cord BloodAllogeneic - RelatedThalassemia MajorHematology2017Standard TherapyTurkey4,1
5766Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland51
5767Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland47
5768Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland46
5769Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
5770Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland52
5771Bone Marrow FamilyAllogeneicChronic Granulomatous DiseaseHematology2017Standard TherapyPoland4
5772Bone Marrow FamilyAllogeneicHurler SyndromeHematology2017Standard TherapyPoland2
5773Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland68
5774Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland69
5775Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland50
5776Bone Marrow FamilyAllogeneicMyelofibrosisHematology2017Standard TherapyPoland29
5777Bone Marrow FamilyAllogeneicMyeloproliferative NeoplasmsHematology2017Standard TherapyPoland7
5778Bone Marrow FamilyAllogeneicNo DataHematology2017Standard TherapyPoland68
5779Bone Marrow FamilyAllogeneicNo Datano data2017Standard TherapyPoland39
5780Bone Marrow FamilyAllogeneicNo DataHematology2017Standard TherapyPoland39
5781Bone Marrow FamilyAllogeneicNo DataHematology2017Standard TherapyPoland65
5782Bone Marrow FamilyAllogeneicNo DataHematology2017Standard TherapyPoland32
5783Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland56
5784Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7
5785Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland6
5786Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland30
5787Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland10
5788Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland14
5789Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland16
5790Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland38
5791Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland9
5792Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland21
5793Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland3
5794Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland8
5795Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland14
5796Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland4
5797Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7
5798Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland2
5799Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7
5800Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland18
5801Bone MarrowAllogeneicAcute Megakaryocytic LeukemiaHematology2017Standard TherapyPoland2
5802Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland54
5803Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland19
5804Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland76
5805Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland22
5806Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
5807Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
5808Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland67
5809Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland13
5810Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
5811Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland1
5812Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
5813Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland57
5814Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland10
5815Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland68
5816Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
5817Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland10
5818Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland17
5819Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland51
5820Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland56
5821Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland24
5822Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland9
5823Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland12
5824Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland2
5825Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany70
5826Bone MarrowAllogeneicAcute Myeloid Leukemia (High Risk)Hematology2017Standard TherapyGermany31
5827Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2017Standard TherapyPoland2
5828Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2017Standard TherapyPoland4
5829Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2017Standard TherapyPoland51
5830Bone MarrowAllogeneicFanconi AnemiaHematology2017Standard TherapyPoland10
5831Bone MarrowAllogeneicFanconi AnemiaHematology2017Standard TherapyPoland10
5832Bone MarrowAllogeneicHyper-Igm SyndromeHematology2017Standard TherapyPoland2
5833Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2017Standard TherapyPoland1
5834Bone MarrowAllogeneicLeukemiaHematology2017Standard TherapyPoland40
5835Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland60
5836Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland61
5837Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland2
5838Bone MarrowAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland50
5839Bone MarrowAllogeneicNijmegen Breakage SyndromeHematology2017Standard TherapyPoland8
5840Bone MarrowAllogeneicNo DataHematology2017Standard TherapyPoland32
5841Bone MarrowAllogeneicOther Combined ImmunodeficiencyHematology2017Standard TherapyPoland11
5842Bone MarrowAllogeneicPrimary Immunodeficiency; Nijmegen Breakage SyndromeHematology2017Standard TherapyPoland6
5843Bone MarrowAllogeneicPure Red Cell AplasiaHematology2017Standard TherapyPoland5
5844Bone MarrowAllogeneicSecondary Acute Myelogenous Leukemia After Ewing SarcomaHematology2017Standard TherapyPoland16
5845Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland6
5846Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland1
5847Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland1
5848Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland2
5849Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland1
5850Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland8
5851Bone MarrowAllogeneicT-Cell Leukemia/LymphomaHematology2017Standard TherapyPoland18
5852Bone MarrowAllogeneicThalassemia MajorHematology2017Standard TherapyPoland11
5853Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2017Standard TherapyPoland2
5854ApheresisAllogeneicAccrued Hemophagocytic LymphohistiocytosisHematology2017Standard TherapyGermany43
5855ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland24
5856ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland43
5857ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland17
5858ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland53
5859ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland43
5860ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland3
5861ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland12
5862ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland19
5863ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland60
5864ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland33
5865ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland56
5866ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland59
5867ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland35
5868ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland23
5869ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland12
5870ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland38
5871ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland62
5872ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland51
5873ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland19
5874ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland11
5875ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland4
5876ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland41
5877ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland64
5878ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland30
5879ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland57
5880ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland56
5881ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland17
5882ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland36
5883ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland43
5884ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland21
5885ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland53
5886ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland67
5887ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland6
5888ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland64
5889ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland24
5890ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland10
5891ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland26
5892ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland8
5893ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland13
5894ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyGermany26
5895ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyGermany39
5896ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland51
5897ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
5898ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland48
5899ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland54
5900ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland32
5901ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland47
5902ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland48
5903ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland20
5904ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland44
5905ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland66
5906ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland75
5907ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland61
5908ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland63
5909ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
5910ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
5911ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland45
5912ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland64
5913ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland46
5914ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
5915ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland57
5916ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland32
5917ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland75
5918ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
5919ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland64
5920ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
5921ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland56
5922ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
5923ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland75
5924ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland69
5925ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland51
5926ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland70
5927ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland34
5928ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland52
5929ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
5930ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland67
5931ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland67
5932ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland48
5933ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
5934ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
5935ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
5936ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland64
5937ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland39
5938ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland54
5939ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland35
5940ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland29
5941ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland58
5942ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
5943ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland38
5944ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland32
5945ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland63
5946ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
5947ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland67
5948ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland58
5949ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland43
5950ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland42
5951ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
5952ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland68
5953ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland52
5954ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland49
5955ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
5956ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
5957ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland51
5958ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland35
5959ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland57
5960ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland31
5961ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland64
5962ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
5963ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland49
5964ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
5965ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland22
5966ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland54
5967ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland61
5968ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland40
5969ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland58
5970ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland68
5971ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
5972ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland46
5973ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
5974ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
5975ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland63
5976ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland16
5977ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland57
5978ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland71
5979ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland24
5980ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
5981ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland66
5982ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland69
5983ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
5984ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
5985ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland63
5986ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland37
5987ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland23
5988ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland26
5989ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland46
5990ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland68
5991ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland71
5992ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
5993ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland58
5994ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland27
5995ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland72
5996ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland72
5997ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland37
5998ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland71
5999ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany58
6000ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany38
6001ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany64
6002ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany57
6003ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany56
6004ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany52
6005ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany63
6006ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany44
6007ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany62
6008ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany54
6009ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany25
6010ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany71
6011ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany34
6012ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany49
6013ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany68
6014ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany39
6015ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany30
6016ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany57
6017ApheresisAllogeneicAcute Myeloid Leukemia; Myelodysplastic SyndromeHematology2017Standard TherapyPoland64
6018ApheresisAutologousAngioimmunoblastic Lymphadenopathy With DysproteinemiaHematology2017Standard TherapyGermany36
6019ApheresisAllogeneicAplastic AnemiaHematology2017Standard TherapyPoland23
6020ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland44
6021ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland28
6022ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland64
6023ApheresisAllogeneicB-Cell Chronic Lymphoblastic LeukemiaHematology2017Standard TherapyPoland48
6024ApheresisAutologousB-Cell LymphomaHematology2017Standard TherapyGermany65
6025ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2017Standard TherapyGermany57
6026ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2017Standard TherapyGermany50
6027ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2017Standard TherapyGermany68
6028ApheresisAllogeneicBlastic Plasmacytoid Dendritic Cell NeoplasmHematology2017Standard TherapyPoland56
6029ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland57
6030ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland45
6031ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland47
6032ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland67
6033ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland65
6034ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland51
6035ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland7
6036ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyGermany31
6037ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2017Standard TherapyPoland29
6038ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2017Standard TherapyPoland74
6039ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2017Standard TherapyPoland57
6040ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland54
6041ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland58
6042ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland51
6043ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland61
6044ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland72
6045ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland60
6046ApheresisAllogeneicChronic Myeloproliferative Neoplasm Blast CrisisHematology2017Standard TherapyPoland29
6047ApheresisAllogeneicCommon Variable Immunodeficiency, Relapsed Hemophagocytic SyndromeHematology2017Standard TherapyPoland44
6048ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2017Standard TherapyPoland61
6049ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2017Standard TherapyGermany41
6050ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2017Standard TherapyGermany67
6051ApheresisAutologousFollicular B-Cell Non-Hodgkin-Lymphoma Grade I-Ii RelapseHematology2017Standard TherapyGermany59
6052ApheresisAllogeneicFollicular CaHematology2017Standard TherapyPoland42
6053ApheresisAutologousFollicular LymphomaHematology2017Standard TherapyGermany47
6054ApheresisAllogeneicHemophagocytosisHematology2017Standard TherapyPoland52
6055ApheresisAllogeneicHodgkin LymphomaHematology2017Standard TherapyPoland25
6056ApheresisAllogeneicLangerhans LymphohistiocytosisHematology2017Standard TherapyPoland2
6057ApheresisAutologousLight-Chain MyelomaHematology2017Standard TherapyGermany62
6058ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany58
6059ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany63
6060ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany61
6061ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany64
6062ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany59
6063ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany68
6064ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany50
6065ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany56
6066ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany62
6067ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany53
6068ApheresisAllogeneicMorbus HodgkinHematology2017Standard TherapyGermany38
6069ApheresisAutologousMorbus HodgkinHematology2017Standard TherapyGermany60
6070ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany61
6071ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany65
6072ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6073ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany61
6074ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany60
6075ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany58
6076ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany61
6077ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany63
6078ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany58
6079ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany72
6080ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany63
6081ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany50
6082ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany52
6083ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany72
6084ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany57
6085ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany56
6086ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany59
6087ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6088ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany72
6089ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany69
6090ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany52
6091ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany67
6092ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6093ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6094ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany50
6095ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany67
6096ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany53
6097ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany62
6098ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany44
6099ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany62
6100ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany56
6101ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany60
6102ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6103ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6104ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland60
6105ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland3
6106ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland56
6107ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland54
6108ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland75
6109ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland64
6110ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland64
6111ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland46
6112ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland53
6113ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland71
6114ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland50
6115ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6116ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland67
6117ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland65
6118ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland68
6119ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland59
6120ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6121ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland69
6122ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland54
6123ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland65
6124ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6125ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland54
6126ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland49
6127ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland39
6128ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland67
6129ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland69
6130ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland76
6131ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland70
6132ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland53
6133ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland69
6134ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6135ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland66
6136ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland68
6137ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6138ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland61
6139ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland61
6140ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland22
6141ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland40
6142ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland57
6143ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6144ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland70
6145ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyGermany51
6146ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyGermany53
6147ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyGermany68
6148ApheresisAllogeneicMyelodysplastic Syndrome In Fanconi AnemiaHematology2017Standard TherapyPoland23
6149ApheresisAllogeneicMyelodysplastic Syndrome With Excess Of BlastsHematology2017Standard TherapyGermany62
6150ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland63
6151ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland63
6152ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland66
6153ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland62
6154ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland55
6155ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland62
6156ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland62
6157ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland72
6158ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyGermany70
6159ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2017Standard TherapyPoland47
6160ApheresisAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland44
6161ApheresisAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland56
6162ApheresisAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland57
6163ApheresisAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland38
6164ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2017Standard TherapyPoland7
6165ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2017Standard TherapyGermany37
6166ApheresisAllogeneicNiemann–Pick DiseaseHematology2017Standard TherapyPoland2
6167ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland36
6168ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland58
6169ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland53
6170ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland1
6171ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland55
6172ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland63
6173ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland56
6174ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland47
6175ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland57
6176ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland65
6177ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland58
6178ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland42
6179ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland36
6180ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland63
6181ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland68
6182ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland52
6183ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland53
6184ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland56
6185ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland65
6186ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland55
6187ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland69
6188ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland69
6189ApheresisAutologousNon-Hodgkin LymphomaHematology2017Standard TherapyGermany72
6190ApheresisAutologousNon-Hodgkin LymphomaHematology2017Standard TherapyGermany51
6191ApheresisAutologousNon-Hodgkin LymphomaHematology2017Standard TherapyGermany57
6192ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2017Standard TherapyGermany52
6193ApheresisAllogeneicOsteopetrosisMetabolic2017Standard TherapyPoland3
6194ApheresisAllogeneicOther MalignancyHematology2017Standard TherapyPoland59
6195ApheresisAllogeneicOther MyelofibrosisHematology2017Standard TherapyPoland71
6196ApheresisAllogeneicPost–Polycythemia Vera MyelofibrosisHematology2017Standard TherapyGermany61
6197ApheresisAutologousPrimary Central Nervous System LymphomaHematology2017Standard TherapyGermany51
6198ApheresisAutologousPrimary Central Nervous System LymphomaHematology2017Standard TherapyGermany66
6199ApheresisAutologousPrimary Central Nervous System LymphomaHematology2017Standard TherapyGermany50
6200ApheresisAllogeneicPrimary ImmunodeficiencyHematology2017Standard TherapyPoland4
6201ApheresisAllogeneicPrimary ImmunodeficiencyHematology2017Standard TherapyPoland2
6202ApheresisAllogeneicPrimary MyelofibrosisHematology2017Standard TherapyPoland29
6203ApheresisAllogeneicPrimary MyelofibrosisHematology2017Standard TherapyPoland32
6204ApheresisAllogeneicProlymphocytic LeukemiaHematology2017Standard TherapyPoland38
6205ApheresisAllogeneicProlymphocytic LeukemiaHematology2017Standard TherapyPoland63
6206ApheresisAllogeneicRichter's Transformation At Chronic Lymphocytic LeukemiaHematology2017Standard TherapyGermany60
6207ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2017Standard TherapyPoland24
6208ApheresisAllogeneicSecondary Myelodysplastic SyndromeHematology2017Standard TherapyGermany61
6209ApheresisAllogeneicSevere Aplastic AnemiaHematology2017Standard TherapyPoland14
6210ApheresisAllogeneicSevere Aplastic AnemiaHematology2017Standard TherapyPoland27
6211ApheresisAllogeneicSevere Aplastic AnemiaHematology2017Standard TherapyPoland32
6212ApheresisAllogeneicSevere Aplastic AnemiaHematology2017Standard TherapyPoland16
6213ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland30
6214ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7
6215ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland25
6216ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland28
6217ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2017Standard TherapyGermany24
6218ApheresisAllogeneicT-Cell Lymphoblastic LymphomaHematology2017Standard TherapyGermany19
6219ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2017Standard TherapyGermany56
6220ApheresisAutologousT-Cell-LymphomaHematology2017Standard TherapyGermany63
6221ApheresisAllogeneicΒ - Thalassemia MajorHematology2017Standard TherapyPoland4
6222Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2016Experimental TherapyPoland22
6223Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2016Experimental TherapyPoland32,3
6224Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2016Experimental TherapyPoland44,7
6225Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2016Experimental TherapyPoland14
6226Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2016Experimental TherapyPoland6
6227Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2016Experimental TherapyPoland60,5
6228Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2016Experimental TherapyPoland3,11
6229Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophyNeurology2016Experimental TherapyPoland11,11
6230Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophyNeurology2016Experimental TherapyPoland6,11
6231Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophyNeurology2016Experimental TherapyPoland9,7
6232Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophy; EncephalopathyNeurology2016Experimental TherapyPoland8,4
6233Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2016Experimental TherapyPoland86,5
6234Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland44,5
6235Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland60,8
6236Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland32,2
6237Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland53,7
6238Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland59,4
6239Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland33,4
6240Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland37,4
6241Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland39,3
6242Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland63,2
6243Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland54,11
6244Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland53,9
6245Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland46,9
6246Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland58
6247Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55
6248Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland58,1
6249Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,7
6250Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland52,6
6251Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland59,11
6252Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland60,9
6253Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland59
6254Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,9
6255Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland42,7
6256Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland45,1
6257Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland53,4
6258Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland36,1
6259Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland59,1
6260Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,2
6261Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland49,7
6262Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,1
6263Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland46,1
6264Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland72,4
6265Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland54,3
6266Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland56,1
6267Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,8
6268Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland64,7
6269Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland64,2
6270Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland62,8
6271Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland56,5
6272Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland51,3
6273Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland33,1
6274Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland60,4
6275Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland73,7
6276Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,6
6277Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,4
6278Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland79,2
6279Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland72,6
6280Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland48,4
6281Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland54,2
6282Cord TissueAllogeneic - Unrelated & RelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland50,9
6283Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,9
6284Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland62,6
6285Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,2
6286Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,9
6287Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland49,4
6288Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,7
6289Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland58,1
6290Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,8
6291Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland39,6
6292Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland47,11
6293Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland49,3
6294Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,2
6295Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland31,9
6296Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland53,4
6297Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland65,9
6298Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland52,7
6299Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland71,5
6300Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland68,5
6301Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland44,5
6302Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,7
6303Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland51,9
6304Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland49,3
6305Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland68,2
6306Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,4
6307Cord TissueAllogeneic - Unrelated & RelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland41,2
6308Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland72,1
6309Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland56,8
6310Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland48,1
6311Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland56,3
6312Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,1
6313Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPolandno data
6314Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,2
6315Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland60,8
6316Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,5
6317Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2016Experimental TherapyPoland20,3
6318Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2016Experimental TherapyPoland20,11
6319Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland18,4
6320Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6
6321Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland12,11
6322Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland8,5
6323Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland7,11
6324Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland8,5
6325Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6,9
6326Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland10,1
6327Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6,2
6328Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland11,3
6329Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6,1
6330Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland13,2
6331Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland8,4
6332Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland5
6333Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland12,3
6334Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland24,5
6335Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland10,3
6336Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6
6337Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland20,9
6338Cord TissueAllogeneic - UnrelatedCartilage DamageOrthopedy2016Experimental TherapyPoland57
6339Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2016Experimental TherapyPoland28,6
6340Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland7,1
6341Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland5,1
6342Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland10,11
6343Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland10,3
6344Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland12,2
6345Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland2,11
6346Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland9,7
6347Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland10,3
6348Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland2,9
6349Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland9,11
6350Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland2,1
6351Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland4,2
6352Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland12,6
6353Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland3
6354Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland9,9
6355Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland3
6356Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland13,7
6357Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland2,2
6358Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland12,11
6359Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland10,8
6360Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland1,1
6361Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland7,6
6362Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland6,8
6363Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland16,4
6364Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland13,1
6365Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland4,1
6366Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland3,7
6367Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland4,4
6368Cord TissueAllogeneic - UnrelatedChondronecrosis Femoral CondyleOrthopedy2016Experimental TherapyPoland54
6369Cord TissueAllogeneic - UnrelatedChoroideremiaOphthalmology2016Experimental TherapyPoland50,8
6370Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2016Experimental TherapyPoland19,2
6371Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2016Experimental TherapyPoland8 months
6372Cord TissueAllogeneic - UnrelatedDegeneration Of The Cartilage Of The Knee JointOrthopedy2016Experimental TherapyPoland54
6373Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2016Experimental TherapyPoland3,1
6374Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2016Experimental TherapyPoland7,4
6375Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2016Experimental TherapyPoland2,7
6376Cord TissueAllogeneic - UnrelatedDiffuse Cartilage Damage Left Medial Compartment Of The KneeOrthopedy2016Experimental TherapyPoland50
6377Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland48,8
6378Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland14,4
6379Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland34,7
6380Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland9,2
6381Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland4,8
6382Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland10
6383Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland19,2
6384Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2016Experimental TherapyPoland2,11
6385Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2016Experimental TherapyPoland3
6386Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2016Experimental TherapyPoland4,3
6387Cord TissueAllogeneic - UnrelatedEndometrial AtrophyGynecology2016Experimental TherapyPoland37,3
6388Cord TissueAllogeneic - UnrelatedEndometrial AtrophyGynecology2016Experimental TherapyPoland39,1
6389Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland19,5
6390Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland14,9
6391Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland13,11
6392Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland14,7
6393Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland14,9
6394Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland16,2
6395Cord TissueAllogeneic - UnrelatedEpileptic EncephalopathyNeurology2016Experimental TherapyPoland3,6
6396Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland35,3
6397Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland39,1
6398Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland25,4
6399Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland59,6
6400Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland30,3
6401Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland15
6402Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland31,11
6403Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland33,4
6404Cord TissueAllogeneic - UnrelatedFetal Alcohol Spectrum DisordersNeurology2016Experimental TherapyPoland5,2
6405Cord TissueAllogeneic - UnrelatedGangliosidosis T. 1Neurology2016Experimental TherapyPoland1,4
6406Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2016Experimental TherapyPoland6,9
6407Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2016Experimental TherapyPoland65,8
6408Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2016Experimental TherapyPoland69,6
6409Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2016Experimental TherapyPoland69,3
6410Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2016Experimental TherapyPoland49
6411Cord TissueAllogeneic - UnrelatedHereditary AtaxiaNeurology2016Experimental TherapyPoland69
6412Cord TissueAllogeneic - UnrelatedInjuries To The Spinal NervesNeurology2016Experimental TherapyPoland5 months
6413Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2016Experimental TherapyPoland2,9
6414Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2016Experimental TherapyPoland2,11
6415Cord TissueAllogeneic - UnrelatedMalformation SyndromeNeurology2016Experimental TherapyPoland3,5
6416Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2016Experimental TherapyPoland35,5
6417Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2016Experimental TherapyPoland31,9
6418Cord TissueAllogeneic - UnrelatedMyopia; Hyperopia; Astigmatism; Abnormal Refraction And Accommodation; Optic AtrophyOphthalmology2016Experimental TherapyPoland37,1
6419Cord TissueAllogeneic - UnrelatedNeurodevelopmental DisordersNeurology2016Experimental TherapyPoland4,5
6420Cord TissueAllogeneic - UnrelatedNo DataOphthalmology2016Experimental TherapyPoland66,1
6421Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2016Experimental TherapyPoland69,9
6422Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2016Experimental TherapyPoland69,1
6423Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2016Experimental TherapyPoland66
6424Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2016Experimental TherapyPoland79,8
6425Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2016Experimental TherapyPoland33,5
6426Cord TissueAllogeneic - UnrelatedPatella Cartilage DamageOrthopedy2016Experimental TherapyPoland60
6427Cord TissueAllogeneic - UnrelatedPatella Cartilage DamageOrthopedy2016Experimental TherapyPoland60
6428Cord TissueAllogeneic - UnrelatedPatella Cartilage DamageOrthopedy2016Experimental TherapyPoland53
6429Cord TissueAllogeneic - UnrelatedPolyneuropathyNeurology2016Experimental TherapyPoland70,8
6430Cord TissueAllogeneic - UnrelatedPremature Ovarian FailureGynecology2016Experimental TherapyPoland23,4
6431Cord TissueAllogeneic - UnrelatedPremature Ovarian FailureGynecology2016Experimental TherapyPoland34,9
6432Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland38
6433Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland63,1
6434Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland32,7
6435Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland23,6
6436Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland54,6
6437Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPolandno data
6438Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland59,4
6439Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland60,7
6440Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland44,8
6441Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland29,11
6442Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland44,8
6443Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland55,4
6444Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland54,8
6445Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland41,4
6446Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland49,3
6447Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland61,11
6448Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland45,8
6449Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland38,1
6450Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland68,5
6451Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland38,4
6452Cord TissueAllogeneic - UnrelatedSpastic TetraparesisOrthopedy2016Experimental TherapyPoland28,8
6453Cord TissueAllogeneic - UnrelatedSpastic TetraparesisOrthopedy2016Experimental TherapyPoland47,9
6454Cord TissueAllogeneic - UnrelatedSpastic TetraparesisOrthopedy2016Experimental TherapyPoland58,4
6455Cord TissueAllogeneic - UnrelatedSpastic TetraparesisOrthopedy2016Experimental TherapyPoland18
6456Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland2,4
6457Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland4,8
6458Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland1,5
6459Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland7,4
6460Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland1,3
6461Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland2,11
6462Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland15,9
6463Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland2,11
6464Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland4,9
6465Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland33,5
6466Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland22,2
6467Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland28
6468Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland33,11
6469Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland20,7
6470Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland24,5
6471Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland25,6
6472Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland18,8
6473Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland7,4
6474Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland48,3
6475Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland58,1
6476Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland37,11
6477Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland29,7
6478Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland17,9
6479Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland44,5
6480Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland34,9
6481Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland3,3
6482Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland34,2
6483Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland17,1
6484Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland1,1
6485Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2016Experimental TherapyPoland64
6486Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2016Experimental TherapyPoland62,5
6487Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2016Experimental TherapyPoland54,3
6488Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2016Experimental TherapyPoland41,8
6489Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2016Experimental TherapyPoland53
6490Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2016Experimental TherapyPoland24,5
6491Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2016Experimental TherapyPoland37,7
6492Cord TissueAllogeneic - UnrelatedTetraparesisOrthopedy2016Experimental TherapyPoland27,9
6493Cord TissueAllogeneic - UnrelatedTetraparesisOrthopedy2016Experimental TherapyPoland27,2
6494Cord TissueAllogeneic - UnrelatedTraumatic Brain InjuryNeurology2016Experimental TherapyPoland54,9
6495Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2016Standard TherapyHungary7
6496Cord BloodAllogeneic - UnrelatedAcute Myeloid LeukemiaHematology2016Standard TherapyPoland6
6497Cord BloodAutologousAutismNeurology2016Experimental TherapyPoland6
6498Cord BloodAutologousBrain DamageNeurology2016Experimental TherapyGermany1
6499Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2016Experimental TherapyUK6
6500Cord BloodAllogeneic - RelatedHermansky-Pudlak Syndrome Type 2Hematology2016Standard TherapyTurkey6
6501Cord BloodAllogeneic - RelatedThalassemia MajorHematology2016Standard TherapyGermany4,3
6502Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland38
6503Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland38
6504Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6505Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland32
6506Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland62
6507Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland72
6508Bone Marrow FamilyAllogeneicChronic Myelomonocytic Leukemia, Minimal Residual DiseaseHematology2016Standard TherapyPoland50
6509Bone Marrow FamilyAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland18
6510Bone Marrow FamilyAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland32
6511Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland59
6512Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland67
6513Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland62
6514Bone Marrow FamilyAllogeneicNo Datano data2016Standard TherapyPoland59
6515Bone Marrow FamilyAllogeneicNo Datano data2016Standard TherapyPoland4
6516Bone Marrow FamilyAllogeneicPlasma Cell DisorderHematology2016Standard TherapyPoland54
6517Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland9
6518Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland6
6519Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland14
6520Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland7
6521Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland11
6522Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland18
6523Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland5
6524Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland25
6525Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland1
6526Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland5
6527Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland15
6528Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland6
6529Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland64
6530Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland55
6531Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland64
6532Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland12
6533Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland67
6534Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland29
6535Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland33
6536Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland39
6537Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland9
6538Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland45
6539Bone MarrowAllogeneicAnemiaHematology2016Standard TherapyPoland16
6540Bone MarrowAllogeneicAnemiaHematology2016Standard TherapyPoland5
6541Bone MarrowAllogeneicAplastic AnemiaHematology2016Standard TherapyPoland20
6542Bone MarrowAllogeneicBilineal Leukemia - Acute Lymphoblastic Leukemia; Acute Myeloid LeukemiaHematology2016Standard TherapyPoland27
6543Bone MarrowAllogeneicDiamond Blackfan AnemiaHematology2016Standard TherapyPoland2
6544Bone MarrowAllogeneicDigeorge SyndromeHematology2016Standard TherapyPoland24
6545Bone MarrowAllogeneicFanconi AnemiaHematology2016Standard TherapyPoland7
6546Bone MarrowAllogeneicFanconi AnemiaHematology2016Standard TherapyPoland41
6547Bone MarrowAllogeneicHigh-Risk Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland18
6548Bone MarrowAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland17
6549Bone MarrowAllogeneicHurler SyndromeMetabolic2016Standard TherapyPoland2
6550Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2016Standard TherapyPoland3
6551Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland1
6552Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland56
6553Bone MarrowAllogeneicMyelofibrosisHematology2016Standard TherapyPoland31
6554Bone MarrowAllogeneicMyeloproliferative SyndromeHematology2016Standard TherapyPoland22
6555Bone MarrowAllogeneicNo Datano data2016Standard TherapyPoland3
6556Bone MarrowAllogeneicNo Datano data2016Standard TherapyPoland7
6557Bone MarrowAllogeneicNo DataHematology2016Standard TherapyPoland33
6558Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland46
6559Bone MarrowAllogeneicOsteopetrosisMetabolic2016Standard TherapyPoland6
6560Bone MarrowAllogeneicOsteopetrosisMetabolic2016Standard TherapyPoland1
6561Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2016Standard TherapyPoland9
6562Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2016Standard TherapyPoland9
6563Bone MarrowAllogeneicSevere Aplastic Anemia; Paroxysmal Nocturnal HemoglobinuriaHematology2016Standard TherapyPoland17
6564Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2016Standard TherapyPoland2
6565Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2016Standard TherapyPoland4
6566Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2016Standard TherapyPoland7 months
6567Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2016Standard TherapyPoland12
6568Bone MarrowAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland4
6569Bone MarrowAllogeneicThalassemia MajorHematology2016Standard TherapyGermany18
6570ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland56
6571ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland43
6572ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland61
6573ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland24
6574ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland13
6575ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland58
6576ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland20
6577ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland23
6578ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland27
6579ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland30
6580ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland37
6581ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland38
6582ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland28
6583ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland30
6584ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland39
6585ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland66
6586ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland20
6587ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland56
6588ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland9
6589ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland33
6590ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland21
6591ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland35
6592ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany57
6593ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany29
6594ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany1
6595ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany42
6596ApheresisAllogeneicAcute Lymphoblastic Leukemia - RelapseHematology2016Standard TherapyGermany27
6597ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland58
6598ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland62
6599ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland40
6600ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland18
6601ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6602ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland64
6603ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland54
6604ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland54
6605ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland18
6606ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland31
6607ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland35
6608ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland46
6609ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland29
6610ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland32
6611ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland49
6612ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland64
6613ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland42
6614ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland13
6615ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland8
6616ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland46
6617ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland40
6618ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland32
6619ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6620ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland43
6621ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6622ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland47
6623ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland15
6624ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland37
6625ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland57
6626ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland56
6627ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland52
6628ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland35
6629ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland72
6630ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland46
6631ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland51
6632ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland62
6633ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland69
6634ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland51
6635ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland55
6636ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland63
6637ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland65
6638ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland46
6639ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland18
6640ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland48
6641ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland67
6642ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland59
6643ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland9 months
6644ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland36
6645ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6646ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland68
6647ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland63
6648ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland60
6649ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland37
6650ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland61
6651ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland51
6652ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland65
6653ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland53
6654ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland59
6655ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland65
6656ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland41
6657ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland50
6658ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland68
6659ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland54
6660ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland24
6661ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland44
6662ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland55
6663ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland30
6664ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland50
6665ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland47
6666ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland47
6667ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland63
6668ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland19
6669ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany62
6670ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany29
6671ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany39
6672ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany48
6673ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany69
6674ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany38
6675ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany66
6676ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany50
6677ApheresisAutologousAcute Myeloid LeukemiaHematology2016Standard TherapyGermany74
6678ApheresisAutologousAcute Myeloid LeukemiaHematology2016Standard TherapyGermany18
6679ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany54
6680ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany62
6681ApheresisAutologousAcute Myeloid LeukemiaHematology2016Standard TherapyGermany55
6682ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany54
6683ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany41
6684ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany53
6685ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany68
6686ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany71
6687ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany68
6688ApheresisAllogeneicAcute Myeloid Leukemia M2/M4Hematology2016Standard TherapyPoland59
6689ApheresisAllogeneicAdrenoleukodystrophyMetabolic2016Standard TherapyPoland1
6690ApheresisAutologousAmyloid Light-Chain AmyloidosisHematology2016Standard TherapyGermany45
6691ApheresisAutologousAmyloidosisHematology2016Standard TherapyGermany71
6692ApheresisAutologousAnaplastic LymphomaHematology2016Standard TherapyGermany57
6693ApheresisAllogeneicAplastic AnemiaHematology2016Standard TherapyPoland23
6694ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland44
6695ApheresisAutologousB-Cell LymphomaHematology2016Standard TherapyGermany55
6696ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2016Standard TherapyGermany57
6697ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2016Standard TherapyGermany42
6698ApheresisAutologousBurkitt LymphomaHematology2016Standard TherapyGermany40
6699ApheresisAllogeneicC-Acute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany60
6700ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2016Standard TherapyPoland52
6701ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2016Standard TherapyPoland61
6702ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2016Standard TherapyPoland62
6703ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2016Standard TherapyPoland62
6704ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2016Standard TherapyPoland46
6705ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2016Standard TherapyPoland40
6706ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2016Standard TherapyPoland53
6707ApheresisAllogeneicComposite LymphomaHematology2016Standard TherapyPoland51
6708ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2016Standard TherapyGermany39
6709ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2016Standard TherapyGermany51
6710ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2016Standard TherapyGermany64
6711ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2016Standard TherapyGermany69
6712ApheresisAllogeneicFanconi AnemiaHematology2016Standard TherapyPoland7
6713ApheresisAutologousFollicular LymphomaHematology2016Standard TherapyGermany38
6714ApheresisAutologousFollicular LymphomaHematology2016Standard TherapyGermany63
6715ApheresisAutologousFollicular LymphomaHematology2016Standard TherapyGermany63
6716ApheresisAllogeneicHigh-Risk Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland5
6717ApheresisAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland31
6718ApheresisAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland32
6719ApheresisAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland38
6720ApheresisAutologousHodgkin Lymphoma-RelapseHematology2016Standard TherapyGermany44
6721ApheresisAllogeneicLeukemiaHematology2016Standard TherapyPoland53
6722ApheresisAllogeneicLymphoblastic LymphomaHematology2016Standard TherapyPoland33
6723ApheresisAutologousMantle Cell LymphomaHematology2016Standard TherapyGermany56
6724ApheresisAutologousMantle Cell LymphomaHematology2016Standard TherapyGermany63
6725ApheresisAutologousMantle Cell LymphomaHematology2016Standard TherapyGermany53
6726ApheresisAutologousMantle Cell LymphomaHematology2016Standard TherapyGermany60
6727ApheresisAllogeneicMorbus HodgkinHematology2016Standard TherapyGermany32
6728ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany59
6729ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany59
6730ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany44
6731ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany58
6732ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany70
6733ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany67
6734ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany62
6735ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany63
6736ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany58
6737ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany73
6738ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany65
6739ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany55
6740ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany67
6741ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany59
6742ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany66
6743ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany58
6744ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany68
6745ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany63
6746ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany57
6747ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany68
6748ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany56
6749ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany61
6750ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany55
6751ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany64
6752ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany64
6753ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany52
6754ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany55
6755ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany67
6756ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany49
6757ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany56
6758ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany47
6759ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany53
6760ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany58
6761ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany49
6762ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany69
6763ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany61
6764ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany54
6765ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany65
6766ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany48
6767ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland60
6768ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland56
6769ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland50
6770ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland73
6771ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland47
6772ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland67
6773ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland62
6774ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland61
6775ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland68
6776ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland65
6777ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland15
6778ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland52
6779ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland20
6780ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland60
6781ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland9
6782ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland61
6783ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland63
6784ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland15
6785ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland37
6786ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland59
6787ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland62
6788ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland58
6789ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland69
6790ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland66
6791ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyGermany67
6792ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyGermany57
6793ApheresisAllogeneicMyelodysplastic Syndrome - RcmdHematology2016Standard TherapyPoland32
6794ApheresisAllogeneicMyelodysplastic Syndrome - RaebHematology2016Standard TherapyPoland56
6795ApheresisAllogeneicMyelofibrosisHematology2016Standard TherapyPoland72
6796ApheresisAllogeneicMyelofibrosisHematology2016Standard TherapyPoland66
6797ApheresisAllogeneicMyelofibrosisHematology2016Standard TherapyPoland67
6798ApheresisAllogeneicMyeloma MultiplexHematology2016Standard TherapyPoland63
6799ApheresisAllogeneicMyeloma MultiplexHematology2016Standard TherapyPoland51
6800ApheresisAllogeneicMyeloma MultiplexHematology2016Standard TherapyPoland38
6801ApheresisAllogeneicMyeloproliferative SyndromeHematology2016Standard TherapyPoland52
6802ApheresisAllogeneicMyeloproliferative SyndromeHematology2016Standard TherapyGermany63
6803ApheresisAutologousNeuroblastomaHematology2016Standard TherapyGermany5
6804ApheresisAllogeneicNo Datano data2016Standard TherapyPoland45
6805ApheresisAllogeneicNo Datano data2016Standard TherapyPoland70
6806ApheresisAllogeneicNo Datano data2016Standard TherapyPoland43
6807ApheresisAllogeneicNo Datano data2016Standard TherapyPoland69
6808ApheresisAllogeneicNo Datano data2016Standard TherapyPoland28
6809ApheresisAllogeneicNo Datano data2016Standard TherapyPoland1
6810ApheresisAllogeneicNo Datano data2016Standard TherapyPoland30
6811ApheresisAllogeneicNo Datano data2016Standard TherapyPoland71
6812ApheresisAllogeneicNo Datano data2016Standard TherapyPoland58
6813ApheresisAllogeneicNo Datano data2016Standard TherapyPoland17
6814ApheresisAllogeneicNo Datano data2016Standard TherapyPoland59
6815ApheresisAllogeneicNo Datano data2016Standard TherapyPoland58
6816ApheresisAllogeneicNo Datano data2016Standard TherapyPoland55
6817ApheresisAllogeneicNo Datano data2016Standard TherapyPoland44
6818ApheresisAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland38
6819ApheresisAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland58
6820ApheresisAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland32
6821ApheresisAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland39
6822ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany61
6823ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany73
6824ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany27
6825ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany65
6826ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany61
6827ApheresisAllogeneicPlasma Cell DisorderHematology2016Standard TherapyPoland47
6828ApheresisAutologousPlasmacytomaHematology2016Standard TherapyGermany58
6829ApheresisAutologousPlasmacytomaHematology2016Standard TherapyGermany68
6830ApheresisAutologousPlasmacytomaHematology2016Standard TherapyGermany48
6831ApheresisAutologousPrimary Central Nervous System LymphomaHematology2016Standard TherapyGermany62
6832ApheresisAutologousPrimary Central Nervous System LymphomaHematology2016Standard TherapyGermany51
6833ApheresisAutologousPrimary Central Nervous System LymphomaHematology2016Standard TherapyGermany62
6834ApheresisAllogeneicPrimary ImmunodeficiencyHematology2016Standard TherapyPoland5
6835ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyPoland50
6836ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyPoland67
6837ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyPoland67
6838ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyGermany56
6839ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyGermany58
6840ApheresisAllogeneicRefractory Anemia With Excess BlastsHematology2016Standard TherapyPoland62
6841ApheresisAllogeneicSevere Aplastic Anemia / AmyloidosisHematology2016Standard TherapyPoland45
6842ApheresisAllogeneicSecondary Acute Myeloid Leukemia At Myeloproliferative SyndromeHematology2016Standard TherapyGermany28
6843ApheresisAllogeneicSevere Aplastic AnemiaHematology2016Standard TherapyPoland18
6844ApheresisAutologousSmall Cell Ovarian CarcinomaHematology2016Standard TherapyGermany18
6845ApheresisAllogeneicT Cell Lymphoma/ Nos - Not Otherwise SpecifiedHematology2016Standard TherapyPoland55
6846ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland19
6847ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland21
6848ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland41
6849ApheresisAllogeneicT-Cell Leukemia/LymphomaHematology2016Standard TherapyPoland31
6850ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2016Standard TherapyGermany48
6851ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2016Standard TherapyGermany24
6852ApheresisAutologousT-Cell-LymphomaHematology2016Standard TherapyGermany55
6853ApheresisAutologousT-Cell-LymphomaHematology2016Standard TherapyGermany33
6854ApheresisAllogeneicT-Cell-Prolymphocytic LeukemiaHematology2016Standard TherapyPoland61
6855ApheresisAllogeneicWiskott-Aldrich SyndromeHematology2016Standard TherapyPoland1
6856ApheresisAllogeneicX-Linked Lymphoproliferative DiseaseHematology2016Standard TherapyPoland12
6857Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland1,4
6858Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland11 months
6859Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland51,5
6860Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland6,6
6861Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland13,4
6862Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophy; EncephalopathyNeurology2015Experimental TherapyPoland23
6863Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61,6
6864Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61
6865Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland56
6866Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland51
6867Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland65
6868Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland60
6869Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland52
6870Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland59,4
6871Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61,5
6872Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland58
6873Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61,6
6874Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland62
6875Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland26,5
6876Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland27
6877Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland63,11
6878Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland67,6
6879Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland37,6
6880Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland58,1
6881Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland46,2
6882Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland48,7
6883Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61,3
6884Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland54
6885Cord TissueAllogeneic - UnrelatedAnterior Ischemic Optic NeuropathyOphthalmology2015Experimental TherapyPoland54,1
6886Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland5,4
6887Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland3
6888Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland12,5
6889Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland6,1
6890Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland4,6
6891Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland5,6
6892Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland8,7
6893Cord TissueAllogeneic - UnrelatedBilateral BlindnessOphthalmology2015Experimental TherapyPoland36,1
6894Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2015Experimental TherapyPoland18,7
6895Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2015Experimental TherapyPoland26,1
6896Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland3,8
6897Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland15,8
6898Cord TissueAllogeneic - Unrelated & RelatedCerebral PalsyNeurology2015Experimental TherapyPoland7,1
6899Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland13,1
6900Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland8,11
6901Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland2,7
6902Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland12,1
6903Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland4,1
6904Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland22
6905Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland9,9
6906Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland1,6
6907Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland14,1
6908Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland16,9
6909Cord TissueAllogeneic - UnrelatedCeroid LipofuscinosisNeurology2015Experimental TherapyPoland5,1
6910Cord TissueAllogeneic - UnrelatedCeroid LipofuscinosisNeurology2015Experimental TherapyPoland7,1
6911Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2015Experimental TherapyPoland10
6912Cord TissueAllogeneic - UnrelatedDecerebration RigidityNeurology2015Experimental TherapyPoland9,6
6913Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2015Experimental TherapyPoland3,6
6914Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development, DeafnessNeurology2015Experimental TherapyPoland3,3
6915Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2015Experimental TherapyPoland14,5
6916Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2015Experimental TherapyPoland8 months
6917Cord TissueAllogeneic - Unrelated & RelatedEncephalopathyNeurology2015Experimental TherapyPoland11,2
6918Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2015Experimental TherapyPoland30,1
6919Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2015Experimental TherapyPoland66
6920Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2015Experimental TherapyPoland65
6921Cord TissueAllogeneic - UnrelatedIatrogenic Spinal Cord InjuryNeurology2015Experimental TherapyPoland17,2
6922Cord TissueAllogeneic - UnrelatedIntracranial InjuryNeurology2015Experimental TherapyPoland24,3
6923Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2015Experimental TherapyPoland18,8
6924Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2015Experimental TherapyPoland15,8
6925Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2015Experimental TherapyPoland45,1
6926Cord TissueAllogeneic - UnrelatedPolyneuropathyNeurology2015Experimental TherapyPoland74,2
6927Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2015Experimental TherapyPoland34,5
6928Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2015Experimental TherapyPoland23,2
6929Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2015Experimental TherapyPoland33,3
6930Cord TissueAllogeneic - UnrelatedSevere Developmental DelayNeurology2015Experimental TherapyPoland1,1
6931Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2015Experimental TherapyPoland2
6932Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland31,2
6933Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland18,8
6934Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland40
6935Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland26,1
6936Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland37,1
6937Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland32,1
6938Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland21,4
6939Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland24,7
6940Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland34,4
6941Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2015Experimental TherapyPoland11 months
6942Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2015Experimental TherapyPoland26,2
6943Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2015Experimental TherapyPoland35,6
6944Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2015Experimental TherapyPoland44,6
6945Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2015Experimental TherapyPoland24,3
6946Cord TissueAllogeneic - UnrelatedStrokeNeurology2015Experimental TherapyPoland62,8
6947Cord TissueAllogeneic - UnrelatedStrokeNeurology2015Experimental TherapyPoland54,9
6948Cord TissueAllogeneic - UnrelatedTraumatic EncephalopathyNeurology2015Experimental TherapyPoland20,11
6949Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2015Standard TherapyPoland4
6950Cord BloodAutologousBrain DamageNeurology2015Experimental TherapyGermany5
6951Cord BloodAutologousHypoxia-Ischemic Encephalopathy (Hie)Neurology2015Experimental TherapyUK6 months
6952Cord BloodAutologousNeuroblastomaHematology2015Standard TherapyGermany5
6953Cord BloodAllogeneic - RelatedScid (Severe Combined Immunodeficiency)Hematology2015Standard TherapyUK3 months
6954Cord BloodAllogeneic - RelatedSickle Cell AnemiaHematology2015Standard TherapyUK2,6
6955Cord BloodAllogeneic - RelatedThalassemiaHematology2015Standard TherapyUK12
6956Cord BloodAllogeneic - RelatedThalassemia MajorHematology2015Standard TherapyTurkey3
6957Cord BloodAllogeneic - RelatedThalassemia MajorHematology2015Standard TherapyTurkey2
6958Bone Marrow FamilyAllogeneicChronic Lymphocytic LeukemiaHematology2015Standard TherapyGermany74
6959Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2015Standard TherapyGermany64
6960ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2015Standard TherapyGermany23
6961ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany72
6962ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany43
6963ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany63
6964ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany73
6965ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany61
6966ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany33
6967ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany42
6968ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany57
6969ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany37
6970ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany72
6971ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany63
6972ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany66
6973ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany45
6974ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany48
6975ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany59
6976ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany58
6977ApheresisAutologousAnaplastic Large Cell LymphomaHematology2015Standard TherapyGermany57
6978ApheresisAutologousAnaplastic T-Cell Lymphoma - RelapseHematology2015Standard TherapyGermany26
6979ApheresisAllogeneicAplastic Anemia - RelapseHematology2015Standard TherapyGermany53
6980ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany59
6981ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany48
6982ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany23
6983ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany62
6984ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2015Standard TherapyGermany51
6985ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2015Standard TherapyGermany50
6986ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2015Standard TherapyGermany31
6987ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2015Standard TherapyGermany57
6988ApheresisAutologousEwing SarcomaHematology2015Standard TherapyGermany24
6989ApheresisAutologousGerm Cell TumorHematology2015Standard TherapyGermany17
6990ApheresisAutologousGray Zone LymphomaHematology2015Standard TherapyGermany26
6991ApheresisAutologousHodgkin RelapseHematology2015Standard TherapyGermany29
6992ApheresisAutologousLymphomaHematology2015Standard TherapyGermany53
6993ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany56
6994ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany66
6995ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany53
6996ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany63
6997ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany58
6998ApheresisAutologousMantle Cell Lymphoma-RelapseHematology2015Standard TherapyGermany66
6999ApheresisAllogeneicMorbus HodgkinHematology2015Standard TherapyGermany25
7000ApheresisAllogeneicMorbus HodgkinHematology2015Standard TherapyGermany22
7001ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany58
7002ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany54
7003ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany62
7004ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany70
7005ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany69
7006ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany56
7007ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany75
7008ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany70
7009ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany60
7010ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany72
7011ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany56
7012ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany65
7013ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany37
7014ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany54
7015ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany29
7016ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany68
7017ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany50
7018ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7019ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany69
7020ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany60
7021ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany72
7022ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany43
7023ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany53
7024ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany73
7025ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany66
7026ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7027ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany70
7028ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany71
7029ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany62
7030ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany56
7031ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany74
7032ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany50
7033ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany51
7034ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany63
7035ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany53
7036ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany72
7037ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany48
7038ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany63
7039ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany60
7040ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany65
7041ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany71
7042ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7043ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7044ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7045ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany64
7046ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany48
7047ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany49
7048ApheresisAllogeneicMultiple Myeloma, Second Acute Myeloid LeukemiaHematology2015Standard TherapyGermany64
7049ApheresisAllogeneicMyelodysplastic SyndromeHematology2015Standard TherapyGermany57
7050ApheresisAllogeneicMyelodysplastic SyndromeHematology2015Standard TherapyGermany60
7051ApheresisAllogeneicMyelodysplastic SyndromeHematology2015Standard TherapyGermany29
7052ApheresisAllogeneicMyelodysplastic SyndromeHematology2015Standard TherapyGermany73
7053ApheresisAllogeneicNon-Hodgkin LymphomaHematology2015Standard TherapyGermany62
7054ApheresisAllogeneicNon-Hodgkin LymphomaHematology2015Standard TherapyGermany22
7055ApheresisAutologousNon-Hodgkin LymphomaHematology2015Standard TherapyGermany61
7056ApheresisAllogeneicPost–Polycythemia Vera MyelofibrosisHematology2015Standard TherapyGermany54
7057ApheresisAutologousPrimary Central Nervous System LymphomaHematology2015Standard TherapyGermany61
7058ApheresisAutologousPrimary Central Nervous System LymphomaHematology2015Standard TherapyGermany41
7059ApheresisAutologousPrimary Central Nervous System LymphomaHematology2015Standard TherapyGermany70
7060ApheresisAllogeneicPrimary MyelofibrosisHematology2015Standard TherapyGermany70
7061ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany44
7062Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2014Experimental TherapyPoland6
7063Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2014Experimental TherapyPoland60,1
7064Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2014Experimental TherapyPoland24,1
7065Cord TissueAllogeneic - UnrelatedAutismNeurology2014Experimental TherapyPoland12,6
7066Cord TissueAllogeneic - UnrelatedAutismNeurology2014Experimental TherapyPoland8,3
7067Cord TissueAllogeneic - UnrelatedBirth Asphyxia; RetinopathyNeurology2014Experimental TherapyPoland11 months
7068Cord TissueAllogeneic - UnrelatedCentral Motor Coordination Impairment After Hypoxic Ischemic Lesion At BirthNeurology2014Experimental TherapyPoland2,1
7069Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2014Experimental TherapyPoland4,1
7070Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2014Experimental TherapyPoland15,1
7071Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2014Experimental TherapyPoland6
7072Cord TissueAllogeneic - UnrelatedNeuropathyNeurology2014Experimental TherapyPoland23,6
7073Cord BloodAllogeneic - UnrelatedAcute Lymphoblastic LeukemiaHematology2014Standard TherapySpain 15
7074Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2014Standard TherapyTurkey8,8
7075Cord BloodAllogeneicAcute Lymphoblastic LeukemiaHematology2014Standard TherapyGermany45
7076Cord BloodAutologousAcute Myeloid LeukemiaHematology2014Standard TherapyPortugal6
7077Cord BloodAllogeneic - RelatedBeta ThalassemiaHematology2014Standard TherapyGermany6
7078Cord BloodAutologousCerebral PalsyNeurology2014Experimental TherapyPortugal4
7079Cord BloodAutologousCerebral PalsyNeurology2014Experimental TherapyUK1
7080Cord BloodAutologousHsv Encephalitis And Nmda Receptor Antibody EncephalitisNeurology2014Experimental TherapyUK2
7081Cord BloodAutologousHypoxia-Ischemic Encephalopathy (Hie)Neurology2014Experimental TherapyUK3 months
7082Cord BloodAllogeneic - RelatedLeukemiaHematology2014Standard TherapyUK4
7083Cord BloodAutologousSevere Aplastic AnemiaHematology2014Standard TherapyGermany11
7084Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany35
7085Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany73
7086Bone MarrowAllogeneicNon-Hodgkin-Lymphoma-RelapseHematology2014Standard TherapyGermany44
7087Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2014Standard TherapyGermany60
7088ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany52
7089ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany69
7090ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany51
7091ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany69
7092ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany52
7093ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany29
7094ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany76
7095ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany48
7096ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany53
7097ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2014Standard TherapyGermany45
7098ApheresisAllogeneicAplastic AnemiaHematology2014Standard TherapyGermany27
7099ApheresisAllogeneicAplastic AnemiaHematology2014Standard TherapyGermany44
7100ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2014Standard TherapyGermany46
7101ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2014Standard TherapyGermany67
7102ApheresisAutologousBing–Neel Syndrome; LymphomaHematology2014Standard TherapyGermany64
7103ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2014Standard TherapyGermany42
7104ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2014Standard TherapyGermany57
7105ApheresisAllogeneicComposite LymphomaHematology2014Standard TherapyGermany59
7106ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2014Standard TherapyGermany53
7107ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2014Standard TherapyGermany50
7108ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2014Standard TherapyGermany63
7109ApheresisAutologousGerm Cell TumorHematology2014Standard TherapyGermany24
7110ApheresisAutologousLymphoma-RelapseHematology2014Standard TherapyGermany56
7111ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany51
7112ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany62
7113ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany58
7114ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany62
7115ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany51
7116ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany59
7117ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany68
7118ApheresisAllogeneicMantle Cell LymphomaHematology2014Standard TherapyGermany60
7119ApheresisAutologousMarginal Zone LymphomaHematology2014Standard TherapyGermany52
7120ApheresisAllogeneicMorbus HodgkinHematology2014Standard TherapyGermany31
7121ApheresisAutologousMorbus Hodgkin-RelapseHematology2014Standard TherapyGermany44
7122ApheresisAutologousMorbus Hodgkin-RelapseHematology2014Standard TherapyGermany37
7123ApheresisAutologousMorbus Hodgkin-RelapseHematology2014Standard TherapyGermany19
7124ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany70
7125ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany71
7126ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany60
7127ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany71
7128ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany66
7129ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany60
7130ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany53
7131ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany59
7132ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany60
7133ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany30
7134ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany64
7135ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany70
7136ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany77
7137ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany52
7138ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany60
7139ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany69
7140ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany63
7141ApheresisAllogeneicMultiple MyelomaHematology2014Standard TherapyGermany63
7142ApheresisAllogeneicMyelodysplastic SyndromeHematology2014Standard TherapyGermany68
7143ApheresisAllogeneicMyelodysplastic SyndromeHematology2014Standard TherapyGermany49
7144ApheresisAllogeneicMyelodysplastic SyndromeHematology2014Standard TherapyGermany55
7145ApheresisAllogeneicMyelodysplastic SyndromeHematology2014Standard TherapyGermany57
7146ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2014Standard TherapyGermany56
7147ApheresisAllogeneicMyeloproliferative SyndromeHematology2014Standard TherapyGermany60
7148ApheresisAutologousNeuroblastomaHematology2014Standard TherapyGermany7
7149ApheresisAutologousNon-Hodgkin LymphomaHematology2014Standard TherapyGermany60
7150ApheresisAllogeneicNon-Hodgkin LymphomaHematology2014Standard TherapyGermany43
7151ApheresisAutologousPost-Transplant Lymphoproliferative DisorderHematology2014Standard TherapyGermany60
7152ApheresisAutologousPrimary Central Nervous System LymphomaHematology2014Standard TherapyGermany69
7153ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany64
7154ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany42
7155ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany51
7156ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany56
7157ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany75
7158ApheresisAutologousSecondary LymphomaHematology2014Standard TherapyGermany59
7159ApheresisAutologousT-Cell Lymphoblastic LymphomaHematology2014Standard TherapyGermany54
7160ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2014Standard TherapyGermany46
7161ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2014Standard TherapyGermany48
7162ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2014Standard TherapyGermany43
7163ApheresisAllogeneicT-Cell Non-Hodgkin Lymphoma RelapseHematology2014Standard TherapyGermany56
7164Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2013Experimental TherapyPoland18,9
7165Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2013Experimental TherapyPoland2,11
7166Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2013Experimental TherapyPoland3,5
7167Cord TissueAllogeneic - UnrelatedAcute Myeloid LeukemiaHematology2013Experimental TherapyPoland3,5
7168Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2013Experimental TherapyPoland18,8
7169Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2013Experimental TherapyPoland17,5
7170Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2013Standard TherapyGermany8
7171Cord BloodAllogeneic - RelatedAcute Myeloid LeukemiaHematology2013Standard TherapyPoland3
7172Cord BloodAllogeneic - RelatedAplastic AnemiaHematology2013Standard TherapyPoland3
7173Cord BloodAllogeneic - RelatedLeukemiaHematology2013Standard TherapyTurkey7
7174Cord BloodAllogeneic - RelatedThalassemiaHematology2013Standard TherapyUK5
7175Cord BloodAllogeneic - RelatedThalassemia MajorHematology2013Standard TherapyTurkey7,12
7176Cord BloodAllogeneic - RelatedThalassemia MajorHematology2013Standard TherapyTurkey3
7177Cord BloodAllogeneic - RelatedThalassemia MajorHematology2013Standard TherapyTurkey?
7178Cord BloodAllogeneic - RelatedWiskott-Aldrich SyndromeHematology2013Standard TherapyGermany3
7179Cord BloodAllogeneic - RelatedX-Linked Lymphoproliferative SyndromeHematology2013Standard TherapyPoland10 months
7180Bone Marrow FamilyAllogeneicFollicular Lymphoma + Non-Hodgkin-HodgkinHematology2013Standard TherapyGermany38
7181Bone Marrow FamilyAllogeneicMultiple MyelomaHematology2013Standard TherapyGermany58
7182Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2013Standard TherapyGermany73
7183Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2013Standard TherapyGermany71
7184ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2013Standard TherapyGermany44
7185ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany17
7186ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany55
7187ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany51
7188ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany21
7189ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany18
7190ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany59
7191ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany55
7192ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2013Standard TherapyGermany62
7193ApheresisAutologousAngioimmunoblastic Lymphadenopathy With Dysproteinemia - RelapseHematology2013Standard TherapyGermany51
7194ApheresisAutologousAngioimmunoblastic Lymphadenopathy With Dysproteinemia - RelapseHematology2013Standard TherapyGermany54
7195ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2013Standard TherapyGermany55
7196ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2013Standard TherapyGermany62
7197ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2013Standard TherapyGermany52
7198ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2013Standard TherapyGermany32
7199ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2013Standard TherapyGermany51
7200ApheresisAutologousBurkitt LymphomaHematology2013Standard TherapyGermany49
7201ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany48
7202ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany48
7203ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany64
7204ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany61
7205ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany54
7206ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2013Standard TherapyGermany62
7207ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2013Standard TherapyGermany54
7208ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2013Standard TherapyGermany39
7209ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2013Standard TherapyGermany43
7210ApheresisAllogeneicHypoplastic Myelodysplastic SyndromeHematology2013Standard TherapyGermany32
7211ApheresisAutologousMantle Cell LymphomaHematology2013Standard TherapyGermany47
7212ApheresisAutologousMorbus Hodgkin-RelapseHematology2013Standard TherapyGermany50
7213ApheresisAutologousMorbus Hodgkin-RelapseHematology2013Standard TherapyGermany62
7214ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany70
7215ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany52
7216ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany48
7217ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany65
7218ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany62
7219ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany73
7220ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany55
7221ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany53
7222ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany56
7223ApheresisAllogeneicMultiple MyelomaHematology2013Standard TherapyGermany61
7224ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany54
7225ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany60
7226ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany64
7227ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany66
7228ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany59
7229ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany65
7230ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany59
7231ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany65
7232ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany45
7233ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany50
7234ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany78
7235ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany46
7236ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany53
7237ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany65
7238ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany61
7239ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany40
7240ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany58
7241ApheresisAllogeneicMycosis FungoidesHematology2013Standard TherapyGermany62
7242ApheresisAllogeneicMyelodysplastic SyndromeHematology2013Standard TherapyGermany62
7243ApheresisAutologousNeuroblastomaHematology2013Standard TherapyGermany3
7244ApheresisAutologousNeuroblastomaHematology2013Standard TherapyGermany1
7245ApheresisAllogeneicNo DataHematology2013Standard TherapyGermany51
7246ApheresisAutologousNon-Hodgkin LymphomaHematology2013Standard TherapyGermany60
7247ApheresisAutologousNon-Hodgkin LymphomaHematology2013Standard TherapyGermany60
7248ApheresisAutologousNon-Hodgkin LymphomaHematology2013Standard TherapyGermany60
7249ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2013Standard TherapyGermany68
7250ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2013Standard TherapyGermany73
7251ApheresisAutologousPlasmacytomaHematology2013Standard TherapyGermany62
7252ApheresisAllogeneicPrimary Central Nervous System LymphomaHematology2013Standard TherapyGermany52
7253ApheresisAllogeneicPrimary MyelofibrosisHematology2013Standard TherapyGermany43
7254ApheresisAllogeneicPrimary Myelofibrosis, Second Acute Myeloid LeukemiaHematology2013Standard TherapyGermany60
7255ApheresisAllogeneicPrimary OsteomyelofibrosisHematology2013Standard TherapyGermany59
7256ApheresisAllogeneicT-Cell Acute Myeloid LeukemiaHematology2013Standard TherapyGermany61
7257ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2013Standard TherapyGermany45
7258ApheresisAutologousTeratocarcinomaHematology2013Standard TherapyGermany49
7259ApheresisAutologousTesticular Cancer RelapseHematology2013Standard TherapyGermany27
7260Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2012Experimental TherapyPoland19,7
7261Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2012Experimental TherapyPoland7,1
7262Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2012Experimental TherapyPoland4,3
7263Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2012Standard TherapyGermany2
7264Cord BloodAllogeneic - RelatedBeta ThalassemiaHematology2012Standard TherapyGermany14
7265Cord BloodAutologousBrain DamageNeurology2012Experimental TherapyGermany3
7266Cord BloodAutologousCerebral PalsyNeurology2012Experimental TherapyPortugal3
7267Cord BloodAllogeneic - RelatedMyelodysplastic SyndromeHematology2012Standard TherapyHungary3
7268Cord BloodAllogeneic - RelatedT-Cell Acute Lymphoblastic LeukemiaHematology2012Standard TherapyTurkey4,1
7269Cord BloodAllogeneic - RelatedThalassemia MajorHematology2012Standard TherapyTurkey6,7
7270Cord BloodAllogeneic - RelatedThalassemia Major, Acute Lymphoblastic LeukemiaHematology2012Standard TherapyTurkey3,6
7271Cord BloodAutologousTyp-1-DiabetesEndocrinology2012Experimental TherapyGermany5
7272Bone MarrowAutologousIschemic MyopathyHematology2012Standard TherapyGermany64
7273Bone MarrowAutologousIschemic MyopathyHematology2012Standard TherapyGermany75
7274Bone MarrowAutologousIschemic MyopathyHematology2012Standard TherapyGermany55
7275Bone MarrowAutologousIschemic MyopathyHematology2012Standard TherapyGermany56
7276Bone MarrowAllogeneicMyelodysplastic Syndrome Refractory Anemia With Blast ExcessHematology2012Standard TherapyGermany70
7277ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2012Standard TherapyGermany18
7278ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany42
7279ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany43
7280ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany60
7281ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany39
7282ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany62
7283ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany55
7284ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany17
7285ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2012Standard TherapyGermany48
7286ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2012Standard TherapyGermany46
7287ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2012Standard TherapyGermany68
7288ApheresisAllogeneicAcute Myeloid Leukemia (High Risk)Hematology2012Standard TherapyGermany57
7289ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2012Standard TherapyGermany47
7290ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2012Standard TherapyGermany43
7291ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2012Standard TherapyGermany70
7292ApheresisAutologousCentral Nervous System Non-Hodgkin LymphomaHematology2012Standard TherapyGermany54
7293ApheresisAutologousCerebral Diffuse Large B-Cell Lymphoma-RelapseHematology2012Standard TherapyGermany55
7294ApheresisAutologousDiffuse Large B-Cell Non-Hodgkin-LymphomaHematology2012Standard TherapyGermany54
7295ApheresisAutologousExtragonadal Germ Cell TumorHematology2012Standard TherapyGermany59
7296ApheresisAutologousFollicular LymphomaHematology2012Standard TherapyGermany54
7297ApheresisAutologousFollicular LymphomaHematology2012Standard TherapyGermany57
7298ApheresisAutologousFollicular Lymphoma-RelapseHematology2012Standard TherapyGermany59
7299ApheresisAutologousLymphoblastic B-Cell Non-Hodgkin-LymphomaHematology2012Standard TherapyGermany52
7300ApheresisAutologousMantle Cell LymphomaHematology2012Standard TherapyGermany61
7301ApheresisAutologousMantle Cell LymphomaHematology2012Standard TherapyGermany52
7302ApheresisAutologousMantle Cell LymphomaHematology2012Standard TherapyGermany57
7303ApheresisAutologousMantle Cell LymphomaHematology2012Standard TherapyGermany55
7304ApheresisAutologousMedulloblastomaHematology2012Standard TherapyGermany42
7305ApheresisAutologousMorbus Hodgkin-RelapseHematology2012Standard TherapyGermany27
7306ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany51
7307ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany60
7308ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany52
7309ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany71
7310ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany61
7311ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany53
7312ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany55
7313ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany70
7314ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany46
7315ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany64
7316ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany56
7317ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany68
7318ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany48
7319ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany59
7320ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany62
7321ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany72
7322ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany50
7323ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany60
7324ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany65
7325ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany67
7326ApheresisAllogeneicMyelodysplastic SyndromeHematology2012Standard TherapyGermany49
7327ApheresisAllogeneicMyelodysplastic SyndromeHematology2012Standard TherapyGermany69
7328ApheresisAutologousNon-Hodgkin LymphomaHematology2012Standard TherapyGermany62
7329ApheresisAutologousNon-Hodgkin LymphomaHematology2012Standard TherapyGermany57
7330ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2012Standard TherapyGermany62
7331ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2012Standard TherapyGermany57
7332ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2012Standard TherapyGermany44
7333ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2012Standard TherapyGermany43
7334ApheresisAllogeneicOsteomyelofibrosisHematology2012Standard TherapyGermany61
7335ApheresisAutologousPlasmablastic LymphomaHematology2012Standard TherapyGermany54
7336ApheresisAutologousPlasmacytomaHematology2012Standard TherapyGermany69
7337ApheresisAutologousTesticular Cancer RelapseHematology2012Standard TherapyGermany36
7338Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2011Experimental TherapyPoland17,2
7339Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2011Standard TherapyPoland5
7340Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2011Standard TherapyUK8
7341Cord BloodAllogeneic - RelatedAcute Myeloid LeukemiaHematology2011Standard TherapyHungary2
7342Cord BloodAutologousBrain DamageNeurology2011Experimental TherapyGermany3
7343Cord BloodAutologousBrain DamageNeurology2011Experimental TherapyGermany7
7344Cord BloodAutologousCerebral PalsyNeurology2011Experimental TherapyPortugal6
7345Cord BloodAllogeneic - RelatedChronic Granulomatous DiseaseHematology2011Standard TherapyPoland7,5
7346Cord BloodAllogeneic - RelatedFanconi AnemiaHematology2011Standard TherapyPoland12
7347Cord BloodAllogeneic - RelatedHistiocytosisHematology2011Standard TherapyPoland2,5
7348Cord BloodAllogeneicScid (Severe Combined Immunodeficiency)Hematology2011Standard TherapyGermany1
7349Cord BloodAllogeneic - RelatedThalassemia MajorHematology2011Standard TherapyTurkey15
7350Cord BloodAllogeneic - RelatedThalassemia MajorHematology2011Standard TherapyTurkey15
7351Cord BloodAutologousTyp-1-DiabetesEndocrinology2011Experimental TherapyGermany2
7352Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany65
7353Bone Marrow FamilyAllogeneicMultiple MyelomaHematology2011Standard TherapyGermany50
7354Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany64
7355Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany45
7356Bone MarrowAutologousCoronary Artery DiseaseHematology2011Standard TherapyGermany68
7357Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany70
7358Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany55
7359Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany64
7360Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany71
7361Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany62
7362Bone MarrowAutologousIschemic MyopathyHematology2011Standard TherapyGermany62
7363Bone MarrowAutologousIschemic MyopathyHematology2011Standard TherapyGermany69
7364Bone MarrowAutologousIschemic MyopathyHematology2011Standard TherapyGermany40
7365Bone MarrowAutologousPeripheral Artery DiseaseHematology2011Standard TherapyGermany74
7366Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2011Standard TherapyGermany31
7367ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2011Standard TherapyGermany41
7368ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2011Standard TherapyGermany42
7369ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2011Standard TherapyGermany31
7370ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany64
7371ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany42
7372ApheresisAutologousAcute Myeloid LeukemiaHematology2011Standard TherapyGermany73
7373ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany54
7374ApheresisAutologousAcute Myeloid LeukemiaHematology2011Standard TherapyGermany70
7375ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany65
7376ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany69
7377ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany25
7378ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany48
7379ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany59
7380ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2011Standard TherapyGermany53
7381ApheresisAutologousAnaplastic Lymphoma Kinase Positive Anaplastic Large-Cell LymphomaHematology2011Standard TherapyGermany60
7382ApheresisAutologousAngioimmunoblastic T-Cell LymphomaHematology2011Standard TherapyGermany63
7383ApheresisAllogeneicAplastic AnemiaHematology2011Standard TherapyGermany62
7384ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany41
7385ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany61
7386ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany51
7387ApheresisAutologousCentral Nervous System Non-Hodgkin LymphomaHematology2011Standard TherapyGermany41
7388ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2011Standard TherapyGermany62
7389ApheresisAutologousFollicular Lymphoma-RelapseHematology2011Standard TherapyGermany68
7390ApheresisAutologousGerm Cell TumorHematology2011Standard TherapyGermany28
7391ApheresisAutologousLymphoblastic LymphomaHematology2011Standard TherapyGermany49
7392ApheresisAutologousMantle Cell LymphomaHematology2011Standard TherapyGermany62
7393ApheresisAutologousMantle Cell LymphomaHematology2011Standard TherapyGermany51
7394ApheresisAutologousMantle Cell LymphomaHematology2011Standard TherapyGermany67
7395ApheresisAutologousMorbus HodgkinHematology2011Standard TherapyGermany70
7396ApheresisAutologousMorbus HodgkinHematology2011Standard TherapyGermany24
7397ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany58
7398ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany70
7399ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany59
7400ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany44
7401ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany52
7402ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany70
7403ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany55
7404ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany69
7405ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany58
7406ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany58
7407ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany60
7408ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany56
7409ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany66
7410ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany57
7411ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany47
7412ApheresisAllogeneicMultiple MyelomaHematology2011Standard TherapyGermany66
7413ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany60
7414ApheresisAllogeneicMultiple MyelomaHematology2011Standard TherapyGermany61
7415ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany69
7416ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany54
7417ApheresisAllogeneicMyelodysplastic SyndromeHematology2011Standard TherapyGermany68
7418ApheresisAllogeneicMyelofibrosisHematology2011Standard TherapyGermany40
7419ApheresisAutologousNon-Hodgkin LymphomaHematology2011Standard TherapyGermany47
7420ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2011Standard TherapyGermany61
7421ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2011Standard TherapyGermany43
7422ApheresisAutologousPlasmacytomaHematology2011Standard TherapyGermany68
7423ApheresisAutologousPlasmacytomaHematology2011Standard TherapyGermany51
7424ApheresisAutologousPrimary Central Nervous System LymphomaHematology2011Standard TherapyGermany43
7425ApheresisAllogeneicPrimary MyelofibrosisHematology2011Standard TherapyGermany36
7426ApheresisAllogeneicRefractory Acute Myeloid LeukemiaHematology2011Standard TherapyGermany27
7427ApheresisAutologousRichter's TransformationHematology2011Standard TherapyGermany71
7428ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany50
7429ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany48
7430ApheresisAllogeneicT-Cell Non-Hodgkin Lymphoma RelapseHematology2011Standard TherapyGermany56
7431ApheresisAutologousTesticular Cancer RelapseHematology2011Standard TherapyGermany43
7432Cord BloodAutologousBrain DamageNeurology2010Experimental TherapyGermany5
7433Cord BloodAutologousBrain DamageNeurology2010Experimental TherapyGermany4
7434Cord BloodAutologousCerebral PalsyNeurology2010Experimental TherapyPortugal1
7435Cord BloodAutologousCerebral PalsyNeurology2010Experimental TherapyPortugal1
7436Cord BloodAutologousCerebral PalsyNeurology2010Experimental TherapyPortugal6
7437Cord BloodAutologousCerebral PalsyNeurology2010Experimental TherapyUK3
7438Cord BloodAllogeneic - RelatedPre-B Acute Lymphoblastic Leukemia Hematology2010Standard TherapyHungary1,5
7439Cord BloodAutologousTyp-1-DiabetesEndocrinology2010Experimental TherapyGermany3
7440Cord BloodAutologousTyp-1-DiabetesEndocrinology2010Experimental TherapyGermany2
7441Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany57
7442Bone MarrowAutologousChronic Ischemic CardiomyopathyHematology2010Standard TherapyGermany71
7443Bone MarrowAutologousCoronary Artery DiseaseHematology2010Standard TherapyGermany75
7444Bone MarrowAutologousCoronary Artery Disease; CardiomyopathyHematology2010Standard TherapyGermany52
7445Bone MarrowAutologousDilated CardiomyopathyHematology2010Standard TherapyGermany67
7446Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany70
7447Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany49
7448Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany48
7449Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany50
7450Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany54
7451Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany73
7452Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany47
7453Bone MarrowAutologousMyocardial InfarctionHematology2010Standard TherapyGermany51
7454Bone MarrowAutologousMyocardial InfarctionHematology2010Standard TherapyGermany54
7455Bone MarrowAutologousMyocardial InfarctionHematology2010Standard TherapyGermany51
7456Bone MarrowAutologousPeripheral Artery DiseaseHematology2010Standard TherapyGermany56
7457Bone MarrowAutologousPeripheral Artery Disease With UlcerHematology2010Standard TherapyGermany79
7458ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2010Standard TherapyGermany26
7459ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2010Standard TherapyGermany64
7460ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany47
7461ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany44
7462ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany48
7463ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany59
7464ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany50
7465ApheresisAllogeneicAcute Myeloid Leukemia; Myelodysplastic SyndromeHematology2010Standard TherapyGermany66
7466ApheresisAllogeneicAtypical Myelodysplastic SyndromeHematology2010Standard TherapyGermany25
7467ApheresisAllogeneicB-Cell Chronic Lymphoblastic LeukemiaHematology2010Standard TherapyGermany56
7468ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2010Standard TherapyGermany54
7469ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2010Standard TherapyGermany52
7470ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2010Standard TherapyGermany45
7471ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2010Standard TherapyGermany57
7472ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2010Standard TherapyGermany43
7473ApheresisAutologousDiffuse Large B-Cell Non-Hodgkin-LymphomaHematology2010Standard TherapyGermany57
7474ApheresisAutologousExtramedullary PlasmacytomaHematology2010Standard TherapyGermany48
7475ApheresisAllogeneicMantle Cell LymphomaHematology2010Standard TherapyGermany61
7476ApheresisAutologousMantle Cell LymphomaHematology2010Standard TherapyGermany72
7477ApheresisAllogeneicMantle Cell LymphomaHematology2010Standard TherapyGermany53
7478ApheresisAutologousMorbus HodgkinHematology2010Standard TherapyGermany29
7479ApheresisAutologousMorbus Hodgkin-RelapseHematology2010Standard TherapyGermany21
7480ApheresisAutologousMorbus Hodgkin-RelapseHematology2010Standard TherapyGermany23
7481ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany43
7482ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany57
7483ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany62
7484ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany45
7485ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany47
7486ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany52
7487ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany52
7488ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany67
7489ApheresisAllogeneicMultiple MyelomaHematology2010Standard TherapyGermany55
7490ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany57
7491ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany51
7492ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany53
7493ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany69
7494ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany58
7495ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany70
7496ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany64
7497ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany69
7498ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany68
7499ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany63
7500ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany61
7501ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany56
7502ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany68
7503ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany52
7504ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany60
7505ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany64
7506ApheresisAllogeneicMyelodysplastic SyndromeHematology2010Standard TherapyGermany70
7507ApheresisAllogeneicMyelodysplastic SyndromeHematology2010Standard TherapyGermany57
7508ApheresisAllogeneicMyelodysplastic SyndromeHematology2010Standard TherapyGermany60
7509ApheresisAllogeneicMyelodysplastic SyndromeHematology2010Standard TherapyGermany33
7510ApheresisAllogeneicMyelodysplastic Syndrome; Acute Myelogenous LeukemiaHematology2010Standard TherapyGermany54
7511ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2010Standard TherapyGermany48
7512ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2010Standard TherapyGermany44
7513ApheresisAutologousPrimary Central Nervous System LymphomaHematology2010Standard TherapyGermany66
7514ApheresisAllogeneicPrimary MyelofibrosisHematology2010Standard TherapyGermany60
7515ApheresisAllogeneicPrimary MyelofibrosisHematology2010Standard TherapyGermany59
7516ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2010Standard TherapyGermany48
7517ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2010Standard TherapyGermany61
7518ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2010Standard TherapyGermany41
7519ApheresisAllogeneicT-Cell Non-Hodgkin Lymphoma RelapseHematology2010Standard TherapyGermany43
7520ApheresisAutologousT-Cell-LymphomaHematology2010Standard TherapyGermany49
7521ApheresisAutologousTesticular CarcinomaHematology2010Standard TherapyGermany39
7522Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2009Standard TherapyGermany10
7523Cord BloodAllogeneic - RelatedBeta ThalassemiaHematology2009Standard TherapyGermany10
7524Cord BloodAutologousBrain DamageNeurology2009Experimental TherapyGermany2
7525Cord BloodAutologousBrain DamageNeurology2009Experimental TherapyGermany4 months
7526Cord BloodAutologousCerebral PalsyNeurology2009Experimental TherapyPortugal2
7527Cord BloodAutologousCerebral PalsyNeurology2009Experimental TherapyPortugal2
7528Cord BloodAutologousCerebral PalsyNeurology2009Experimental TherapyUK3
7529Cord BloodAllogeneic - RelatedMyelodysplastic SyndromeHematology2009Standard TherapyPoland5
7530Cord BloodAllogeneic - RelatedThalassemia MajorHematology2009Standard TherapyTurkey12
7531Cord BloodAutologousTyp-1-DiabetesEndocrinology2009Experimental TherapyGermany3
7532Cord BloodAutologousTyp-1-DiabetesEndocrinology2009Experimental TherapyGermany3
7533Cord BloodAutologousTyp-1-DiabetesEndocrinology2009Experimental TherapyGermany3
7534Bone MarrowAutologousCardiomyopathyHematology2009Standard TherapyGermany67
7535Bone MarrowAutologousCardiomyopathyHematology2009Standard TherapyGermany50
7536Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany49
7537Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany64
7538Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany55
7539Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany56
7540Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany46
7541Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany46
7542Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany63
7543Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany57
7544Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany47
7545Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany57
7546Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany61
7547Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany44
7548Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany32
7549Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany57
7550Bone MarrowAutologousNon St-Elevated Myocardial InfarctionHematology2009Standard TherapyGermany56
7551ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2009Standard TherapyGermany24
7552ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2009Standard TherapyGermany43
7553ApheresisAutologousAcute Lymphoblastic Leukemia; Lymphoma - RelapseHematology2009Standard TherapyGermany47
7554ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany42
7555ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany49
7556ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany56
7557ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany57
7558ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany56
7559ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany61
7560ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany57
7561ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2009Standard TherapyGermany60
7562ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2009Standard TherapyGermany43
7563ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2009Standard TherapyGermany61
7564ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2009Standard TherapyGermany47
7565ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2009Standard TherapyGermany49
7566ApheresisAutologousHodgkin RelapseHematology2009Standard TherapyGermany46
7567ApheresisAutologousMantle Cell LymphomaHematology2009Standard TherapyGermany69
7568ApheresisAutologousMantle Cell Non-Hodgkin-LymphomaHematology2009Standard TherapyGermany56
7569ApheresisAutologousMucosa Associated Lymphoid Tissue/ Diffuse Large Cell LymphomaHematology2009Standard TherapyGermany55
7570ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany68
7571ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany55
7572ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany51
7573ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany58
7574ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany63
7575ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany63
7576ApheresisAllogeneicMultiple Myeloma; Myelodysplastic SyndromeHematology2009Standard TherapyGermany44
7577ApheresisAutologousNon-Hodgkin LymphomaHematology2009Standard TherapyGermany70
7578ApheresisAutologousNon-Hodgkin LymphomaHematology2009Standard TherapyGermany57
7579ApheresisAutologousNon-Hodgkin LymphomaHematology2009Standard TherapyGermany67
7580ApheresisAutologousNon-Hodgkin LymphomaHematology2009Standard TherapyGermany68
7581ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2009Standard TherapyGermany46
7582ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2009Standard TherapyGermany74
7583ApheresisAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2009Standard TherapyGermany39
7584ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany63
7585ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany50
7586ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany60
7587ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany49
7588ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany68
7589ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany57
7590ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany53
7591ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany64
7592ApheresisAllogeneicSevere Aplastic AnemiaHematology2009Standard TherapyGermany55
7593ApheresisAllogeneicSevere Aplastic Anemia And Paroxysmal Nocturnal HemoglobinuriaHematology2009Standard TherapyGermany47
7594Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2008Standard TherapyPoland5
7595Cord BloodAutologousBrain DamageNeurology2008Experimental TherapyGermany1
7596Cord BloodAutologousCerebral IschemiaNeurology2008Experimental TherapyPoland1,5
7597Cord BloodAllogeneic - RelatedThalassemia MajorHematology2008Standard TherapyTurkey7
7598Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2008Standard TherapyGermany17
7599Bone Marrow FamilyAllogeneicChronic Myelogenous LeukemiaHematology2008Standard TherapyGermany53
7600Bone MarrowAutologousCardiomyopathyHematology2008Standard TherapyGermany46
7601Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany60
7602Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany44
7603Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany67
7604Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany58
7605Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany56
7606Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany72
7607Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany69
7608Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany53
7609Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany70
7610Bone MarrowAutologousPeripheral Artery DiseaseHematology2008Standard TherapyGermany76
7611ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany56
7612ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany58
7613ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany70
7614ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany56
7615ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany65
7616ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany38
7617ApheresisAllogeneicB-Cell Non-Hodgkin Lymphoma - RelapseHematology2008Standard TherapyGermany49
7618ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2008Standard TherapyGermany51
7619ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2008Standard TherapyGermany49
7620ApheresisAutologousDiffuse Large B-Cell Non-Hodgkin-LymphomaHematology2008Standard TherapyGermany44
7621ApheresisAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany73
7622ApheresisAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany46
7623ApheresisAutologousMantle Cell LymphomaHematology2008Standard TherapyGermany64
7624ApheresisAutologousMorbus HodgkinHematology2008Standard TherapyGermany25
7625ApheresisAllogeneicMultiple MyelomaHematology2008Standard TherapyGermany52
7626ApheresisAllogeneicMultiple MyelomaHematology2008Standard TherapyGermany45
7627ApheresisAutologousMultiple MyelomaHematology2008Standard TherapyGermany61
7628ApheresisAutologousMultiple MyelomaHematology2008Standard TherapyGermany58
7629ApheresisAutologousMultiple MyelomaHematology2008Standard TherapyGermany67
7630ApheresisAutologousMultiple MyelomaHematology2008Standard TherapyGermany57
7631ApheresisAllogeneicMyelodysplastic SyndromeHematology2008Standard TherapyGermany58
7632ApheresisAutologousMyosarcomaHematology2008Standard TherapyGermany56
7633ApheresisAutologousNon-Hodgkin LymphomaHematology2008Standard TherapyGermany55
7634ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2008Standard TherapyGermany65
7635ApheresisAllogeneicOsteomyelofibrosisHematology2008Standard TherapyGermany62
7636ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany68
7637ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany52
7638ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany53
7639ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany67
7640ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany69
7641ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany56
7642ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany59
7643ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany52
7644ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany60
7645ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany67
7646ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany68
7647ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany57
7648ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany62
7649ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany63
7650ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany66
7651ApheresisAllogeneicRefractory Acute Myeloid LeukemiaHematology2008Standard TherapyGermany71
7652ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2008Standard TherapyGermany53
7653ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2008Standard TherapyGermany55
7654ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2008Standard TherapyGermany65
7655ApheresisAllogeneicSevere Aplastic AnemiaHematology2008Standard TherapyGermany29
7656ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2008Standard TherapyGermany38
7657ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2008Standard TherapyGermany28
7658ApheresisAutologousT-Cell Non-Hodgkin Lymphoma RelapseHematology2008Standard TherapyGermany21
7659Cord BloodAllogeneic - RelatedNeuroblastomaHematology2007Standard TherapyPoland8
7660Cord BloodAllogeneic - RelatedScid (Severe Combined Immunodeficiency)Hematology2007Standard TherapyPortugal1
7661Cord BloodAllogeneic - RelatedThalassemiaHematology2007Standard TherapyUK7
7662Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2007Standard TherapyGermany68
7663Bone MarrowAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2007Standard TherapyGermany38
7664ApheresisAllogeneicAplastic AnemiaHematology2007Standard TherapyGermany49
7665ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2007Standard TherapyGermany57
7666ApheresisAutologousMyocardial InfarctionHematology2007Standard TherapyGermany61
7667ApheresisAutologousNon-Hodgkin LymphomaHematology2007Standard TherapyGermany57
7668Cord BloodAllogeneic - RelatedAplastic AnemiaHematology2005Standard TherapyGermany5
7669Cord BloodAutologousBrain DamageNeurology2005Experimental TherapyGermany1
7670Cord BloodAllogeneic - RelatedLeukemiaHematology2005Standard TherapyUKno data
7671Cord BloodAllogeneic - RelatedThalassemiaHematology2005Standard TherapyUK4
7672Cord BloodAutologousAcute Lymphoblastic LeukemiaHematology2004Standard TherapyGermany3